Search criteria | ||||
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study | ||||
Avraham Karasik (1), Stefanie Lanzinger (2,3), Elise Chia-Hui Tan (4), Daisuke Yabe (5,6,7 8), Dae Jung Kim (9), Wayne H-H Sheu (10), Cheli Melzer-Cohen (1), Reinhard W. Holl (2), Kyoung-Hwa Ha (9), Kamlesh Khunti (11), Francesco Zaccardi (11), Anuradhaa Subramanian (12), Krishnarajah Nirantharakumar (12,13,14), Thomas Nyström (15), Leo Niskanen (16), Majken Linnemann Jensen (17), Fabian Hoti (18), Riho Klement (19), Anouk Déruaz-Luyet (20), Moe H.Kyaw (21), Lisette Koeneman (22), Dorte Vistisen (23, 24) Bendix Carstensen (23), Sigrun Halvorsen (25), Gisle Langslet (26), Soulmaz Fazeli Farsani (20), Elisabetta Patorno (27), Júlio Núñez (28), EMPRISE Europe and Asia Study Group | ||||
"1 Maccabi Institute for Research and Innovation Center, Tel Aviv University, Tel Aviv, Israel 2 Institute for Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany 3 German Centre for Diabetes Research (DZD), München-Neuherberg, Germany 4 Department of Health Service Administration, China Medical University, Taichung, Taiwan 5 Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Kyoto, Japan 6 Department of Diabetes, Metabolism and Endocrinology/Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan 7 Center for Healthcare Information Technology, Tokai National Higher Education and Research System, Nagoya, Japan 8 Preemptive Food Research Center, Gifu University Institute for Advanced Study, Gifu, Japan 9 Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea 10 Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan 11 Leicester Real World Evidence Unit, Leicester Diabetes Centre, University of Leicester, Leicester, UK 12 Institute of Applied Health Research, University of Birmingham, Birmingham, UK 13 Midlands Health Data Research UK, Birmingham, UK 14 DEMAND Hub, University of Birmingham, Birmingham, UK 15 Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Sweden 16 Päijät-Häme Joint Authority for Health and Wellbeing, Päijät-Häme Central Hospital, Lahti Finland and University of Eastern Finland, Kuopio, Finland 17 IQVIA Solutions Denmark A/S, Copenhagen, Denmark 18 IQVIA, Espoo, Finland 19 IQVIA, Tartu, Estonia 20 Boehringer Ingelheim International GmbH, Ingelheim, Germany 21 Boehringer Ingelheim International GmbH, US 22 Lilly Deutschland GmbH, Bad Homburg, Germany 23 Steno Diabetes Center Copenhagen, Herlev, Denmark 24 Department of Public Health, University of Copenhagen, Copenhagen, Denmark 25 Department of Cardiology, Oslo University Hospital Ullevål, and University of Oslo, Oslo, Norway 26 Lipid Clinic, Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway 27 Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA 28 Department of Cardiology, Hospital Clínico Universitario de Valencia, INCLIVA, Universidad de Valencia, CIBER Cardiovascular, Valencia, Spain" | ||||
"Diabetes & Metabolism. 2023 Jan; 101418; ISSN 1262-3636 Virtual Conference: American Diabetes Association, 25-29 June 2021 and EASD 27 September -01 October" |
||||
, Article | ||||
, Denmark, Finland, Germany, Norway, Spain, Sweden, UK | ||||
Abstract: https://doi.org/10.1016/j.diabet.2022.101418 (https://www.sciencedirect.com/science/article/pii/S1262363622000994) | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Diabetes, Drug safety, Drug Utlization Study | 2023 | English | , Clinical setting: hospital, Clinical setting: Primary care | |
Hypercholesterolaemia control in Spain: The same situation with different regional realities | ||||
Juan Pedro-Botet, Núria Plana, José María Mostaza, Juan José Gómez-Doblas, María Rosa Fernández Olmo, Carlos Escobar Cervantes, José Luis Díaz-Díaz, Raquel Campuzano Ruiz, Pedro Valdivielso, Juan Cosín-Sales | ||||
Unidad de Lípidos y Riesgo Vascular, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, España | ||||
Clinica e investigacion en arteriosclerosis: publicacion oficial de la Sociedad Espanola de Arteriosclerosis, S0214-9168(23)00027-X. 27 Apr. 2023, doi:10.1016/j.arteri.2023.04.001 |
||||
, Abstract | ||||
, Spain | ||||
Abstract: https://doi.org/10.1016/j.arteri.2023.04.001 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2023 | Spanish | , Clinical setting: Primary care, Public Health, Quality of life, Survey research | |
Estudio ATLAS URTICARIA: Impacto de la enfermedad en adultos con urticaria crónica en España | ||||
Beatriz Veleiro Pérez1, Francisco Javier Muñoz Bellido2, Isabel Sánchez Matas3, Anna Sala-Cunill4, Ignacio Jauregui Presa5, Paula Ribó González6 | ||||
1Sección de Alergia, Complexo Hospitalario Universitario A Coruña, A Coruña; 2Servicio de Alergología, Complejo Asistencial Universitario de Salamanca. Instituto de Investigación Biomédica de Salamanca (IBSAL). Departamento de Ciencias Biomédicas y del Diagnóstico, Facultad de Medicina, Universidad de Salamanca, Salamanca; 3Servicio de Alergología, Hospital Universitario de Toledo, Toledo; 4Sección Alergia, Departamento de Medicina Interna, Hospital Universitario Vall d' Hebron, Barcelona; 5Servicio de Alergia, Hospital Universitario Cruces. Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo, Bizkaia; 6Servicio de alergología, Hospital Clínic Barcelona. Institut d’Investigacions Biomèdiques August Pi i Sunyer (IRCE), Barcelona. | ||||
XXXIV Congreso Nacional de la Sociedad Española de Alergología e Inmunología Clínica (SEAIC), Santiago de Compostela, Spain, 25-28 October 2023 |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2023 | Spanish | , Quality of life | |
Prevalence of subjective memory complaints: Population study in Spain | ||||
Javier González García a∗, Eva García Aguilar a, Tatiana Vilchez Quinoa, Marta Blanco b and Carmen Barrull b | ||||
a Departamento Médico, ITF Research Pharma, SLU, Alcobendas, Madrid, España b IQVIA España, Barcelona, España | ||||
Revista Española de Geriatría y Gerontología |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S0211139X23001476?via%3Dihub | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Neurological disorders | 2023 | Spanish | ||
Addressing influenza's underestimated burden - Iberian experts call to action | ||||
Ángel Gil-de-Miguel 1 2, Javier Díez-Domingo 3, Federico Martinón-Torres 4 5 6, Esther Redondo Margüello 7, Raúl Ortiz de Lejarazu Leonardo 8, Tomàs Pumarola 9, Jaime Correia de Sousa 10, Carlos Rabaçal 11, João Raposo 12, Carlos Robalo Cordeiro 13, Filipe Froes 14 | ||||
1Public Health and Medical Specialties Department, Health Sciences Faculty, Rey Juan Carlos University, Madrid, Spain. angel.gil@urjc.es. 2Universidad Rey Juan Carlos, Avda. de Atenas, s/n, 28922, Alcorcón, Madrid, Spain. angel.gil@urjc.es. 3Vaccine Research Department, University of Valencia, Valencia, Spain. 4Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario and Universidad de Santiago de Compostela, Galicia, Spain. 5Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago and Universidad de Santiago de Compostela (USC), Galicia, Spain. 6CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain. 7International Health Center Madrid Health, City Council of Madrid, Madrid, Spain. 8National Influenza Centre, Hospital Clínico Universitario, Universidad de Valladolid, Valladolid, Spain. 9Department of Microbiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain. 10Life and Health Sciences Research Institute (ICVS), School of Medicine, PT Government Associate Laboratory, University of Minho, Braga Portugal. ICVS/3B's, Braga/Guimarães, Portugal. 11Vila Franca de Xira Hospital, Lisbon, Portugal. 12APDP and Nova Medical School, Lisbon, Portugal. 13Pulmonology Department, Coimbra University Hospital, University of Coimbra, Coimbra, Portugal. 14Thorax Department, ICU, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal. | ||||
, Article | ||||
, Portugal, Spain | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/37158822/ | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Respiratory disease | 2023 | English | , Burden of illness | |
The Path Towards Effective Respiratory Syncytial Virus Immunization Policies: Recommended Actions | ||||
Federico Martinón-Torres 1, José Antonio Navarro-Alonso 2, Maria Garcés-Sánchez 3, Antoni Soriano-Arandes 4 | ||||
1Translational Paediatrics and Infectious Diseases, Hospital Clínico Universitario and Universidad de Santiago de Compostela, Galicia, Spain; Genetics, Vaccines and Paediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago and Universidad de Santiago de Compostela (USC), Galicia, Spain; CIBER Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: Federico.Martinon.Torres@sergas.es. 2Asociación Española de Vacunología, Madrid, Spain. 3Paediatrics Service, Nazaret Health Centre, Valencia, Spain. 4Paediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Barcelona, Catalunya, Spain. | ||||
, Article | ||||
, Spain | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S0300289623001874?via%3Dihub | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Respiratory disease | 2023 | English | , Burden of illness | |
Clinical and economic hospital burden of acute respiratory infection (BARI) due to respiratory syncytial virus in Spanish children, 2015-2018 | ||||
F Martinón-Torres 1 2 3, M Carmo 4, L Platero 5, G Drago 5, J L López-Belmonte 5, M Bangert 6, J Díez-Domingo 7 | ||||
1Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago and Universidad de Santiago de Compostela (USC), Galicia, Spain. federico.martinon.torres@sergas.es. 2Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain. federico.martinon.torres@sergas.es. 3Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario and Universidad de Santiago de Compostela (USC), Rúa da Choupana, S/N, Santiago de Compostela, 15706, Galicia, A Coruña, Spain. federico.martinon.torres@sergas.es. 4IQVIA, Barcelona, Spain. 5Sanofi, Madrid, Spain. 6Sanofi, Lyon, France. 7Vaccine Research Department, FISABIO, Valencia, Spain. | ||||
BMC Infect Dis. 2023 Jun 8;23(1):385. doi: 10.1186/s12879-023-08358-x |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249572/ | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Respiratory disease | 2023 | English | , Burden of illness | |
Excess hospitalizations and mortality associated with seasonal influenza in Spain, 2008–2018 | ||||
T Pumarola 1 2, J Díez-Domingo 3, F Martinón-Torres 4 5 6, E Redondo Margüello 7, R Ortiz de Lejarazu Leonardo 8, M Carmo 9, G Bizouard 10, G Drago 11, J L López-Belmonte 11, H Bricout 12, C de Courville 12, A Gil-de-Miguel 13 | ||||
1Department of Microbiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain. tpsvhebron@gmail.com. 2Universitat Autònoma de Barcelona, Plaça Cívica, 08193, Bellaterra, Barcelona, Spain. tpsvhebron@gmail.com. 3Vaccine Research Department, University of Valencia, Valencia, Spain. 4Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario and Universidad de Santiago de Compostela, Galicia, Spain. 5Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago and Universidad de Santiago de Compostela (USC), Galicia, Spain. 6Consorcio Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain. 7International Health Center Madrid Health, City Council of Madrid, Madrid, Spain. 8Valladolid National Influenza Centre, Hospital Clínico Universitario de Valladolid, Valladolid, Spain. 9IQVIA, Barcelona, Spain. 10IQVIA, Paris, France. 11Sanofi, Barcelona, Spain. 12Sanofi, Lyon, France. 13Public Health and Medical Specialties Department, Health Sciences Faculty, Juan Carlos University, Madrid, Spain. | ||||
BMC Infect Dis. 2023 Feb 7;23(1):86. doi: 10.1186/s12879-023-08015-3 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904529/ | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Respiratory disease | 2023 | English | , Burden of illness | |
Burden of Hospitalizations and Outpatient Visits Associated With Moderate and Severe Acute Graft-Versus-Host Disease in Finland and Sweden: A Real-World Data Analysis | ||||
Lorenzo Sabatelli, PhD,1 Mikko Keränen, MD, PhD,2 Elisabet Viayna, PhD,3 Montserrat Roset, BSc Stats,3 Nuria Lara, MD, MSc,3 Daniel Thunström, MSc Pharm,1 Minja Pfeiffer, PhD,1 Malin Nicklasson, MSc Pharm,4 Maija Itälä-Remes, MD, PhD5 | ||||
"1Incyte Biosciences International Sàrl, Morges, Switzerland; 2Helsinki University Hospital, Helsinki, Finland; 3IQVIA Real World Solutions, Barcelona, Spain; 4Department of Hematology and Coagulation, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 5Turku University Hospital, Turku, Finland " | ||||
Supportive Care in Cancer |
||||
, Article | ||||
, Finland, Spain, Sweden, Switzerland | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Transplant | 2022 | English | , Clinical setting: hospital, Observational study, Population Based Study | |
Nutritional status and use of health resources after the implementation of an enteral nutrition program by PEG probe for neurological patients with home hospitalization | ||||
Blanco Ramos B, Lopez Garcia B, Gómez Bellvert N. | ||||
Hospital General Universitario de Elda (Alicante). Carretera Elda-Sax SN. 03600 | ||||
Nutr Hosp . 2022 Jun 24;39(3):489-498. doi: 10.20960/nh.03813. |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.nutricionhospitalaria.org/articles/03813/show | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders, Nutritional Disorders | 2022 | Spanish | , Clinical setting: hospital, Cost benefit, Observational study, Population Based Study, Quality of life | |
Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 | ||||
Janet Sultana 1 2, Salvatore Crisafulli 3, Mariana Almas 4, Ippazio Cosimo Antonazzo 5 6, Esme Baan 7, Claudia Bartolini 6, Maria Paola Bertuccio 3, Fedele Bonifazi 8 9, Annalisa Capuano 10 11, Antonella Didio 8 9, Vera Ehrenstein 12, Mariagrazia Felisi 8 13, Carmen Ferrajolo 10 11, Andrea Fontana 14, Remy Francisca 7, Annie Fourrier-Reglat 15, Joan Fortuny 16, Rosa Gini 6, Giulia Hyeraci 6, Christel Hoeve 7, Christos Kontogiorgis 17, Valentina Isgrò 18, Panagiotis-Nikolaos Lalagkas 17, Luca L'Abbate 18, Deborah Layton 19, Annalisa Landi 8 9, Silvia Narduzzi 19, Leonardo Roque Pereira 20, Georgios Poulentzas 17, Concetta Rafaniello 10 11, Giuseppe Roberto 6, Giulia Scondotto 3, Liberata Sportiello 10 11, Maddalena Toma 8 9, Massoud Toussi 19, Katia Verhamme 7, Elisabetta Volpe 8 9, Gianluca Trifirò 18, | ||||
Pharmacy Department, Mater Dei Hospital, Msida, Malta. 2Exeter College of Medicine and Health, Exeter, UK. 3Department of Medicine, University of Verona, Verona, Italy. 4Real World Solutions Department, IQVIA, Lisbon, Portugal. 5Research Centre on Public Health (CESP), University of Milan-Bicocca, Milan, Italy. 6Agenzia Regionale di Sanità della Toscana, Florence, Italy. 7Department of Medical Informatics, Erasmus Medical Centre, Rotterdam, The Netherlands. 8TEDDY European Network of Excellence for Paediatric Clinical Research, Pavia, Italy. 9Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Bari, Italy. 10Department of Experimental Medicine, University of Campania "Vanvitelli", Naples, Italy. 11Campania Regional Center of Pharmacovigilance and Pharmacoepidemiology, Naples, Italy. 12Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark. 13CVBF Consorzio per Valutazioni Biologiche e Farmacologiche, Pavia, Italy. 14Unit of Biostatistics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy. 15Univ. Bordeaux, INSERM, Bordeaux Population Health Research Center, Team of Pharmacoepidemiology, UMR 1219, Bordeaux, France. 16RTI Health Solutions, Barcelona, Spain. 17Democritus University of Thrace, Alexandroupolis, Greece. 18Department of Diagnostics and Public Health, University of Verona, Verona, Italy. 19Data Science Hub, Real World Solutions, IQVIA, London, UK. 20Department of Datascience & Biostatistics, University Medical Center Utrecht, Utrecht, The Netherlands. | ||||
Pharmacoepidemiol Drug Saf . 2022 Jun;31(6):689-705. doi: 10.1002/pds.5413. Epub 2022 Feb 11. |
||||
, Article | ||||
, Denmark, France, Italy, Netherlands, Portugal, Spain, UK | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/35092329/ | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Drug Utlization Study | 2022 | English | , Database Study, Review | |
Potential Healthcare Resource Use And Associated Costs Of Every 2 months Injectable Cabotegravir+Rilpivirine Long-acting Implementation In The Spanish NHS Vs. Daily Oral HIV Treatments | ||||
Laura-Amanda Vallejo Aparicio (1), Victoria Neches García (1), Beatriz Hernández (2), Gregorio Casado (3), Ferrán Jodar (3), Marco Pinel (3), Daniel Callejo Velasco (3) | ||||
(1) GSK, Tres Cantos (Madrid), España; (2) ViiV Healthcare, Tres Cantos (Madrid), España; (3)IQIVA, España | ||||
ISPOR Europe 2022; November 6-9, 2022; Virtual and Vienna, Austria |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.ispor.org/docs/default-source/euro2022/ee379cabotegravirrilpivirinelahruassociatedcosts-pdf.pdf?sfvrsn=4efb8fca_0 | ||||
Condition | Year | Language | Analysis type | |
, HIV AIDS, Infectious disease | 2022 | English | , Burden of illness, Cost analysis, Public Health | |
Potential Healthcare Resource Use And Associated Costs Of Every 2 months Injectable Cabotegravir+Rilpivirine Long-acting Implementation In The Spanish NHS Vs. Daily Oral HIV Treatments | ||||
Laura-Amanda Vallejo Aparicio1 , Victoria Neches García1 , Beatriz Hernández 2 , Gregorio Casado3 , Ferrán Jodar 3 , Marco Pinel 3 , Daniel Callejo Velasco3 | ||||
1GSK, Tres Cantos (Madrid), España; 2ViiV Healthcare, Tres Cantos (Madrid), España; 3IQIVA, España | ||||
ISPOR Europe 2022; November 6-9, 2022; Virtual and Vienna, Austria |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.ispor.org/docs/default-source/euro2022/ee379cabotegravirrilpivirinelahruassociatedcosts-pdf.pdf?sfvrsn=4efb8fca_0 | ||||
Condition | Year | Language | Analysis type | |
, HIV AIDS, Infectious disease | 2022 | English | ||
Clinical and economic burden of physician-diagnosed influenza in adults during the 2017/2018 epidemic season in Spain | ||||
Ángel Gil-de-Miguel 1, Federico Martinón-Torres 2 3 4, Javier Díez-Domingo 5, Raúl Ortiz de Lejarazu Leonardo 6, Tomàs Pumarola 7, Mafalda Carmo 8, Georgina Drago 9, Juan Luis López-Belmonte 9, Hélène Bricout 10, Caroline de Courville 10, Esther Redondo Margüello 11 | ||||
1Public Health and Medical Specialties Department, Health Sciences Faculty, Juan Carlos University, Madrid, Spain. angel.gil@urjc.es. 2Genetics, Vaccines and Paediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago and Universidad de Santiago de Compostela (USC), Galicia, Spain. 3Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain. 4Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario and Universidad de Santiago de Compostela (USC), Galicia, Spain. 5Vaccine Research Department, FISABIO, Valencia, Spain. 6National Influenza Centre, Hospital Clínico Universitario, Universidad de Valladolid, Valladolid, Spain. 7Virology Section, Department of Microbiology, Barcelona Centre for International Health Research (CRESIB, Hospital Clínic - Universitat de Barcelona), Barcelona, Spain. 8IQVIA, Barcelona, Spain. 9Sanofi, Barcelona, Spain. 10Sanofi, Lyon, France. 11International Health Centre Madrid Health, City Council of Madrid, Madrid, Spain. | ||||
, Article | ||||
, Spain | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/36527015/ | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Respiratory disease | 2022 | English | , Burden of illness | |
Clinical and economic burden of respiratory syncytial virus in Spanish children: the BARI study | ||||
F Martinón-Torres 1 2 3, M Carmo 4, L Platero 5, G Drago 6, J L López-Belmonte 6, M Bangert 7, J Díez-Domingo 8, M Garcés-Sánchez 9 | ||||
1Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario and Universidad de Santiago de Compostela, Galicia, Spain. Federico.Martinon.Torres@sergas.es. 2Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago and Universidad de Santiago de Compostela (USC), Rúa da Choupana, s/n, Santiago de Compostela, Galicia, 15706, A Coruña, Spain. Federico.Martinon.Torres@sergas.es. 3CIBER Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain. Federico.Martinon.Torres@sergas.es. 4IQVIA, Barcelona, Spain. 5Sanofi, Madrid, Spain. 6Sanofi, Barcelona, Spain. 7Sanofi, Lyon, France. 8Vaccine Research Department, FISABIO, Valencia, Spain. 9Pediatrics Service, Nazaret Health Center, Valencia, Spain. | ||||
BMC Infect Dis . 2022 Sep 29;22(1):759. doi: 10.1186/s12879-022-07745-0. |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520861/ | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Respiratory disease | 2022 | English | , Burden of illness | |
Effectiveness and safety of empagliflozin in routine care in Europe and East Asia: results from the empagliflozin comparative effectiveness and safety (EMPRISE) study | ||||
A. Karasik1 , S. Lanzinger2 , E. Chia-Hui Tan3 , D. Yabe4 , D. Jung Kim5 , W. H-H Sheu6 , C. MelzerCohen1 , R.W. Holl2 , K. Ha5 , T. Nyström7 , L. Niskanen8 , M. Linnemann Jensen9 , M.H. Kyaw10, J. Núñez11, EMPRISE EU and East Asia Study Group; | ||||
Maccabi Research & Innovation Center, Tel Aviv University, Tel Aviv, Israel, 2 Inst. for Epidemiology & Medical Biometry, Uni. of Ulm, Ulm, Germany, 3National Research Inst. of Chinese Medicine, Taipei, Taiwan, 4Dept. of Diabetes and Endocrinology, Gifu University Graduate School of Medicine, Gifu, Japan, 5Dept. of Endocrinology & Metabolism, Ajou Uni. School of Medicine, Suwon, Republic of Korea, 6Taipei Veterans General Hospital, Taipei, Taiwan, 7Dept. of Clinical Science & Education, Södersjukhuset, Karolinska Institutet, Solna, Sweden, 8Department of Medicine, Päijät-Häme Central Hospital, Lahti, Finland, 9 IQVIA, Copenhagen, Denmark, 10Boehringer Ingelheim Pharmaceutical Inc., Ridgefield, USA, 11Dept. of Cardiology, Hospital Clínico Universitario de Valencia, Valencia, Spain | ||||
https://doi.org/10.2337/DB21-127-LB Virtual EASD 2021, 57 Annual Meeting, 27 September - 10 October 2021 |
||||
, Abstract | ||||
, Finland, Germany, Israel, Japan, South Korea, Spain, Sweden, Taiwan | ||||
Abstract: https://easddistribute.m-anage.com/from.storage?image=gOIMdpw6-DbPpKIQZ5HFcJGqJ2quHgbqFewkkUQkLblXdwzJ9kfmAYikI6R6NFu_GLAQJwEZKsC1PXU8ndyryA2 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Diabetes | 2021 | English | , Database Study, Methodology, Population Based Study | |
Empagliflozin use versus dipeptidyl peptidase 4 inhibitors reduces risk ofcardiovascular and renal disease among type 2 diabetes patients in routinecare in europe and israel: EMPRISE study results | ||||
T Nystroem1;AKarasik2; J Nunez3; S Lanzinger4; C Melzer-Cohen2; R W Holl4;P Casajust5; E Toresson Grip6; M Carrasco7; J Foersch8; K Karlsdotter9;M Tuovinen10; R Klement11;MHKyaw12; L Niskanen | ||||
Karolinska Institutet,Department of Clinical Science and Education, Södersjukhuset, Solna, Sweden;2Tel Aviv University, Maccabi Research and Innovation Center, Tel Aviv, Israel;3University of Valencia, Department of Cardiology, Hospital Clínico Universitariode Valencia, INCLIVA, CIBER Cardiovascular, Valencia, Spain;4University of Ulm,Institute of Epidemiology and Medical Biometry, ZIBMT, Ulm, Germany;5Trial FormSupport, Real-World Evidence, Barcelona, Spain;6Swedish Institute for HealthEconomics Quantify Research, Stockholm, Sweden;7Boehringer Ingelheim EspañaS.A., Barcelona, Spain;8Boehringer Ingelheim Pharma GmbH & Co. Kg, HP CountryMedical Affairs, Ingelheim Am Rhein, Germany;9Boehringer Ingelheim AB, Stock-holm, Sweden;10Boehringer Ingelheim KY, Secondment Boehringer Ingelheim UKHEOR Team, Helsinki, Finland;11IQVIA, Global Database Studies, Tartu, Estonia;12Boehringer Ingelheim Pharmaceutical Inc., Connecticut, United States of America;13University of Eastern Finland, Kuopio, Finland; | ||||
European Journal of Heart Failure (2021)23(Suppl. S2) 2–322doi:10.1002/ejhf.2297 |
||||
, Abstract, Article | ||||
, Finland, Germany, Israel, Spain, Sweden | ||||
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.2297 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Diabetes | 2021 | English | , Database Study, Meta analysis, Methodology, Population Based Study | |
The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study | ||||
Gómez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, Pérez G3, Saah A3, Alemany L8 | ||||
1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain | ||||
IPVC, Barcelona, Spain, 23-27 March 2020 |
||||
, Oral presentation | ||||
, China, France, Germany, Italy, Japan, Portugal, Spain | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Oncology | 2020 | English | , Burden of illness, Observational study, Retrospective Field Study | |
Clinical management of serious infections attributable to carbapenem-resistant Gram-negative pathogens in Spanish hospitals | ||||
Ferrer R1, Calvo-Montes J2, Maseda E3, Salavert M4, Bou G5, Díaz-Regañón J6, López D6, Lozano V6, Gómez-Ulloa D7, Fenoll R7, Sánchez E7, McCann E8 | ||||
1 Vall d'Hebron University Hospital, Barcelona, Spain 2 Marqués de Valdecilla University Hospital, Santander, Spain 3 La Paz University Hospital, Madrid, Spain 4 La Fe University and Polytechnic Hospital, Valencia, Spain 5 La Coruña University Hospital, La Coruña, Spain, Spain 6 Merck Sharp & Dohme Corp., Madrid, Spain 7 IQVIA, Barcelona, Spain 8 Merck & Co., Inc., Kenilworth, NJ, US | ||||
ECCMID, Paris, France, 18-21 April 2020 |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2020 | English | , Observational study, Retrospective Field Study | |
Resource utilisation associated with infections attributable to carbapenem-resistant Gram-negative pathogens in southern European hospitals | ||||
Durante Mangoni E1, Georgopoulos D2, Fernández-Martínez M3, Mastroianni C4, Viale P5, Bassetti M6, Ferrer R7, Giamarellos-Bourboulis E8, Maseda E9, Salavert M10, Perivoliotis E11 ,Bou Arevalo G12, Koutsoukou A13, Mantzarlis K14, Lozano V15, Gómez-Ulloa D16, Roset M16, McCann E17 | ||||
1 ‘L. Vanvitelli’ University, Monaldi Hospital, Naples, Italy 2 University Hospital of Crete, Crete, Greece 3 Marqués de Valdecilla University Hospital, Santander, Spain 4 Policlinico Umberto I, Rome, Italy 5 Policlinico S. Orsola-Malpighi, Bologna, Italy 6 University of Genova and Policlinico San Martino, Genova, Italy 7 Vall d'Hebron University Hospital, Barcelona, Spain 8 National and Kapodistrian University of Athens, Athens, Greece 9 University Hospital La Paz, Madrid, Spain 10 Hospital Universitario y Politécnico de La Fe, València, Spain 11 Evaggelismos General Hospital, Athens, Greece 12 Hospital Universitario La Coruña, La Coruña, Spain 13 National and Kapodistrian University and General Hospital for Chest Diseases 'I Sotiria’ , Athens, Greece 14 University Hospital of Larissa, Larisa, Greece 15 Merck Sharp & Dohme, Madrid, Spain 16 IQVIA, Barcelona, Spain 17 Merck & Co., Inc., Kenilworth, NJ, US | ||||
ECCMID, Paris, France, 18-21 April 2020 |
||||
, Oral presentation | ||||
, Greece, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2020 | English | , Observational study, Retrospective Field Study | |
Outcomes and predictors of outcomes of serious infections attributable to carbapenem-resistant Gram-negative pathogens in southern European hospitals | ||||
Georgopoulos D1, Durante Mangoni E2, Mastroianni C3, Viale P4, Arnáiz de las Revillas F5, Bassetti M6, Ferrer R7, Giamarellos-Bourboulis E8, Maseda E9, Salavert M10, Malachias S11, Bou Arevalo G12, Kyriakoudi A13, Tsolaki V14, Lopez D15, Gómez-Ulloa D16, Lara N16, McCann E17 | ||||
1 University Hospital of Crete, Crete, Greece 2 ‘L. Vanvitelli’, Monaldi Hospital, Naples, Italy 3 Policlinico Umberto I, Rome, Italy 4 Policlinico S. Orsola-Malpighi, Bologna, Italy 5 Marqués de Valdecilla University Hospital, Santander, Spain 6University of Genova and Policlinico San Martino, Genova, Italy 7 Vall d'Hebron University Hospital, Barcelona, Spain 8 National and Kapodistrian University of Athens, Athens, Greece 9 University Hospital La Paz, Madrid, Spain 10 Hospital Universitario y Politécnico de La Fe, València, Spain 11 Evaggelismos General Hospital, Athens, Greece 12 Hospital Universitario La Coruña, La Coruña, Spain 13 National and Kapodistrian University and General Hospital for Chest Diseases 'I Sotiria’, Athens, Greece 14 University Hospital of Larissa, Larisa, Greece 15 Merck Sharp & Dohme, Madrid, Spain 16 IQVIA, Barcelona, Spain 17 Merck & Co., Inc., Kenilworth, NJ, US | ||||
ECCMID, Paris, France, 18-21 April 2020 |
||||
, Oral presentation | ||||
, Greece, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2020 | English | , Observational study, Retrospective Field Study | |
Predictors of iron‑deficiency anemia in primary care older adults: a real‑world European multi‑country longitudinal study | ||||
Vetrano DL, Zucchelli A, Marconi E, Levi M, Pegoraro V, Cataldo N, Heiman F, Cricelli C, Lapi F | ||||
Vetrano DL: Department of Geriatrics, Catholic University of Rome and IRCCS Fondazione Policlinico “A. Gemelli”, Rome, Italy. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy. Heiman F: HEOR Engagement Manager, IQVIA, RWS, Milan, Italy | ||||
Aging Clin Exp Res (2020). https://doi.org/10.1007/s40520-019-01454-6 |
||||
, Article | ||||
, Belgium, Germany, Italy, Spain | ||||
Abstract: https://link.springer.com/article/10.1007/s40520-019-01454-6 | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2020 | English | , Epidemiological study, Retrospective database analysis | |
Investigation of factors considered in the health technology assessment conducted by regulatory authority in eight countries | ||||
Akira Yuasa 1, Naohiro Yonemoto 1, Sven Demiya 2, Chihiro Foellscher 2, Shunya Ikeda 3 (rwesheorj 2) | ||||
1) Pfizer Japan Inc., Tokyo, Japan 2) IQVIA Solutions Japan, Tokyo, Japan 3) Graduate School of Medicine, International University of Health and Welfare, Tokyo, Japan | ||||
ISPOR 2020 Conference |
||||
, Abstract | ||||
, Australia, Canada, France, Germany, Italy, Japan, Spain, UK | ||||
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2020-3182/101019 | ||||
Condition | Year | Language | Analysis type | |
2020 | English | |||
Patrones de tratamiento biológico en pacientes con enfermedades articulares inflamatorias. Estudio retrospectivo de 4 años de seguimiento | ||||
Juan D. Cañete1, Antonio Naranjo2, Javier Calvo3, Carmen Ordás4, Belén Aragón5, Gonzalo Nocea5, Montse Roset6, Antonio Fernández-Nebro7 | ||||
1 Servicio de Reumatología, Hospital Clínic e IDIBAPS, Barcelona, España 2 Departamento de Reumatología, Hospital Dr. Negrín, Universidad de las Palmas de Gran Canaria, Las Palmas de Gran Canaria, España 3 Departamento de Reumatología, Hospital General Universitario de Valencia, Valencia, España 4 Departamento de Reumatología, Hospital de Cabueñes, Gijón, España 5 Departamento de Health Economics and Outcomes Research, MSD, Madrid, España 6 Departamento de Health Economics and Outcomes Research, IQVIA, Barcelona, España 7 Departamento de Reumatología, Instituto de Investigación Biomédica (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, España | ||||
Reumatología Clínica, 2019. DOI: 10.1016 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://reumatologiaclinica.org/es-patrones-tratamiento-biologico-pacientes-con-avance-S1699258X18302596 | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study | 2019 | Spanish | , Clinical setting: hospital, Observational study | |
Cost-utility model for 2nd generation treatment of chronic HCV in general population: impact of EASL recommendations in 2016 and 2018 | ||||
Natlia Pascual-Argent (1,2); Carlos Crespo (1,3); Laura Planellas (4); Mriam Solozabal (4), Nria Perulero (4); Jaume Puig-Junoy (1,2) | ||||
(1) UPF Barcelona School of Management; (2) Dept. Economa y Empresa CRES UPF; (3) Universitat de Barcelona; (4) HEOR-RWE, IQVIA Spain | ||||
XXXIX Jornadas de Economa de la Salud. Albacete, 12 al 14 de junio de 2019 |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/pdfs/Jornadas_AES_2019-Libro_abstracts.pdf | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Health economics, Infectious disease | 2019 | Spanish | , Clinical setting: hospital, Cost effectiveness | |
USO DE DATOS DE PRACTICA REAL PARA ANALIZAR LOS TRATAMIENTOS PRESCRITOS EN LA DIABETES TIPO 2 EN ESPA?A | ||||
Maria Targhetta*, Jean Paul Tang*, Hector Gutierrez*, Nuria Perulero*, Daniel Callejo*, Miriam Solozabal* | ||||
IQVIA Spain | ||||
XXXIX Jornadas de Economa de la Salud. Albacete, 12 al 14 de junio de 2019 |
||||
, Oral presentation | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/pdfs/Jornadas_AES_2019-Libro_abstracts.pdf | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2019 | Spanish | , Clinical setting: Primary care, Population Based Study, Retrospective database analysis | |
Análisis de la implementación de los Informes de Posicionamiento Terapéutico en España | ||||
Míriam Solozabal, Laura Planellas, Elisabet Viayna, Neus Canal | ||||
Health Economics & Outcomes Research. Real-World Insights. IQVIA España | ||||
Revista Española de Economía de la Salud. 2019; 14(3):596-605 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.economiadelasalud.com/Articulo.aspx?i=v14n3d018 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Pricing and reimbursement, Public Health | 2019 | Spanish | , Clinical setting: hospital, Clinical setting: Primary care, Internet or Interactive voice response system, Pricing & Reimbursement, Public Health | |
Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe | ||||
Fife D, Waller J, Kaplan S, Hu P, Phillips S, Oliveria SA, Richarz U | ||||
Fife: Janssen Research and Development, LLC Waller: Adephi Real World Kaplan: Teva Pharmaceutical Indusries Ltd. Hu: Janssen Global Services Phillips: IQVIA Oliveria, IQVIA Richarz: Janssen Research and Development, LLC | ||||
Clin Drug Investig (2019). https://doi.org/10.1007/s40261-019-00831-3 |
||||
, Article | ||||
, Belgium, France, Germany, Spain, UK | ||||
Abstract: https://link.springer.com/article/10.1007/s40261-019-00831-3 | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Drug Utlization Study | 2019 | English | , Population Based Study, Retrospective database analysis | |
European Multi-Country Drug Utilization Study of Dulaglutide | ||||
Ayad K. Ali1, Karen E. Wells2, Mathieu Ros3, Massoud Toussi3 | ||||
1Eli Lilly and Company, Indianapolis, IN, USA 2IQVIA, Oakland, MI, USA 3IQVIA, Courbevoie, France | ||||
ICPE, Philadelphia, USA, 24-28 August 2019 |
||||
, Abstract | ||||
, France, Germany, Spain, Sweden, UK | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Drug safety | 2019 | English | , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis | |
European survey on stable angina: real world insights on patients' characteristics, perception of disease, and quality of life | ||||
Heiman F1, Peduto I1, Pegoraro V1, Cipelli R1, Ambrosio G2, Camm AJ3, Collins P4, Dechend R5, Lopez-Sendon J6, Manolis AJ7 | ||||
1 IQVIA, Milan, Italy 2 Division of Cardiology, University of Perugia School of Medicine, Perugia, Italy 3 Imperial College London, London, United Kingdom - Cardiology Clinical Academic Group, Molecular & Clinical Sciences Institute, St. Georges University of London, London, United Kingdom 4 National Heart and Lung Institute, Imperial College London, United Kingdom - Royal Brompton Hospital, London, United Kingdom 5 Experimental and Clinical Research Center, A joint cooperation between the Max-Delbruck Center for Molecular Medicine and the Charit Medical Faculty, Berlin, Germany - HELIOS-Clinic, Berlin, Germany 6 Cardiology, Hospital Universitario La Paz, IdiPaz, Madrid, Spain 7 Department of Cardiology, Asklepeion General Hospital, Athens, Greece | ||||
ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2019 | English | , Survey research | |
Gender differences in determinants of iron-deficiency anemia: a population-based study conducted in four European countries | ||||
Levi M1, Simonetti M2, Marconi E2, Brignoli O3, Cancian M3, Masotti A4, Pegoraro V5, Heiman F5, Cricelli C3, Lapi F2 | ||||
1 Local Health Unit Tuscany Centre, Florence, Italy 2 Health Search, Italian College of General Practitioners and Primary Care, Florence, Italy 3 Italian College of General Practitioners and Primary Care, Florence, Italy 4 Department of Transfusion Medicine, Pordenone, Italy 5 IQVIA, Milan, Italy | ||||
Annals of Hematology (2019) 98:15731582 |
||||
, Article | ||||
, Belgium, Germany, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2019 | English | , Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis | |
Adoption of immuno-oncology in NSCLC, a real-world study in EU5. | ||||
Alejandra Martinez De Pinillos,Isabel Ricote Lobera,Cristina Martinez,Caroline Anger,Filippo Guglielmetti,Roberto Jorge Bitton | ||||
IQVIA, London, United Kingdom; IQVIA, Madrid, Spain; IQVIA, Milan, Italy; IQVIA, Buenos Aires, Argentina | ||||
Journal of Clinical Oncology201937:15_suppl,e20631-e20631 |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e20631 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Retrospective database analysis | |
EPIDEMIOLOGY OF ATTENTION DEFICIT HYPERACTIVITY DISORDERS IN SPAIN BASED ON REAL-WORLD DATA | ||||
Ramos-Quiroga JA (1), Targhetta M (2), Gasche D (2), Rubio M (2), Perulero N (3) | ||||
1Hospital Universitari Vall d’Hebron, Barcelona, Spain, 2IQVIA Information, Madrid, Spain; 3IQVIA Information, Barcelona, Spain | ||||
ISPOR Europe, Copenhagen, Denmark, 2-6 November 2019 |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2019 | English | , Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Retrospective database analysis | |
A REAL-WORLD DATA STUDY TO ANALYSE THE PHARMACOLOGICAL TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN SPAIN | ||||
Ramos-Quiroga JA (1), Tang JP (2), Solozabal M (2), De Prado A (2), Miñarro C (2), Callejo-Velasco D (2) | ||||
1Hospital Universitari Vall d’Hebron, Barcelona, Spain, 2IQVIA Information, Madrid, Spain | ||||
ISPOR Europe, Copenhagen, Denmark, 2-6 November 2019 |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2019 | English | , Clinical setting: Primary care, clinical setting: Secondary care, Retrospective database analysis | |
EMPAGLIFLOZIN VS SITAGLITPIN, SAXAGLIPTIN AND LIRAGLUTIDE IN SPAIN. A BUDGET IMPACT MODEL BASED ON THE CORE DIABETES MODEL AND CARDIOVASCULAR OUTCOMES TRIALS | ||||
Carrasco Perez M, Ustyugova A, Rubio M, Callejo-Velasco D, Gasche D, Gonzalez-Rojas Guix N | ||||
Boehringer Ingelheim and IQVIA | ||||
ISPOR Europe, Copenhagen, Denmark, 2-6 November 2019 |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2019 | English | , Budget impact, Clinical setting: Primary care | |
Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain. | ||||
Schlueter M, Finn E, Díaz S, Dilla T, Inciarte-Mundo J, Fakhouri W. | ||||
IQVIA, Real World Evidence, London N1 9JY, UK. Lilly Spain, Health Outcomes & RWE, Alcobendas 28108, Spain. Lilly Spain, Medical, Alcobendas 28108, Spain. Lilly, Global Patient Reported Outcomes and Real World Evidence (GPORWE) International, Windlesham, Surrey GU20 6PH, UK. | ||||
Clinicoecon Outcomes Res. 2019 Jun 6;11:395-403 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.dovepress.com/cost-effectiveness-analysis-of-baricitinib-versus-adalimumab-for-the-t-peer-reviewed-fulltext-article-CEOR | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2019 | English | , Retrospective cohort analysis | |
A Survey Among Health Care Professionals to Assess Their Knowledge and Understanding on Darzalex® (Daratumumab) Educational Materials Regarding the Risk of Interference for Blood Typing in 12 European Countries | ||||
Mathieu Rosé, Intissar Bourahla, Alessandro Ghiddi, Assem Al-Akabawi, Edmond Chan, Massoud Toussi | ||||
IQVIA, Courbevoie, France; Janssen EMEA, Medical Affairs, Italy; Janssen EMEA, Medical Affairs, UK | ||||
Presented at ISPE’s 35th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 2019), August 24–28, 2019 at the Pennsylvania Convention Center, Philadelphia, PA, USA. |
||||
, Poster | ||||
, Austria, Czech, Denmark, Finland, France, Germany, Hungary, Norway, Slovakia, Spain, Sweden, Switzerland | ||||
Abstract: https://www.coodoc.com/pages/p1822-Daratumumab-ICPE-2019 | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2019 | English | , Public Health, Survey research | |
Real-world treatment patterns of patients diagnosed with complicated urinary tract infections, complicated intra-abdominal infections, and hospital acquired and ventilator-associated bacterial pneumonia attributable to carbapenem-resistant Gram-negative bacilli in Spain | ||||
Ferrer R1, Fariñas MC2, Bou Arevalo G3, Maseda E4, Salavert M5, Gómez Ulloa D6, Fenoll R6, Sánchez E6, Doshi I7, Diaz-Regañon J8, Mccann E7 | ||||
1 Hospital Universitari Vall d’Hebron, Barcelona, Spain 2 Hospital Marqués de Valdecilla, Santander, Spain 3 Hospital Universitario A Coruña, La Coruña, Spain 4 Hospital Universitario La Paz, Madrid, Spain 5 Hospital Universitario y Politécnico La Fe, Valencia, Spain 6 IQVIA, Barcelona, Spain 7 Merck & Co., Inc., Kenilworth, NJ, US 8 Merck Sharp & Dohme Corp., Madrid, Spain | ||||
ECCMID, Amsterdam, Netherlands, 13-16 April 2019 |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2019 | English | , Observational study, Retrospective database analysis | |
Biological Treatment Patterns with Inflammatory Joint Diseases. Retrospective Study with 4 Years Follow-up | ||||
Cañete JD1, Naranjo A2, Calvo J3, Ordás C4, Aragón B5, Nocea G5, Roset M6, Fernández-Nebro A7 | ||||
1 Servicio de Reumatología, Hospital Clínic e IDIBAPS, Barcelona, Spain 2 Departamento de Reumatología, Hospital Dr. Negrín, Universidad de las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain 3 Departamento de Reumatología, Hospital General Universitario de Valencia, Valencia, Spain 4 Departamento de Reumatología, Hospital de Cabueñes, Gijón, Spain 5 Departamento de Health Economics and Outcomes Research, MSD, Madrid, Spain 6 IQVIA, Barcelona, Spain 7 Departamento de Reumatología, Instituto de Investigación Biomédica (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, Spain | ||||
Reumatol Clin. 2019 Jan 28. pii: S1699-258X(18)30259-6 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30704919 | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2019 | Spanish | , Population Based Study, Survey research | |
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe | ||||
Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Amarenco P4, Annemans L5 | ||||
1 Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, UK 2 IQVIA, Zaventem, Belgium 3 Amgen (Europe) GmbH, Rotkreuz, Switzerland 4 Department of Neurology and Stroke Centre, Bichat Hospital, Paris, France 5 University of Ghent, Belgium | ||||
Eur J Prev Cardiol. 2019 Jul;26(11):1150-1157. |
||||
, Article | ||||
, Belgium, France, Poland, Portugal, Spain, Switzerland, UK | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30955367 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Health economics | 2019 | English | , Burden of illness, Clinical setting: Primary care, direct to patient research, Observational study | |
Natural hisotry of oral human papillomavirus infection in healthy populations: Design of the Prevalence of Oral HPV infection, a Global assessment, THE PROGRESS STUDY | ||||
Pedros M1, Morais E2, Roset M1, Kothari S3, Alemany L5, Mirghani H6, Mehanna H7, Waterboer T8, Roberts C3, Vendetti N3, Walia A3, Drury R2, Luxembourg A3, Giuliano A9 | ||||
1 IQVIA, Barcelona, Spain 2 MSD, Lyon, France 3 Merck & Co, Inc., Kenilworth, NJ, US 5 Catalan Institute of Oncology, Cancer Epidemiology Research Program and IDIBELL i CIBERESP, Barcelona, Spain 6 Hôpital Européen Georges-Pompidou Université Paris-Descartes, Paris, France 7 Institute of Head & Neck Studies and Education (InHANSE), University of Birmingham, Birmingham, United kingdom 8 German Cancer Research Center (DKFZ), Heidelberg, Germany 9 Moffitt Cancer Center, Florida, US | ||||
EUROGIN, Monaco, France, 4-7 December 2019 |
||||
, Oral presentation | ||||
, China, France, Germany, Italy, Japan, Spain, UK, USA | ||||
Abstract: http://merck.creative.studios.s3-website-us-east-1.amazonaws.com/EUROGIN_2019/2019_EUROGIN_Pedros_NaturalHistory.pdf | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Infectious disease, Methodology | 2019 | English | , Epidemiological study, Observational study, Population Based Study | |
Impact of Stable Angina on health status and quality of life perception of currently treated patients. The BRIDGE 2 survey | ||||
Manolis AJ, Ambrosio G, Collins P, Dechend F, Lopez-Sendon J, Pegoraro V, Camm AJ | ||||
Manolis AJ: Department of Cardiology, Asklepeion General Hospital, Athens, Greece. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy. | ||||
Eur J Intern Med. 2019 Dec;70:60-67. doi: 10.1016/j.ejim.2019.09.013 |
||||
, Article | ||||
, Germany, Italy, Spain, UK | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S0953620519303267?via%3Dihub | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2019 | English | , Quality of life, Survey research | |
Treatment algorithm for multiple myeloma: real-world insights across five European countries | ||||
Dr Rocci1, Bulger P1, Martinez de Pinillos A2 , Anger C2 , Nasuti P2, Manuguid F2 | ||||
1Manchester University NHS Foundation Trust, Manchester Royal Infirmary, 2 IQVIA London UK | ||||
ESMO 2018 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Available resources for the management of chronic obstructive pulmonary disease exacerbations in Spain | ||||
Soler-Cataluña JJ1, Fernández Villar A2, Piñera Salmerón PL3, Román-Rodríguez M4, Huerta Hernández A5, Roset Gamisans M6 | ||||
1 Servicio de Neumología, Hospital de Arnau de Vilanova-Lliria, Valencia, España. 2 Servicio de Neumología, Hospital Álvaro Cunqueiro. Instituto de Investigación Biomédica Galicia Sur, Vigo (Pontevedra), España. 3 Servicio de Urgencias, Hospital General Universitario Reina Sofía, Murcia, España. 4 Médico de familia, Centro de Salud Son Pisà, Islas Baleares, Mallorca, España. 5 Departamento de Evaluación de Medicamentos, GlaxoSmithKline, Tres Cantos, Madrid, España. 6 Health Economics and Outcomes Research, IQVIA, Barcelona, España. | ||||
Semergen. 2018 Oct;44(7):449-457 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30206038 | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice | 2018 | Spanish | , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Observational study | |
Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia | ||||
Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3 | ||||
1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA | ||||
, China, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e21085 | ||||
Condition | Year | Language | Analysis type | |
2018 | English | |||
Patterns of care and of biomolecular characterization of Right, Transverse, and Left Colorectal Cancer from real-life evidence in Asia Pacific and European countries | ||||
Ettore M1, Mpima S2, Guglielmetti F1, Nasuti P2 | ||||
1IQVIA , Milan, Italy 2IQVIA , London, UK | ||||
ESMO 2018 |
||||
, Poster | ||||
, China, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
Abstract: ESMO 2018 Congress | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe. | ||||
Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Annemans L4, Amarenco P5 | ||||
1 Imperial College London, London, United Kingdom 2 IQVIA, Zaventem, Belgium 3 Amgen Europe GmbH, Zug, Switzerland 4 Ghent University, Ghent, Belgium 5 Hospital Bichat-Claude Bernard, Paris, France | ||||
European Society of Cardiology (ESC) Congress, 2018, Munich, Germany |
||||
, Poster | ||||
, Belgium, France, Poland, Portugal, Spain, Switzerland, UK | ||||
Abstract: https://esc365.escardio.org/Congress/ESC-Congress-2018/Poster-Session-3-Health-economics/176943-patient-and-caregiver-productivity-loss-and-indirect-costs-associated-with-cardiovascular-events-in-europe | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Health economics | 2018 | English | , Burden of illness, Cost of illness | |
EXPLAINING THE DISPARITIES OF MARKET ACCESS FOR GLIFLOZINS IN FRANCE, SPAIN, GERMANY AND THE UNITED-KINGDOM | ||||
Bodaghi Charles, Benque Emma, Troubat Arnaud | ||||
IQVIA France - RWI | ||||
ISPOR 2018 |
||||
, Poster | ||||
, France, Germany, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Clinical setting: Home care, Pricing & Reimbursement | |
Verification of guideline conform mCRC treatment with EGFR inhibitors with real-world evidence data from EU5 countries | ||||
Hoyer L, Schmidt N | ||||
IQVIA Frankfurt Germany | ||||
ESMO 2018 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
PATTERNS OF CARE OF ADVANCED SOFT TISSUE SARCOMAS (STS) NON-GIST IN FOUR EUROPEAN COUNTRIES (EU4) | ||||
Mari E1,Martinez de Pinillos A2, Nasuti P2,Guglielmetti F1, Anger C2 | ||||
1IQVIA Milan Italy , 2IQVIA London UK | ||||
CTOS 2018 Rome |
||||
, Poster | ||||
, France, Germany, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Patterns of Therapy in Regional Lymph Node Positive Prostate Cancer in Europe and Asia: An International Analysis | ||||
Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R, Payne H 1 | ||||
1 University College Hospital, London, UK 2 IQVIA , London, UK | ||||
ESMO 2018 |
||||
, Poster | ||||
, China, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
Abstract: ESMO 2018 Congress | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Drug treatment in melanoma: a real-world analysis across Europe and Japan | ||||
Martinez de Pinillos, Anger C, Nasuti P | ||||
IQVIA London UK | ||||
ESMO 2018 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Initial Management of localised prostate cancer in the Elderly: An International Data Review | ||||
Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R1, Payne H1 | ||||
1 University College Hospital, London, UK 2 IQVIA , London, UK | ||||
SIOG 2018 |
||||
, Poster | ||||
, China, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia | ||||
Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3 | ||||
1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA | ||||
JCO ( ASCO 2018) |
||||
, Abstract | ||||
, Asia Pacific, China, Europe, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e21085 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
DESCRIPTIVE ANALYSIS OF THE USE OF TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKAEMIA IN EUROPE, A REAL-WORLD PERSPECTIVE | ||||
Martinez de Pinillos A1, Nasuti P1, Anger C1, Ricorte I2 | ||||
1 IQVIA London UK , 2IQVIA Madrid Spain | ||||
ISPOR Europe 2018 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Clinical characteristics of Glioblastoma Multiforme (GBM) Patients Who Reached 400 Days Post Diagnostic from a Retrospective Real-World Data | ||||
Mitrofan L.M.1,Krukas-Hampel M.R.2, Mendoza L.A.3 | ||||
1 IQVIA, Paris, FR; 2IQVIA New York, US; 3IQVIA, Prague, CZ | ||||
ESMO 2018 |
||||
, Poster | ||||
, Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Clinical Characteristics of 3,030 Glioblastoma Multiforme (GBM) Patients in High, Upper Middle and Lower Middle Economic Regions Based on Real-World Data (RWD) | ||||
Mitrofan L1 , M.R. Krukas-Hampel M.R2 , L.A. Mendoza L.A3 | ||||
IQVIA, Paris, FR; IQVIA New York, US; IQVIA, Prague, CZ | ||||
ESMO 2018 |
||||
, Poster | ||||
, Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Real-World Use of Dulaglutide in Europe: A Multi-Country Drug Utilization Study | ||||
Ali AK, Toussi M, Phillips S, Roste M | ||||
Ali AK: Eli Lilly and Company; Toussi M: IQVIA; Phillips S: IQVIA; Roste M: IQVIA | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, France, Germany, Spain, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Drug Utlization Study, Drug Utlization Study | 2018 | English | , Database Study, Epidemiological study | |
Epidemiologic and economic burden of HPV diseases in Spain: implication of additional 5 types from the 9-valent vaccine. | ||||
López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4, Perulero N4. | ||||
1Medical Affairs, MSD, Madrid, Spain.22Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain.33Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain.4Health Economics and Outcomes Research, Real World Insights, IQVIA, Barcelona, Spain. | ||||
Infect Agent Cancer. 2018 May 2;13:15. |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29743937 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Immunology and Vaccination, Infectious disease, Oncology | 2018 | English | , Burden of illness, clinical setting: Secondary care, Literature Review, Review, Survey research | |
Valoración de la innovación, ¿es “el innovómetro” una herramienta útil y su clasificación reproducible? | ||||
Otermin A, Callejo D, Gasche D, Viayna E, Rubio M, Sumalla M, Solozabal M. | ||||
HEOR-RWI, IQVIA | ||||
XXXVIII Jornadas de Economía de la Salud, Gran Canaria 2018 |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/es/ | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Pricing and reimbursement | 2018 | Spanish | , Pricing & Reimbursement | |
Análisis coste-utilidad de antivirales de acción directa de segunda generación para la hepatitis C: Una revisión sistemática. | ||||
Puig-Junoy J123, Pascual-Argente N23, Puig-Codina L2, Planellas L4, Solozabal M4. | ||||
1Pompeu Fabra University (UPF), Department of Economics and Business; 2UPF Barcelona School of Management; 3Center for Research in Health and Economics (CRES-UPF); 4IQVIA, Real-World Insights, Barcelona | ||||
XXXVIII Jornadas de Economía de la Salud, Gran Canaria 2018 |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/es/ | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Infectious disease | 2018 | Spanish | , Clinical setting: hospital, Literature Review, Review, Survey research | |
Spanish validation of a specific measure to assess work-related problems in people with multiple sclerosis: The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23) | ||||
Martínez-Ginés ML, García-Domínguez JM, Forero L, Canal N, Rebollo P, Prefasi D, Honan CA, Maurino J. | ||||
Department of Neurology, Hospital Universitario Gregorio Marañón, Madrid, SpainDepartment of Neurology, Hospital Universitario Puerta del Mar, Cádiz, Spain IQVIA, Barcelona, Spain Medical Department, Roche Farma, Madrid, Spain Department of Psychology, School of Medicine, University of Tasmania, Newnham, Australia | ||||
Mult Scler Relat Disord. 2018 May;22:115-119 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29656271 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2018 | English | , Burden of illness, Clinical setting: hospital, Patient questionnaire | |
Real World Data y Real World Evidence como fuentes de evidencia en oncología. Estado actual y perspectivas de futuro | ||||
Daniel Callejo y Anna de Prado | ||||
IQVIA Spain | ||||
New Medical Economics nº 79;22-24 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://issuu.com/raizpublicidad/docs/nme_num79/22 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | Spanish | , Clinical setting: hospital, Review | |
Assessing Treatment Tolerability for Rheumatoid Arthritis. Validation and Practical Applications of the ‘TOL-AR-18 Questionnaire | ||||
Corominas H, Espadaler L, Gómez A, Ros I, Urruticoechea A, Sarmiento M, Sanmartí R | ||||
Corominas H.: Rheumatology and Autoimmune diseases Division, Hospital Universitari de Sant Pau & Hospital Dos de Maig, Barcelona, Spain Sarmiento M: Real-World Evidence Solutions, IMS Health, Spain | ||||
Reumatología Clínica 2018; Sep 5. [Epub ahead of print] |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.reumatologiaclinica.org/en/assessing-treatment-tolerability-for-rheumatoid/avance-resumen/S1699258X18301232/ | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes, Rheumatology | 2018 | English | , Clinical setting: hospital, Observational study | |
A real-world data study regarding hospital resources use and costs associated with melanoma cancer in Spain | ||||
Carmen Barrull, Ángel Baltasar, Daniel Callejo, Vanessa Gómez, Neus Canal, Miriam Solozabal | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-melanoma-cancer-in.pdf?la=en&hash=8C1394471FDDA3956BBF8788628C6443F1E3D5B6 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: hospital, Cost analysis, Retrospective database analysis | |
A real-world data study regarding hospital resources use and costs associated with colorectal cancer in Spain | ||||
Laura Planellas, Míriam Solozabal, Carmen Barrull, Anna de Prado, Neus Canal, Vanessa Gómez | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-colorectal-cancer.pdf?la=en&hash=FE374C80DDC224B135913C13D65857DAE36D0007 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: hospital, Cost analysis, Retrospective database analysis | |
Cost-utility analysis of second-generation direct-acting antivirals for hepatitis C: a systematic review | ||||
Jaume Puig-Junoya,b,c, Natàlia Pascual-Argenteb,c, Lluc Puig-Codinab, Laura Planellasd, Míriam Solozabald | ||||
aDepartment of Economics and Business (UPF), Pompeu Fabra University, Barcelona, Spain; bUPF Barcelona School of Management, Pompeu Fabra University, Barcelona, Spain; cUPF Center for Research in Health and Economics (CRES-UPF), Pompeu Fabra University, Barcelona, Spain; dHEOR-RWI, IQVIA Spain | ||||
Expert Review of Gastroenterology and Hepatology. Volume 12, 2018 - Issue 12 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.tandfonline.com/doi/abs/10.1080/17474124.2018.1540929?journalCode=ierh20 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Infectious disease | 2018 | English | , Clinical setting: hospital, Literature Review, Review | |
Hospital resources use and costs associated with 6 prevalent cancer in Spain, a Real World Data study | ||||
Daniel Callejo , Laura Planellas, Míriam Solozabal, Carmen Barrull, Neus Canal, Anna de Prado | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe, Barcelona, Spain, 10-14 November 2018 |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/hospital-resources-use-and-costs-associated-with-6-prevalent-cancers-in-spain-a-real-world-data-stud.pdf?la=en&hash=C28017910D9722573D7A318AB3782530D5F50054 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: hospital, Cost analysis, Retrospective database analysis | |
A real-world data study regarding hospital resources use and costs associated with breast cancer in Spain | ||||
Daniel Callejo , Vanessa Gómez, Míriam Solozabal, Laura Planellas, Ágata Carreño, Ángel Baltasar | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe, Barcelona, Spain, 10-14 November 2018 |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-breast-cancer-in-s.pdf?la=en&hash=8547AD20386AF0B3E1DA95EDA710A7EEF6E40C68 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: hospital, Cost analysis, Retrospective database analysis | |
A real-world data study regarding hospital resources use and costs associated with bladder cancer in Spain | ||||
Anna de Prado, Ángel Baltasar, Vanessa Gómez, Carme Barrull, Àgata Carreño, Laura Planellas | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-bladder-cancer-in.pdf?la=en&hash=9A2EA74E7E8AEC14E41A2D6DACD80911C716853F | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: hospital, Cost analysis, Retrospective database analysis | |
A real-world data study regarding hospital resources use and costs associated with lung cancer in Spain | ||||
Anna de Prado, Daniel Callejo, Vanessa Gómez, Angel Baltasar, Neus Canal, Carme Barrull | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-lung-cancer-in-spa.pdf?la=en&hash=8F884E874C670E07BCA72315DC3B6E042F558F23 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: hospital, Cost analysis, Retrospective database analysis | |
How a new innovation assessment tool relates to recent drug launches for Spanish National acess | ||||
Míriam Solozabal, Elisabet Viayna, Marta Rubio, Mireia Sumalla, Ane Otermin, David Gasche, Laura Planellas, Daniel Callejo | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-13/how-a-new-innovation-assessment-tool-relates-to-recent-drug-launches-for-spanish-national-access.pdf?la=en&hash=1D16D1D70ADE257D3A09480F1B1EEB002BDE83A4 | ||||
Condition | Year | Language | Analysis type | |
, Pricing and reimbursement | 2018 | English | , Clinical setting: hospital, Pricing & Reimbursement | |
A real-world data study regarding hospital resources use and costs associated with prostate cancer in Spain | ||||
Míriam Solozabal, Anna de Prado, Laura Planellas, Ángel Baltasar, Àgata Carreño, Daniel Callejo | ||||
HEOR-RWI, IQVIA Spain | ||||
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-prostate-cancer-in.pdf?la=en&hash=1DA52D1BC0EDBFCE32B1DB5C46308CE4E06D318F | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: hospital, Cost analysis, Retrospective database analysis | |
Validation of the Spanish version of the Bladder Pain/Interstitial Cystitis-Symptom Score (BPIC-SS) questionnaire. A useful tool for the diagnosis of bladder pain syndrome | ||||
S. Arlandis, A. Franco, A.M. Mora, P. Rebollo | ||||
Hospital Universitario y Politcnico La Fe, Valencia, Spain Hospital Universitario Clnic, Barcelona, Spain Departamento Mdico, Astellas Pharma S.A., Madrid, Spain Health Economics & Outcomes Research, Real-World Evidence Solutions, QuintilesIMS, Barcelona, Spain | ||||
Actas Urol Esp. 2018;42(7):457-464 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.elsevier.es/en-revista-actas-urologicas-espanolas-english-392-articulo-validation-spanish-version-bladder-pain-interstitial-S2173578618300933 | ||||
Condition | Year | Language | Analysis type | |
, Urology, Womens Health | 2018 | English | , clinical setting: Secondary care, Epidemiological study, Observational study | |
Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective | ||||
Marchetti P1, Maass N2, Gligorov J3, Berger K4, MacDougall F5, Montonen J6, Lewis J6. | ||||
Department of Clinical and Molecular Medicine, Sapienza University of Rome and IDI-IRCCS, Rome, Italy. Electronic address: paolo.marchetti@ospedalesantandrea.it. 2 Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Kiel, Germany. 3 Department of Medical Oncology, INSERM U938, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France. 4 Real World Evidence Solutions and HEOR, IMS Health, Munich, Germany. 5 Real World Evidence Solutions and HEOR, IMS Health, London, United Kingdom. 6 AstraZeneca, London, United Kingdom. | ||||
Breast. 2017 Apr;32:247-255. |
||||
, Article | ||||
, France, Germany, Italy, Spain | ||||
Abstract: http://www.sciencedirect.com/science/article/pii/S0960977616302648 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , clinical setting: Secondary care, Retrospective database analysis | |
Characteristics, resource utilization and safety profile of patients prescribed with neuropathic pain treatments: a real-world evidence study on general practices in Europe. | ||||
Katz P1, Pegoraro V2, Liedgens H1. | ||||
1 Grunenthal GmbH , Aachen , Germany. 2 QuintilesIMS, Milan, Italy. | ||||
Current Medical Research and Opinion |
||||
, Article | ||||
, Belgium, Germany, Italy, Spain, UK | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28537441 | ||||
Condition | Year | Language | Analysis type | |
, Pain | 2017 | English | , Database Study, Epidemiological study, Longitudinal study, Observational study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis | |
Perception of symptoms and quality of life –comparison of patients’ and physicians’ views in the COPD MIRROR study | ||||
Celli B1, Blasi F2, Gaga M3, Singh D4, Vogelmeier C5, Pegoraro V6, Caputo N7, Agusti A8. | ||||
1 Pulmonary and Critical Care Medicine Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA 2 Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy 3 7th Respiratory Medicine Department and Asthma Centre, Athens Chest Hospital, Athens, Greece 4 Medicines Evaluation Unit, University of Manchester, University Hospital of South Manchester, Manchester, UK 5 Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-Universität Marburg, Marburg, Germany, German Center for Lung Research (DZL), Giessen, Germany 6 Real World Insight, QuintilesIMS, Milan, Italy 7 Primary Market Research, QuintilesIMS, Milan, Italy 8 Respiratory Institute, Hospital Clinic, IDIBAPS, CibeRes, University of Barcelona, Barcelona, Spain | ||||
International Journal of COPD |
||||
, Article | ||||
, Germany, Italy, Spain | ||||
Abstract: https://www.dovepress.com/perception-of-symptoms-and-quality-of-life-comparison-of-patients-and--peer-reviewed-article-COPD | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2017 | English | , Survey research | |
Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model | ||||
Gerlier L1, Hackett J2, Lawson R2, Dos Santos Mendes S3, Weil-Olivier C4, Schwehm M5, Eichner M6,7 | ||||
1 QuintilesIMS, Real-World Evidence Solutions, Zaventem, Belgium 2 AstraZeneca, Gaithersburg, MD, USA 3 AstraZeneca, Brussels, Belgium (Current affiliation: MSD, Brussels, Belgium) 4 Department of Pediatrics, University Paris VII, Paris, France 5 ExploSYS GmbH, Leinfelden-Echterdingen, Germany 6 Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany 7 Epimos GmbH, Dusslingen, Germany | ||||
JHEOR 2017;5(1):89-108 |
||||
, Article | ||||
, Australia, Belgium, Finland, France, Germany, Greece, Italy, Luxembourg, Netherlands, Poland, Portugal, Spain, Sweden, UK | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Infectious disease, Respiratory disease | 2017 | English | , Epidemiological study, Public Health | |
Epidemiologic and economic burden of HPV-related diseases in Spain: Potential benefit of adding 5 additional types in the nonavalent vaccine. | ||||
López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4, Perulero N4 | ||||
1 Medical Affairs, Sanofi Pasteur MSD, Madrid, Spain 2 Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain 3 Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain 4 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain | ||||
HPV2017 31st International papillomavirus conference, 2017, February 28 – March 4, Cape Town, South Africa |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://hpv2017.org/Documents/HPV%202017%20Final%20Program%20SPIRAL.pdf | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Health economics, Immunology and Vaccination, Oncology | 2017 | English | , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Literature Review, Survey research | |
Análisis de coste-efectividad de empagliflozina en pacientes con diabetes mellitus tipo 2 y enfermedad cardiovascular establecida en España [Analysis of cost-effectiveness of empagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease established in Spain]. | ||||
Barrull C1, Massafrets M2, Planellas L1, Perulero N1 | ||||
1 RWI, QuintilesIMS, Barcelona 2 Market Access Department, Boehringer Ingelheim, Barcelona | ||||
XXXVII Jornadas de Economía de la Salud2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/en/ | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Diabetes, Health economics, Pricing and reimbursement | 2017 | Spanish | , Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Cost effectiveness, Cost utility, Literature Review, Patient questionnaire, Randomised controlled trial | |
Impacto económico de las enfermedades asociadas al VPH en España: beneficio potencial de la vacuna nonavalente frente a la tetravalente [Economic impact of HPV-associated diseases in Spain: potential benefit of nonvalorent versus tetravalent vaccine]. | ||||
López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4 | ||||
1 Medical Affairs, MSD, Madrid, Spain 2 Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain 3 Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain 4 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/en/ | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Health economics, Immunology and Vaccination, Oncology | 2017 | Spanish | , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review, Survey research | |
Estimación de la carga epidemiológica de patologías asociadas a 9 genotipos del virus del papiloma humano en España: revisión de la literatura [Estimating the epidemiological burden of pathologies associated with 9 human papillomavirus genotypes in Spain: Literature review]. | ||||
Lopez N1, Viayna E2, Perulero N2, San-Martin M1 | ||||
1 Sanofi Pasteur-MSD 2 Quintiles IMS | ||||
Vacunas. 2017;18(2):36-42 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.elsevier.es/es-revista-vacunas-72-avance-resumen-estimacion-carga-epidemiologica-patologias-asociadas-S1576988716300644?referer=buscador | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Health economics, Immunology and Vaccination, Oncology | 2017 | Spanish | , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review | |
Carga epidemiológica y económica de las patologías asociadas al virus del papiloma humano en españa: revisión de la literatura [Epidemiological and economic burden of pathologies associated with human papillomavirus in Spain: literature review]. | ||||
Lopez N1, Viayna E2, Perulero N2, San-Martin M1 | ||||
1 Sanofi Pasteur-MSD 2 Quintiles IMS | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/en/ | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Health economics, Immunology and Vaccination, Oncology | 2017 | Spanish | , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review | |
Análisis de las diferencias en el tiempo de elaboración de los informes de posicionamiento terapéutico [Analysis of the differences in the time of elaboration of the reports of therapeutic positioning]. | ||||
Viayna E, Planellas L, Solozabal M | ||||
Quintiles IMS | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Oral presentation | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/en/ | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2017 | Spanish | , Literature Review, Public Health | |
Comparison of incremental cost-utility ratios and sales of direct oral anticoagulants across EU-5 countries. | ||||
Viayna E, Planellas L | ||||
Quintiles IMS | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, 2017, Nov 4 - 8, Glasgow, Scotland, United Kingdom |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://www.ispor.org/Event/index/2017Glasgow | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2017 | English | , Cost utility, Literature Review | |
Modelización del comportamiento de fármacos biosimilares en 5 países de europa [Modeling of the behavior of biosimilar drugs in 5 European countries]. | ||||
Manganelli AG1, Solozabal M2, Planellas L2, Rebollo P2, Puig-Junoy J1 | ||||
1 CRES - Universitat Pompeu Fabra, Barcelona, Spain 2 QuintilesIMS, RWI, Barcelona, Spain | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.aes.es/jornadas/es/#comunicaciones | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Drug Utlization Study | 2017 | Spanish | , Clinical setting: hospital | |
Tiempos de Acceso Regional de Productos Hospitalarios [Regional Access Times for Hospital Products]. | ||||
Solozabal M1, Fraile S2, Gómez V1 | ||||
1 RWI, QuintilesIMS, Barcelona, Spain 2 Hospital Offering development, QuintilesIMS, Madrid, Spain | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Oral presentation | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/es/ | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2017 | Spanish | , Clinical setting: hospital, Market impact, Retrospective database analysis | |
Relación entre los tiempos del proceso de P&F y el acceso regional de productos hospitalarios en España [Relationship between the times of the P & F process and the regional access of hospital products in Spain]. | ||||
Gómez V1, Fraile S2, Solozabal M1 | ||||
1 RWI, QuintilesIMS, Barcelona, Spain 2 Hospital Offering development, QuintilesIMS, Madrid, Spain | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Oral presentation | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/es/ | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2017 | Spanish | , Clinical setting: hospital, Market impact, Retrospective database analysis, Survey research | |
Evolution of the time-to-market of hospital products in Spain. | ||||
Gómez-Navarro V1, Fraile S2, Solozabal M1 | ||||
1 RWI, QuintilesIMS, Barcelona, Spain 2 Hospital Offering development, QuintilesIMS, Madrid, Spain | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, 2017, Nov 4 - 8, Glasgow, Scotland, United Kingdom |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.ispor.org/Event/index/2017Glasgow | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2017 | English | , Clinical setting: hospital, Market impact, Retrospective database analysis, Survey research | |
Clonal selection of TP53MUT and/or Del (p17) in CLL: evaluation of 3,373 CLL patients, A Real World Data story | ||||
Mpima S1, Moehler T2, Kanter S3, Mitrofan L4 | ||||
1 QuintilesIMS Health, Paris, France 2 QuintilesIMS Health, London, UK 3 QuintilesIMS Health, Frankfurt, Germany 4 QuintilesIMS Health, Durham, USA | ||||
ASCO 2017, Journal of Clinical Oncology, 2017, 35(Suppl no. 15):e19004-e19004 |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.e19004 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
Treatment paradigm shift in NSCLC: patient data analysis from 2005 to 2016. | ||||
Mitrofan L1, Sahni MK2, Dhingra D2, Mistry H3, Anger C3 | ||||
1 Quintiles IMS, Paris, France 2 Quintiles IMS, Gurgaon, India 3 Quintiles IMS, London, United Kingdom | ||||
ESMO 2017 Annual meeting, 2017, 8-12 September, Madrid, Spain |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
Changing treatment patterns in metastatic colorectal cancer in EU5 countries from 2014 to 2016. | ||||
Hoyer L, Schmidt N | ||||
QuintilesIMS Global Oncology, Central, East & South Europe | ||||
ESMO 2017 Annual meeting, 2017, 8-12 September, Madrid, Spain |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
COMMONALITIES AND DIFFERENCES IN DATA COLLECTION ACROSS EUROPEAN SPONDYLOARTHRITIS REGISTRIES | ||||
M. L. Hetland* 1, M. Østergaard1, J. Askling2, C. Gabay3, D. Nordstrom4, O. FitzGerald5, M. Hernández Miguel6, M. Santos7 , Z. Rotar8, H. Mann9, F. Iannone10, M. J. Nissen3, E. Hauge1, J. Gomez-Reino11, F. Díaz-González12, M. Tomsic8, K. Pavelka9, F. O'Shea5, C. Sullivan5, M. van de Sande13, I. E. van der Horst-Bruinsma13, G. J. Macfarlane14, G. T. Jones14, B. Gudbjørnsson15, T. K. Kvien16 on behalf of EuroSpA Study Group | ||||
1DANBIO, Glostrup, Denmark, 2ARTIS, Stockholm, Sweden, 3SCQM, Geneva, Switzerland, 4ROB-FIN, Helsinki, Finland, 5ASRI, Dublin, Ireland, 6BIOBADASER, Barcelona, Spain, 7reuma.pt, Almada, Portugal, 8biorx.si, Ljubljana, Slovenia, 9ATTRA, Prague, Czech Republic, 10GISEA, Bari, Italy, 11BIOBADASER, Santiago, 12BIOBADASER, Santa Cruz de Tenerife, Spain, 13ARC, Amsterdam, Netherlands, 14BSRBR-AS, Aberdeen, United Kingdom, 15ICEBIO, Reykjavik, Iceland, 16NORDMARD, Oslo, Norway | ||||
EULAR, Madrid, 2017 |
||||
, Abstract | ||||
, Czech, Denmark, Finland, Ireland, Italy, Norway, Slovenia, Spain, Sweden, Switzerland | ||||
Abstract: http://ard.bmj.com/content/76/Suppl_2/656.3 | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2017 | English | , Epidemiological study | |
Revisión de modelos económicos de coste-efectividad/ coste-utilidad desarrollados con los nuevos agentes antivirales de acción directa para el tratamiento de pacientes con hepatitis c [Review of economic cost-effectiveness / cost-utility models developed with new direct-acting antiviral agents for the treatment of patients with hepatitis C]. | ||||
Planellas L1, Pascual N2, Solozabal M1, Rebollo P1, Puig-Junoy J2 | ||||
1 QuintilesIMS, RWI, Barcelona, Spain 2 CRES - Universitat Pompeu Fabra, Barcelona, Spain | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/es/#comunicaciones | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Infectious disease | 2017 | Spanish | , Cost effectiveness, Literature Review, Review | |
Characteristics of COPD patients initiating treatment with aclidinium or tiotropium in primary care in Catalonia: a population-based study | ||||
Mònica Monteagudo, Montse Roset, Teresa Rodriguez-Blanco, Laura Muñoz, Marc Miravitlles | ||||
1. Primary Care University Research Institute Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain; 2. Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Spain; 3. IMS Health, Barcelona, Spain; 4. Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, Spain; 5. Pneumology Department, Hospital Universitari Vall d’Hebron, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain | ||||
Int J Chron Obstruct Pulmon Dis. 2017 Apr 12;12:1145-1152 |
||||
, Abstract | ||||
, Spain | ||||
Abstract: 1 Primary Care University Research Institute Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain; 2 Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Spain; 3 IMS Health, Barcelona, Spain; 4 Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, Spain; 5 Pneumology Department, Hospital Universitari Vall d’Hebron, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2017 | English | , Observational study | |
Healthcare resource utilization and cost among males with lower urinary tract symptoms with a predominant storage component in Spain: The epidemiological, cross-sectional MERCURY study | ||||
Errando-Smet C1, Müller-Arteaga C2, Hernández M3, Lenero E4, Roset M5. | ||||
1. Department of Urology, Fundació Puigvert, Barcelona, Cartagena, Spain. 2. Department of Urology, Complexo Hospitalario Universitario de Ourense, Ourense, Spain. 3. Department of Medical Affairs, Astellas Pharma Europe B.V., Madrid, Spain. 4. Medical Affairs Global Development, Astellas Pharma, Northbrook, Illinois. 5. Health Economics and Outcomes Research, IMS Health, Barcelona, Spain. | ||||
Neurourol Urodyn. 2018 Jan;37(1):307-315 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28464366 | ||||
Condition | Year | Language | Analysis type | |
, Urology | 2017 | English | , Observational study | |
Real World analysis for immune related side effects in 3000 patients | ||||
Mitrofan L 1, Moehler T 2, Ruiz M 3 | ||||
1IQVIA Paris , France 2IQVIA , Frankfurt, Germany, 3IQVIA, Madrid, Spain | ||||
ESMO - ImmunoOncology |
||||
, Poster | ||||
, Europe, France, Germany, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | ||
Spanish cultural adaptation of the short version of the Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23) | ||||
Martínez-Ginés ML, García-Domínguez JM, Sarmiento M, Maurino J | ||||
Martínez-Ginés ML: Servicio de Neurología, Hospital Universitario Gregorio Marañón, Madrid, España Sarmiento M: QuintilesIMS, Barcelona, España | ||||
Neurología 2017; Apr 5 [Epub ahead of print] |
||||
, Letter | ||||
, Spain | ||||
Abstract: http://www.elsevier.es/es-revista-neurologia-295-avance-resumen-adaptacion-cultural-al-espanol-del-S0213485317301056 | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes, Neurological disorders | 2017 | Spanish | , Patient questionnaire | |
Impact of locally advanced or metastatic prostate cancer on the quality of life | ||||
López-Calderero I, López-Fando L, Ríos-González E, Maisonobe P, Hernández-Yuste E, Sarmiento-Jordán M | ||||
López-Calderero I: Hospital Can Misses, Ibiza, España Sarmiento M: QuintilesIMS, Barcelona, España | ||||
Actas Urológicas Españolas 2017;41(6):368-75 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28256271 | ||||
Condition | Year | Language | Analysis type | |
, Oncology, Urology | 2017 | English | , Quality of life | |
Conjoint analysis to understand preferences of patients with multiple sclerosis for disease-modifying therapy attributes in Spain: a cross-sectional observational study | ||||
Rafael Arroyo1, Angel P Sempere2, Elena Ruiz-Beato3, Daniel Prefasi4, Agata Carreo5, Montse Roset5, Jorge Maurino4 | ||||
1. Department of Neurology, Hospital Universitario Quirnsalud, Madrid, Spain 2. Department of Neurology, Hospital General Universitario de Alicante, Alicante, Spain 3. Health Economics and Outcomes Research Unit, Roche Farma SA, Madrid, Spain 4. Medical Department, Roche Farma SA, Madrid, Spain 5. Health Economics and Outcomes Research, IMS Health, Barcelona, Spain | ||||
BMJ Open. 2017 Mar 8;7(3):e014433. |
||||
, Article | ||||
, Spain | ||||
Abstract: https://bmjopen.bmj.com/content/7/3/e014433 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2017 | English | , clinical setting: Secondary care, Observational study | |
Cross-cultural validation of Lupus Impact Tracker in five European clinical practice settings | ||||
Schneider M, Mosca M, Pego-Reigosa JM, Gunnarsson I, Maurel F, Garofano A, Perna A, Porcasi R, Devilliers H | ||||
Policlinic of Rheumatology, Hiller Research Unit, Heinrich-Heine University, Düsseldorf, Germany. Department of Internal Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy. Department of Rheumatology, Complexo Hospitalario Universitario de Vigo, Ourense y Pontevedra, Spain. Department of Medicine, Unit of Rheumatology, Karolinska Institutet, Solna, Sweden. HEOR, Real-World Evidence Solutions (RWES) unit, IMS Health, Paris-La Défense, France. Global Specialty Pharma Franchise, GlaxoSmithKline; Services Unlimited, Brentford, UK. Immunology Medical Department, GlaxoSmithKline spa, Verona, Italy. Department of Internal Medicine and Systemic Diseases, University Hospital of Dijon, 5bis INSERM U866 5ter INSERM CIC-EC 1432, Dijon, France. | ||||
Rheumatology (Oxford). 2017 May 1;56(5):818-828 |
||||
, Article | ||||
, France, Germany, Italy, Spain, Sweden | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28204765 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Rheumatology | 2017 | English | , Retrospective Field Study | |
TREATMENT PATTERNS OF METASTATIC MELANOMA IN FIVE EUROPEAN COUNTRIES | ||||
Burudpakdee C1, Zhao Z2, Seetasith A1, Ma Q2, Campos Tapias I3, Barber BL2 | ||||
1 MS Health, Fairfax, VA, USA, 2 Amgen Inc, Thousand Oaks, CA, USA, 3 Amgen SA, Barcelona, Spain | ||||
ISPOR 21st, May 2016 Washington, USA |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
Epidemiology of iron deficiency anaemia in four European countries: a population-based study in primary care. | ||||
Levi M1-2, Rosselli M3, Simonetti M1, Brignoli O4, Cancian M4, Masotti A5, Pegoraro V6, Cataldo N6, Heiman F6, Chelo M1, Cricelli I1, Cricelli C4, Lapi F1. | ||||
1 Health Search Italian College of General Practitioners and Primary Care, Florence 2 Department of Health Sciences, University of Florence, Florence, Italy 3 Institute for Liver and Digestive Health, Royal Free Hospital, University College of London, London, UK 4 Italian College of General Practitioners and Primary Care, Florence 5 Department of Transfusion Medicine, Local Health Authority n°5, Pordenone 6 IMS Health Information Solutions Medical Research srl, Milan, Italy | ||||
Eur J Haematol. 2016 May 7. doi: 10.1111/ejh.12776 |
||||
, Article | ||||
, Belgium, Germany, Italy, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Epidemiology+of+iron+deficiency+anaemia+in+four+European+countries%3A+a+population-based+study+in+primary+care. | ||||
Condition | Year | Language | Analysis type | |
, Nutritional Disorders | 2016 | English | , Database Study, Epidemiological study, Longitudinal study, Real World Data, Real World Evidence, Retrospective database analysis | |
Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. | ||||
Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1. | ||||
1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden. 2Centre for Observational Research, Amgen Ltd, Uxbridge, UK. 3IMS Health Sweden, Stockholm, Sweden. | ||||
Clinical Epidemiology |
||||
, Article | ||||
, Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK | ||||
Abstract: http://www-ncbi-nlm-nih-gov.proxy.kib.ki.se/pmc/articles/PMC4887072/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Literature Review | |
Characteristics, resources utilization and safety profile of patients with acute pain: a European real world evidence study. | ||||
Katz P1, Pegoraro V2, Heiman F, Liedgens H1. | ||||
1 Grunenthal GmbH, Aachen, Germany 2 IMS Health Information Solutions Italy Srl, Milan, Italy. | ||||
ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria. |
||||
, Poster | ||||
, Belgium, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Neurological disorders, Pain | 2016 | Italian | , Clinical setting: Primary care, Database Study, Epidemiological study, Longitudinal study, Real World Data, Real World Evidence, Retrospective database analysis | |
Rationale and design of a multi-center survey to evaluate productivity losses and indirect costs after cardiovascular events in Europe. | ||||
Gerlier L1, Sidelnikov E2, Kutikova L2, Lamotte M1, Annemans L3 | ||||
1 QuintilesIMS, Zaventem, Belgium 2 Amgen (Europe) GmbH, Zug, Switzerland 3 University of Ghent, Ghent, Belgium | ||||
19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
||||
, Abstract | ||||
, Belgium, Czech, France, Germany, Hungary, Italy, Poland, Portugal, Romania, Spain, Switzerland, UK | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | ||
USE OF REAL WORLD DATA IN IDENTIFYING RELEVANT COMPARATORS IN MEDICO ECONOMIC MODELS AT EU5 LEVEL: A CASE STUDY ON MULTIPLE MYELOMA | ||||
Jubert H, Kolahi C, Karusisi N, Mitrofan L | ||||
IMS Health France | ||||
19th ISPOR congress 2016 |
||||
, Abstract, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN150.pdf | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Oncology | 2016 | English | , Clinical setting: hospital, Population Based Study, Real World Data, Retrospective database analysis | |
Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based study. | ||||
Peyrin-Biroulet L1, Van Assche G2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11. | ||||
1Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France. Electronic address: peyrinbiroulet@gmail.com. 2Division of Gastroenterology, University Hospitals Leuven, Leuven Belgium. 3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany. 4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain. 5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom. 6Gastroenterology Practice, Minden, Germany. 7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece. 8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy. 9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom. 10IMS Health, Real World Evidence Solutions, Spain. 11Merck & Co., Inc., Kenilworth, NJ, United States | ||||
Dig Liver Dis. 2016 Jun;48(6):601-7. |
||||
, Article | ||||
, Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2016 | English | , Burden of illness, Patient questionnaire, Survey research | |
Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort study | ||||
Van Assche G1, Peyrin-Biroulet L2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11. | ||||
1Division of Gastroenterology, University Hospitals Leuven, Leuven, Belgium. Electronic address: gert.vanassche@uzleuven.be. 2Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France. 3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany. 4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica and Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain. 5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, UK. 6Gastroenterology Practice, Minden, Germany. 7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece. 8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy. 9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, UK. 10IMS Health, Real World Evidence Solutions, Barcelona, Spain. 11Merck & Co., Inc., Rahway, NJ, United States. | ||||
Dig Liver Dis. 2016 Jun;48(6):592-600 |
||||
, Article | ||||
, Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2016 | English | , Burden of illness, Patient questionnaire | |
Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective | ||||
Marchetti P1, Maass N2, Gligorov J3, Berger K4, MacDougall F5, Montonen J6, Lewis J7. | ||||
1Department of Clinical and Molecular Medicine, Sapienza University of Rome and IDI-IRCCS, Rome, Italy. Electronic address: paolo.marchetti@ospedalesantandrea.it. 2Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Kiel, Germany. Electronic address: Nicolai.Maass@uksh.de. 3Department of Medical Oncology, INSERM U938, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France. Electronic address: joseph.gligorov@aphp.fr. 4Real World Evidence Solutions and HEOR, IMS Health, Munich, Germany. Electronic address: KBerger@de.imshealth.com. 5Real World Evidence Solutions and HEOR, IMS Health, London, United Kingdom. Electronic address: FMacDougall@uk.imshealth.com. 6AstraZeneca, London, United Kingdom. Electronic address: jukka.montonen@astrazeneca.com. 7AstraZeneca, London, United Kingdom. Electronic address: Jan.Lewis@astrazeneca.com. | ||||
Breast. 2016 Dec 20. pii: S0960-9776(16)30264-8. |
||||
, Article | ||||
, France, Germany, Italy, Spain | ||||
Abstract: https://linkinghub.elsevier.com/retrieve/pii/S0960-9776(16)30264-8 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility | ||||
Gizzo S1, Garcia-Velasco JA2, Heiman F3, Ripellino C3, Bühler K4 | ||||
1 Department of Woman and Child Health, University of Padua, Padua, Italy 2 Department of Obstetrics and Gynecology, Rey Juan Carlos University Madrid, Madrid, Spain 3 IMS Health Information Solutions Italy Srl, Milan, Italy 4 Centre for Gynaecology, Endocrinology, and Reproductive Medicine, Ulm and Stuttgart, Germany | ||||
Int J Womens Health |
||||
, Manuscript in preparation | ||||
, Germany, Italy, Spain, UK | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153281/ | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Pregnancy | 2016 | English | , Cost effectiveness | |
Novel therapy options for advanced & metastatic melanoma patients in EU5 countries result in a changing treatment pattern especially in BRAF mutant patients. | ||||
Bernhardt M, Schmidt N, Mambrini T | ||||
IMS Health Global Oncology, Central, East & South Europe | ||||
ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://poster-submission.com/esmo2016/visitors/eposter/32626 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
Changing treatment patterns in advanced & metastatic melanoma towards targeted therapies in EU5 countries from 2011 to 2015. | ||||
Bernhardt M, Schmidt N, Mambrini T | ||||
IMS Health Global Oncology, Central, East & South Europe | ||||
ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://poster-submission.com/esmo2016/visitors/eposter/32287 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
Brain metastasis in NSCLC in the era of precision Medicine. | ||||
Mpima S, Anger C, Mitrofan L | ||||
1 IMS Health, London, United Kingdom 2 IMS Health, La Defense, France | ||||
ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2016/Brain-metastases-in-NSCLC-patients-in-the-era-of-precision-medicine | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Observational study | |
17P Deletion and TP53 Gene Mutation (17P/TP53) testing behaviour and treatment patterns for Chronic Lymphocytic Leukaemia (CLL) patients in France, Germany, Italy, Spain and U.K. (EU5). | ||||
Bermudez F, Karanais Y, Mistry H, Anger C | ||||
IMS Health, London, United Kingdom | ||||
ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://poster-submission.com/esmo2016/visitors/eposter/32724 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
Real Life Progression Free Survival and treatment Patterns for Patients with Metastatic Renal Cell Carcinoma treated with Targeted Therapies in France: Analysis of IMS RWD Oncology Cross-sectional Survey Data. | ||||
Maroun R, Mitrofan L, Benjamin L, Nachbaur G, Maunoury F, Le Jeunne P, Durand Zaleski I | ||||
GlaxosmithKline, Health Economics and Outcome Research, Marly le Roi France, Eceve, Paris, France, Quintiles IMS, France Le Mans, France, URC Eco, Paris, France | ||||
ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN47.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Longitudinal study | |
Understand the Role of dermatologists and Oncologists in the treatment of Melanoma in France and the UK. | ||||
Mpima S, Casey V, Nasuti P | ||||
QuintilesIMS, London, United Kingdom | ||||
IPSOR 2016 Annual Meeting |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(16)32943-6/pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Observational study | |
Use of Real World Data in identifying relevant comparators in medico economic models at EU5 level: A case study on Multiple Myeloma. | ||||
Jubert H, Karusisi N, Kolahi C, Mitrofan L | ||||
QuintilesIMS, La Defense, France | ||||
IPSOR 2016 Annual Meeting |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN150.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | ||
Coste del síndrome del intestino irritable con predominio de estreñimiento en España | ||||
Xavier Cortés1, Montse Roset2, Carmen Barrull2, Carolina Sais3, Anna Raya4 | ||||
1 Departamento Médico, Almirall S.A., Barcelona, España; 2 Health Economics & Outcomes Research, IMS Health, Barcelona, España; 3 IASIST, Barcelona, España; 4 Departamento de Marketing, Almirall S.A., Barcelona, España | ||||
PharmacoEcon Span Res Artic (2016) 13(1):1-8. |
||||
, Article | ||||
, Spain | ||||
Abstract: https://link.springer.com/article/10.1007/s40277-015-0048-0 | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Gastrointestinal disorders, Health economics | 2016 | Spanish | , Burden of illness, Clinical setting: Primary care, Cost analysis, Retrospective database analysis | |
Impacto presupuestario del uso de un contraste isoosmolar frente a contrastes de baja osmolaridad en pacientes con alto riesgo de nefropatía inducida por contraste en el entorno hospitalario español | ||||
Eduardo Pinar1, José María Hernández2, Josepa Mauri3, Francisco Picó4, Rafael Ruiz5, Ángel Luis de Francisco6, Carmen Barrull7, Emilio Moreno8, Alexis Sampedro8, Felipe Hernández9 | ||||
1 Servicio de Hemodinámica, Servicio de Cardiología, Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia, España; 2 Unidad de Hemodinámica, Hospital Virgen de la Victoria, Málaga, España; 3 Unitat d’Hemodinàmica i Cardiologia Intervencionista, Hospital Universitari Germans Trias i Pujol, Barcelona, España; 4 Unidad de Cardiología y Hemodinámica, Hospital Quirón, Murcia, España; 5 Servicio de Hemodinámica e Intervención Endovascular, Hospital Virgen Macarena, Sevilla, España; 6 Servicio de Nefrología, Hospital Universitario Marqués de Valdecilla, Santander, España; 7 Health Economics & Outcomes Research, IMS Health, Barcelona, España; 8 Departamento Médico, GE Healthcare, Madrid, España; 9 Servicio de Cardiología, Hospital Universitario Doce de Octubre, Madrid, España | ||||
PharmacoEcon Span Res Artic (2016) 13(1):17-24. |
||||
, Article | ||||
, Spain | ||||
Abstract: https://link.springer.com/article/10.1007%2Fs40277-015-0049-z | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Drug safety, Drug Utlization Study, Health economics | 2016 | Spanish | , Budget impact, Clinical setting: hospital | |
The Burden of Ulcerative Colitis and Crohn’s Disease in Spain | ||||
Cortés X1, Fernández-Salazar L2, Márquez L3, Ramos L4, Díaz Rubio C5, Planellas L6, Gasche D6 | ||||
1Gastroenterology Section, Internal Medicine of Hospital Universitario de Sagunto. University CEU Cardenal Herrera, Department of Medicine, Valencia; 2Department of Gastroenterology of Hospital Clínico Universitario de Valladolid; Department of Gastroenterology of Hospital del Mar de Barcelona; 4Department of Gastroenterology of Hospital Universitario de Canarias; 5Market Access Department, AbbVie; 6HEOR-RWE, IMS Health | ||||
Revista Española de la Economía de Salud (EDS). 2016;11(5):902-913 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.economiadelasalud.com/Articulo.aspx?i=n5d018 | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders, Health economics, Immunology and Vaccination | 2016 | English | , Burden of illness, Clinical setting: hospital, Survey research | |
Análisis del impacto presupuestario de misoprostol en la maduración cervical e inducción del parto a término | ||||
De la Torre A1, Arjona Berral JA1, Gasche D2, Miñarro C2 | ||||
1Unidad de Gestión Clínica de Obstetricia y Ginecología, Hospital Universitario Reina Sofía de Córdoba, Córdoba, España; 2Health Economics & Outcomes Research Real-World Evidence Solutions, IMS Health, S.A., Madrid, España | ||||
Pharmacoecon Span Res Artic (2016) 13:141–147 |
||||
, Spain | ||||
Abstract: https://link.springer.com/article/10.1007/s40277-016-0060-z | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2016 | Spanish | , Budget impact, Clinical setting: hospital, Literature Review | |
AN ASSESMENT OF ENOXAPARINE BENEFIT ON HEALTHCARE BUDGET IN SPAIN | ||||
Delgado M1, Restovic G2, Planellas L2, Rubio M1, Miñarro C3 | ||||
1Sanofi, Barcelona, Spain, 2IMS Health, Barcelona, Spain, 3IMS Health, Madrid, Spain | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2015 | English | ||
ASSESSING THE COST-EFFECTIVENESS OF USING ACLIDINIUM BROMIDE 400 µG /FORMOTEROL FUMARATE DIHYDRATE 12 µG COMPARED TO ACLIDINIUM BROMIDE 400 µG IN THE MANAGEMENT OF MODERATE TO SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE | ||||
Ramos M1, Haughney J2, Henry N3, Lindner L4, Lamotte M1 | ||||
1IMS Health, Vilvoorde, Belgium, 2University of Aberdeen, Aberdeen, UK, 3IMS Health, London, UK, 4AstraZeneca, Barcelona, Spain | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
, Poster | ||||
, Belgium, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2015 | English | , Cost analysis | |
MEDICAL COST OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION (NVAF) AND TREATED WITH VITAMIN K ANTAGONISTS (VKAS) ACCORDING TO INR CONTROL STATUS IN SPAIN | ||||
Postema R1, Bardoulat I2, Roset M3, Maurel F4, Lefevre C5, Evans D5 | ||||
1Bristol-Myers Squibb, Braine-l'Alleud, Belgium, 2IMS Health, Paris, France, 3IMS Health, Barcelona, Spain, 4IMS Health, La Défense, France, 5Bristol-Myers Squibb, Rueil-Malmaison, France | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Vascular disease | 2015 | English | ||
A COMPARISON OF TWO LOW-MOLECULAR-WEIGHT HEPARINS (LMWHS) IN TERMS OF COST PER PATIENT | ||||
Planellas L1, Miñarro C2, Restovic G1, Delgado M3, Rubio M3 | ||||
1IMS Health, Barcelona, Spain, 2IMS Health, Madrid, Spain, 3Sanofi, Barcelona, Spain | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Vascular disease | 2015 | English | ||
A CROSS-SECTIONAL STUDY ON INSULIN TREATMENTS AND GLYCEMIC CONTROL IN TYPE 2 DIABETES IN FRANCE, ITALY, GERMANY, UK AND SPAIN | ||||
Phan T1, Boutmy E2, Coulombel N2 | ||||
1Novo Nordisk Health Care AG, Zürich, Switzerland, 2IMS Health, Boulogne-Billancourt, France | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.ispor.org/research_pdfs/51/pdffiles/PDB13.pdf | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2015 | English | , Retrospective database analysis | |
Economic impact of contrast-induced acute kidney injury associated with invasive cardiology: role of iso-osmolar contrast media in Germany, Italy, Poland and Spain. | ||||
De Francesco M, Ronco C, Wacinski PJ, Wessely R, Hernández P, Lamotte M. | ||||
, Germany, Italy, Poland, Spain | ||||
Abstract: http://dx.doi.org/10.3111/13696998.2015.1105809 | ||||
Condition | Year | Language | Analysis type | |
2015 | English | |||
Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study. | ||||
Emery P1, Gottenberg JE2, Rubbert-Roth A3, Sarzi-Puttini P4, Choquette D5, Taboada VM6, Barile-Fabris L7, Moots RJ8, Ostor A9, Andrianakos A10, Gemmen E11, Mpofu C12, Chung C13, Gylvin LH12, Finckh A14. | ||||
1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK. 2Department of Rheumatology, CHU Strasbourg, Strasbourg, France. 3University of Cologne, Cologne, Germany. 4L Sacco University Hospital, Milan, Italy. 5University of Montreal, Montreal, Canada. 6Facultad de Medicina, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain. 7Hospital de Especialidades Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, México City, Mexico. 8Department of Rheumatology, University of Liverpool, Liverpool, UK. 9Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. 10Hellenic Foundation for Rheumatological Research, Athens, Greece. 11Quintiles, Rockville, Maryland, USA. 12F Hoffmann-La Roche Ltd, Basel, Switzerland. 13Genentech Inc, San Francisco, California, USA. 14University Hospital of Geneva, Geneva, Switzerland. | ||||
Ann Rheum Dis. 2015 Jun;74(6):979-84 |
||||
, Article | ||||
, Canada, Colombia, France, Germany, Greece, Italy, Mexico, Norway, Portugal, Spain, UK | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431330/ | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Rheumatology | 2015 | English | , Clinical setting: hospital, clinical setting: Secondary care, Prospective study, RWLPR (Real-World Late Phase Research-quintiles | |
Dose variation in metastatic breast cancer: Are European Medicines Agency summary of product characteristics (SmPC) being followed? | ||||
Charnock J, Bruce A, Anger C | ||||
IMS Health, London, United Kingdom | ||||
ASCO 2015 Annual Meeting, 2015, May 29-June 2, Chicago, Illinois, USA |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://ascopubs.org/doi/abs/10.1200/jco.2015.33.15_suppl.e11581 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | ||
Evolution of RAS testing in colorectal cancer, in France, Germany, Italy, Spain and UK (EU5). | ||||
Bruce A, Anger C, Gajeperia C | ||||
IMS Health, London, United Kingdom | ||||
ASCO 2015 Annual Meeting, 2015, May 29-June 2, Chicago, Illinois, USA |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://ascopubs.org/doi/abs/10.1200/jco.2015.33.15_suppl.e14679 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Standards of care for first-line HER2+ metastatic breast cancer (mBC): Russia vs. EU5 (France, Germany, Italy, Spain, and UK). | ||||
Bruce A, Hurlock J | ||||
IMS Health, London, United Kingdom | ||||
ESMO 2015 Annual Meeting |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.poster-submission.com/ecc2015/visitors/eposter/29740 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Stratification of high risk HER2-/HR+ patients following AI therapy. | ||||
Mitrofan L, Gajperia C, Charnock J, Anger C | ||||
IMS Health, London, United Kingdom | ||||
ESMO 2015 Annual Meeting |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.poster-submission.com/ecc2015/visitors/eposter/29751 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Cost-Effectiveness Analysis of Delayed-Release Dimethyl Fumarate for The Treatment of Relapsing Remitting Multiple Sclerosis In Spain. | ||||
Gasche D1, Restovic G1, Casado V2, Ramírez-Boix P3, Martínez Lopez J3 | ||||
1IMS Health, Barcelona, Spain; 2Mataro Hospital, Mataro, Barcelona, Spain; 3Biogen, Madrid, Spain | ||||
Value in Health. Volume 18, Issue 7, November 2015, Page A755 |
||||
, Abstract | ||||
, Spain | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S1098301515050123?via%3Dihub | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Health economics, Neurological disorders | 2015 | English | , Clinical setting: hospital, Cost effectiveness, Literature Review | |
Patterns of systemic lupus erythematosus expression in Europe | ||||
Cervera R1, Doria A2, Amoura Z3, Khamashta M4, Schneider M5, Guillemin F6, Maurel F7, Garofano A7, Roset M8, Perna A9, Murray M10, Schmitt C11, Boucot I12 | ||||
1. Departmeent of Autoimmune Diseases, Hospital Clinic, Barcelona Spain, 2. Division of Rheumatology, University of Padova, Italy, 3. Internal medecine Department 2, la pitié Salpetrière Hospital, Paris France, 4. Lupus research Unit, The Rayne inistitue Lambeth Wing, St Thomas 'Hospital London, England, 5. Policlinic of Rheumatology, Heinrich-Heine University, Germany, 6. INSERM CIC-EC, CHU Nancy, France, 7. IMS HEOR, Paris La Défense France, 8. IMS HEOR, Barcelona Spain, 9. Immuno Inflammation & infectious diseases Global Franchise, GSK, UK, 10. Access to Medicine Centre of Excellence GSK, UK, 11. Global Health Outcomes GSK, UK, 12. Medical Dpt GSK, Marly-le-Roi France | ||||
Autoimmunity Reviews - Volume 13, Issue 6, June 2014, Pages 621-629 |
||||
, Article, Manuscript in preparation | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Dermatology, Immunology and Vaccination, Musculoskeletal disease, Neurological disorders | 2014 | English | , Epidemiological study, Observational study, Prospective study | |
Selecting ovarian cancer patients for BRCA mutation testing - Findings from guidelines and literature review | ||||
Eccles D1, Garcia E2, Balmana J3, Ehlken B4, Schroeder C4, Clune J5, Hirst C6, Potter D6, Tyczynski J6 | ||||
1 University of Southampton, Southampton, UK 2 Maastricht UMC, Maastricht, Netherlands 3 Familial Cancer Program, Barcelona, Spain 4 IMS Health, München, Germany 5 AstraZeneca, Melbourne, UK 6 AstraZeneca, Gaithersburg, USA | ||||
Conference of The British Society of Genetic Medicine (BSGM), Liverpool, UK, 22–24 September, 2014 (Poster) |
||||
, Abstract | ||||
, Germany, Netherlands, Spain, UK, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Literature Review | |
Healthcare cost associated to constipation predominant irritable bowel syndrome in Spain | ||||
Raya A1, Barrull C2, Roset M2, Cortes X1, Fortea J1 | ||||
1Almirall S.A, Barcelona, Spain, 2IMS Health, Barcelona, Spain | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2014 | English | , Cost analysis | |
The risk of metabolic disorders in patients treated with asenapine or olanzapine: a study conducted on real-world data in Italy and Spain. | ||||
Maina G1, Ripellino C2 | ||||
1 Department of Neurosciences, University of Torino, Torino, 2 CSD Medical Research S.R.L, Milan, Italy | ||||
Expert Opin Drug Saf. 2014 Sep;13(9):1149-54. doi: 10.1517/14740338.2014.943732. Epub 2014 Jul 18. |
||||
, Article | ||||
, Italy, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25036458 | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Metabolic Disorders | 2014 | English | , Retrospective database analysis | |
Afatinib in the treatment of EGFR mutation-positive NSCLC - A network meta-analysis. | ||||
Popat S1, Mok T2, Yang JC3, Wu YL4, Lungershausen J5, Stammberger U5, Griebsch I5, Fonseca T6, Paz-Ares L7 | ||||
1Royal Marsden Hospital, London, UK. 2State Key Laboratory of Southern China, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong. 3National Taiwan University, Taipei, Taiwan. 4Guangdong Lung Cancer Institute, Guangzhou, China. 5Boehringer Ingelheim GmbH, Ingelheim, Germany. 6IMS Health, London, UK. 7Instituto de Biomedicina de Sevilla - IBIS (University Hospital Virgen del Rocío, US, CSIC), Seville, Spain. | ||||
Lung Cancer. 2014 Aug;85(2):230-8 |
||||
, Article | ||||
, China, Germany, Hong Kong, Spain, Taiwan, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24929780 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Meta analysis | |
The risk of metabolic disorders in patients treated with asenapine or olanzapine: a study conducted on real-world data in Italy and Spain. | ||||
Maina G, Ripellino C, Pegoraro V, Caresano C. | ||||
ISPOR Annual European Congress. 2014, Amsterdam Value in health |
||||
, Poster | ||||
, Italy, Spain | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(14)03164-7/abstract | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Neurological disorders | 2014 | English | , Real World Data | |
Description of GCSF usage in oncology in 5 European countries. | ||||
Anger C1, Schmidt N2, Ricarte C3 | ||||
1 IMS Health, London, United Kingdom 2 IMS Health, Frankfurt, Germany 3 IMS Health, La Defense, France | ||||
ASCO 2014 Annual Meeting, 2014, May 30 - June 03, Chicago, Illinois, USA |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://meetinglibrary.asco.org/record/97923/abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Observational study | |
Evaluation of treatment patterns in acute nausea and vomiting in EU5 countries. | ||||
Schmidt N, Ricarte C, Haas G | ||||
1 IMS Health CES Oncology, Central Europe; 2 Client Service Oncology, IMS Health France | ||||
ESMO 2014 Annual Meeting, 2014, 26 Sep - 30 Sep, Madrid, Spain |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Evaluation-of-treatment-patterns-in-acute-nausea-and-vomiting-in-EU5-countries | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Comparing patterns of BRAF testing and treatment in Metastatic Melanoma (MeM) in France, Germany, Italy, Spain and UK with the US. | ||||
Charnock J, Bruce A, Murch L, Anger C | ||||
Client Service Oncology, IMS Health, UK | ||||
ESMO 2014 Annual Meeting, 2014, 26 Sep - 30 Sep, Madrid, Spain |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: poster-submission.com/cdrom/download_poster/37/27774/1110P | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Patterns of patients stopping their anti-cancer drug due to its associated side effects in France, Germany, Italy, Spain and UK. | ||||
Khanna R, Anger C | ||||
Client Service Oncology, IMS Health, UK | ||||
ESMO 2014 Annual Meeting, 2014, 26 Sep - 30 Sep, Madrid, Spain |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Patterns-of-patients-stopping-their-anti-cancer-drug-due-to-its-associated-side-effects-in-France-Germany-Italy-Spain-and-UK-EU5 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Herpes Zoster-Related Health Care Resource Utilization in Cancer Patients in 5 European Countries | ||||
Gebremeskel B.G.1, Lopez-Gonzalez L.2, Patwardhan P.3, Chin J.4, Schwalm M.S.4, Acosta C.J.3,Margolis J.M.5 | ||||
VALUE IN HEALTH 17 ; A684 |
||||
, Abstract | ||||
, Belgium, France, Germany, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Immunology and Vaccination, Oncology | 2014 | English | , Cost of illness, Retrospective database analysis | |
The cost-effectiveness of exenatide once weekly compared with exenatide twice daily and insulin glargine for the treatment of patients with type two diabetes and body mass index ≥ 30 kg/m2 in Spain | ||||
Fonseca T1, Clegg J2, Caputo G3, Norrbacka K4, Dilla T5, Alvarez M5 | ||||
1IMS Health, London,UK, 2IMS Health, Basel, Switzerland, 3IMS Health, Keppel Towers, Singapore, 4dEli Lilly Finland Ab, , Helsinki, Finland, 5eLilly SA, Spain | ||||
J Med Econ. 2013 Jul;16(7):926-38 |
||||
, Abstract | ||||
, Spain | ||||
Abstract: http://informahealthcare.com/doi/abs/10.3111/13696998.2013.803110 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2013 | English | , Cost effectiveness | |
Cost per treated patient for biologics for rheumatoid arthritis (RA) using US claims data. | ||||
Schabert VF1, Korn JR1, Bilir SP1, DeKoven M1, Harrison DJ2, Joseph G2 | ||||
1 IMS Health, Alexandria, USA, 2 Amgen Inc, Thousand Oaks, USA | ||||
European League Against Rheumatism 2013 Congress, Madrid, Spain |
||||
, Poster | ||||
, Spain, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2013 | English | , Cost analysis | |
Estimating effectiveness and cost of biologics for rheumatoid arthritis: application of a validated algorithm to commercial insurance claims. | ||||
Curtis JR1, Schabert VF2, Harrison DJ3, Yeaw J2, Korn JR2, Quach C4, Yun H5, Joseph GJ3, Collier DH6. | ||||
1Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, Alabama; Department of Epidemiology, University of Alabama, Birmingham, Alabama. Electronic address: jcurtis@uab.edu. 2IMS Health, Alexandria, Virginia. 3Global Health Economics, Amgen Inc, Thousand Oaks, California. 4Health Policy and Management, University of North Carolina, Chapel Hill, North Carolina. 5Department of Epidemiology, University of Alabama, Birmingham, Alabama. 6Inflammation/Development, Amgen Inc, Thousand Oaks, California. | ||||
Clin Ther. 2014 Jul 1;36(7):996-1004. |
||||
, Spain, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2013 | English | , Cost effectiveness | |
Direct Costs of Unintended Pregnancy in Spain | ||||
Lete I1, Hassan F2, Chatzitheofilou I2, Mendivil J3, Bofill A3, Restovic G3, Arbat A3, Filonenko A4 | ||||
1Hospital Universitario Araba, Spain; 2IMS Health, UK; 3Bayer Hispania SL, Spain; 4Bayer Pharma AG, Germany | ||||
15th World Congress on Human Reproduction Venice, Italy, 13 – 16 March, 2013, ID # 400, Topic: 14. Contraception |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.humanrep2013.com/pdf/HR2013-digital%20edition.pdf | ||||
Condition | Year | Language | Analysis type | |
, Womens Health | 2013 | English | , Cost analysis, Cost of illness | |
Costes de los agentes estimulantes de la eritropoyesis en el tratamiento de la anemia inducida por quimioterapia en España: resultados preliminares procedentes de la adaptación de un estudio belga | ||||
Duran A1, Spaepen E2, Lamotte M3, Brosa M4, Gutiérrez L5, Restovic G6 | ||||
1IMS Health, London, 2SBD Analytics, Belgium, 3IMS Health, Belgium, 4Oblikue Consulting, Spain, 5Amgen SA, Spain, 6Independant Consultant, Spain | ||||
Pharmacoecon Span Res Artic (2014) 11:15–23 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://link.springer.com/article/10.1007/s40277-013-0022-7 | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2013 | Spanish | , Cost analysis | |
ADHERENCE TO TREATMENT AND PERSISTENCY IN PATIENTS TREATED WITH VKA IN FRANCE, ITALY, GERMANY, SPAIN AND UK | ||||
COTTÉ FE1, CARRASCO J1, DUPRATLOMON I1, MARCHANT N2, LETIERCE A3 & HUGUET M3 | ||||
(1) Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France; (2) Pfizer Global Access, Walton Oaks, United Kingdom ; (3) Cegedim Strategic Data, Paris, France | ||||
ISPOR Annual European Congress, Dublin. 2013. |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://www.cegedimstrategicdata.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2013 | English | , Retrospective database analysis | |
Anticoagulation treatment with VKA in France, Italy, Germany, Spain and UK. Results from the REACT-AF study. | ||||
COTTÉ FE, CARRASCO J, DUPRAT-LOMON I, MARCHANT N, LETIERCE A & HUGUET M | ||||
(1) Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France; (2) Pfizer Global Access, Walton Oaks, United Kingdom ; (3) Cegedim Strategic Data, Paris, France | ||||
ISPOR Annual European Congress, Dublin. 2013 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://www.cegedimstrategicdata.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2013 | English | , Retrospective database analysis | |
The Use of Oral Anticoagulation Drugs for Stroke Prevention in Nonvalvular Atrial Fibrilation in France, Italy, Germany, Spain and the United Kingdom: Is Current Practice Consistent with the 2012 ESC Recommendations. | ||||
COTTÉ FE, CARRASCO J, DUPRAT-LOMON I, MARCHANT N, LETIERCE A & HUGUET M | ||||
(1) Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France; (2) Pfizer Global Access, Walton Oaks, United Kingdom ; (3) Cegedim Strategic Data, Paris, France | ||||
16th Annual European ISPOR Congress Dublin, Ireland |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)03127-6/abstract | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2013 | English | , Retrospective database analysis | |
The association between asthma control, health care costs, and quality of life in france and Spain. | ||||
Doz M1, Chouaid C, Com-Ruelle L, Calvo E, Brosa M, Robert J, Decuypère L, Pribil C, Huerta A, Detournay B. | ||||
1Cemka-Eval, 43 Boulevard du Maréchal Joffre, Bourg-la-Reine | ||||
BMC Pulmonary Medicine 2013, 13:15 |
||||
, Article | ||||
, France, Spain | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2013 | English | , Cost analysis, Prospective study, Retrospective database analysis | |
Current emesis Patterns of chemotherapy and antiemetic treatments in Western Europe. | ||||
Ricarte C, Anger C | ||||
1 IMS Health, France 2 IMSHealth, UK | ||||
ESMO 2013 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
2013 | English | , Retrospective database analysis | ||
Management costs of the first five years after diagosis in Breast Cancer by Stage in France. | ||||
Atsou L, Bardoulat I, Colin X, Lemasson H, Ricarte C, Maurel F, Ajjouri R, Lancon F | ||||
1 IMS Health, La Defense, France, 2 French National Cancer Institute, Boulogne-Billancourt France Cedex, France | ||||
ISPOR Europe 2013 Annual meeting |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02369-3/abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective cohort analysis | |
Evolution of oral anticancer treatments use in France from 2004 to 2012: the Re-ACTOR Study. | ||||
Benjamin L, Maurel F, Bardoulat I, Ricarte C | ||||
1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France | ||||
ISPOR Europe 2013 Annual meeting |
||||
, Poster | ||||
, China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02489-3/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Current situation of oral anticancer treatments use in France: the ACTOR Study. | ||||
Benjamin L, Maurel F, Bardoulat I, Ricarte C | ||||
1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France | ||||
ISPOR Europe 2013 Annual meeting |
||||
, Abstract | ||||
, China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02492-3/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | ||
Evolution of Molecular Diagnostic test Usage in Solid tumours in EU5 (Analysis of Molecular Biomarker Tests in Oncology). | ||||
Ricarte C, Bruce A, Anger C | ||||
1 IMS Health, La Defense, France 2 IMS Health, London, United Kingdom | ||||
ISPOR Europe 2013 Annual meeting |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02310-3/pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Major surgery in patients with metastatic colorectal cancer in western Europe. | ||||
Zhao Z1, Pelletier EM2, Barber B1, Bhosle M3, Wang S1, Klingman D3, Gao S1 | ||||
1Amgen Inc., Thousand Oaks, CA, USA, 2IMS Consulting, Watertown, MA, USA, 3IMS Consulting, Alexandria, VA, USA | ||||
J Gastrointest Cancer. 2012 Sep;43(3):456-61 |
||||
, Manuscript in preparation | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22125088 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective database analysis | |
Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe. | ||||
Zhao Z1, Pelletier EM2, Barber B1, Bhosle M3, Wang S1, Gao S1, Klingman D3 | ||||
Amgen Inc., Thousand Oaks, CA, USA1, IMS Consulting Group, Watertown, MA, USA2, IMS Consulting Group, Alexandria, VA, USA3 | ||||
Curr Med Res Opin 2012; 28(2):221-229; 2012 Jan 27 [Epub ahead of print] |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective database analysis | |
Cost analysis: treatment of chemotherapy-induced anemia with erythropoiesis-stimulating agents in five European countries | ||||
Duran A1, Spaepen E2,Lamotte M3, Walter E4, Umuhire D5, Lucioni C6, Pinheir B7, Brosa M8, Pujol LKB9, Van Belle S10, Annemans L11 | ||||
1 IMS Health, London, UK 2 SBD Analytics BVBA/SPRL, Bekkevoort, Belgium 3 IMS Health, Vilvoorde, Belgium 4 Institute for Pharmaeconomic Research, Health Economics, Vienna, Austria 5 IMS Health, Paris, France 6 Wolters Kluwer Health Italy, Milan, Italy 7 CISEP, Research Centre on the Portuguese Economy, Lisbon, Portugal 8 Oblikue Consulting, Barcelona, Spain 9 Amgen (Europe) GmbH, Zug, Switzerland 10 Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium 11 I-CHER, Ghent University, Brussels University (VUB), Ghent, Belgium | ||||
Journal of Medical Economics Vol. 15, No. 3, 2012, 1–10 |
||||
, Article | ||||
, Austria, Belgium, France, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2012 | English | , Cost analysis | |
Cost-Effectiveness of Tapentadol in Severe Chronic Pain in Spain: A Cost Analysis of Data From RCTs | ||||
Obradovic M1, Ikenberg R2, Hertel N3, Antoñanzas F4, Gálvez R5, Liedgens H1 | ||||
1 Grünenthal GmbH, Aachen, Germany 2 IMS Health Economics and Outcomes Research, Munich, Germany 3 IMS Health Economics and Outcomes Research, London, UK 4 Department of Economics and Business, University of La Rioja, Logroño, Spain 5 Pain and Palliative Care Unit, University Hospital Virgen de las Nieves, Granada, Spain | ||||
Clinical Therapeutics/Volume 34, Number 4, 2012 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2012 | English | , Cost effectiveness | |
Assessing the budget impact of using ScanBag® in CT in 6 European countries. | ||||
Nivelle E1, Mathou F2, Lamotte M1 | ||||
1 IMS Health, Vilvoorde, Belgium 2 Guerbet SA, Villepinte, France | ||||
15th ISPOR Annual European Congress, 2012, November 3-7, Berlin, Germany |
||||
, Abstract, Poster | ||||
, Belgium, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2012 | English | , Budget impact | |
Cost-effectiveness of Rivaroxaban versus Acenocumarol in the stroke prevention in patients with Non-Valvular Atrial Fibrilation in the Spanish setting | ||||
Restovic G1, Carcedo D1, McLeod EJ2, Guillermin ALG3, Evers T4 | ||||
1Bayer Pharma, Barcelona-Spain, Barcelona, Barcelona, Spain, 2IMS Health, London, UK, 3IMS Health, London , UK, 4Bayer Schering Pharma AG, Wuppertal, Germany | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters2.aspx | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2012 | English | , Cost effectiveness | |
The impact of Atrial Fibrilation symptoms in the health related quality of life in Spanish population (Ulises Study) | ||||
Arribas F1, Montull E2, LLobet X2, Perulero N3, Badia X4 | ||||
1Hospital Universitario 12 de Octubre, MADRID, Spain, 2SANOFI AVENTIS S.A., BARCELONA, Spain, 3IMS Health, S.A., Barcelona, Spain, 4IMS Health, Barcelona, Spain | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters2.aspx | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2012 | English | , Quality of life | |
Cost of Erythropoiesis-stimulating Agents (ESAs) in the treatment of Chemotherapy-related Anaemia in Spain | ||||
Duran A1, Spaepen E2, Lamotte M3, Brosa M4, Gutierrez L5, Restovic G6, Annemans L7 | ||||
1 IMS Health, London, UK 2 SBD Analytics BVBA/SPRL, Belgium 3 IMS Health, Vilvoorde, Belgium 4 Oblikue Consulting, Barcelona, Spain 5 Amgen S.A., Barcelona, Spain; 6 Independent Consultant, Barcelona, Spain 7 I-CHER Interuniversity Centre for Health Economics Research, Gent, Belgium | ||||
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Cost of illness | |
Preliminary validation of collect scale: a co-morbidity assessment tool for patients with Chronic Lymphocytic Leukaemia | ||||
Giraldo P1, Lopez A2, Rios E3, Gonzalez-Grande I4, Roset M5, Castro-Gomez A6, De La Serna J7, Carbonell F8 | ||||
1Hospital Universitario Miguel Servet, Zaragoza, Spain, 2Hospital Universitari Valle d'Hebron, Barcelona, Spain, 3Hospital Virgen de Valme, Sevilla, Spain, 4Roche Farma, S.A., Madrid, Spain, 5IMS Health, Barcelona, Spain, 6Roche, Madrid, Spain, 7Hospital Universitario 12 de Octubre, Madrid, Spain, 8Consorci Hospital General Universitari Valencia, Valencia, Spain | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters4.aspx | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | ||
Improvements in Health-Related Quality of life in Acromegaly with Pasireotide LAR and Octreotide LAR: Results from a large, randomized, Double-Blind Phase III Trial | ||||
Badia X1, Forsythe A2, Nelson LM3, Coles TM3, McLeod LD3, Webb SM4 | ||||
1IMS Health, Barcelona, Barcelona, Spain, 2Novartis Pharmaceuticals, East Hanover, NJ, USA, 3RTI Health Solutions, Research Triangle Park, NC, USA, 4Hospital Sant Pau and CIBERER 747, Universitat Autònoma de Barcelona, Barcelona, Spain | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters4.aspx | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2012 | English | , Prospective study | |
Cost-Effectiveness of Plerixafor plus GCSF for Mobilization of Peripheral blood Stem Cells in Patients with Myeloma and Lymphoma in Spain | ||||
Duarte RF1, Pérez-Simón JA2, Martín G3, de la Rubia J4, Marín P5, Álvarez MA6, Espinós B7, Roset M7 | ||||
1Institut Català D'Oncologia - Hospital Duran i Reynals, L'Hospitalet de Llobregat, Spain, 2Hospital Universitario Virgen del Rocío, Sevilla, Spain, 3Banc de Sang i Teixits, Barcelona, Spain, 4Hospital Universitario La Fe de Valencia, Valencia, Spain, 5Hospital Clínic, Barcelona, Spain, 6Hospital Reina Sofía, Córdoba, Spain, 7IMS Health, Barcelona, Spain | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters3.aspx | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Cost effectiveness | |
Validation of a new tool to assess health-realted quality of life psoriasis: the PSO-LIFE questionnaire. | ||||
Dauden E,Herrera E, Puig L, Sánchez-Carazo J, Toribio J, Caloto Mª, Nocea G, Roset M, Lara N. | ||||
1 Department of Dermatology, University of Hospital of Princess,Madrid 2 Department of Dermatology, University of Hoapital Virgen of the Victory, Málaga 3 Department of Dermatology, Hospital Santa Creu i Sant Pau, Barcelona 4 Department of Dermatology, Hospital General of Valencia, Valencia 5 Department of Dermatology, Hospital Gil Casares, Santiago of Compostela 6 Outcomes Research, MSD, Madrid 7 IMS Health, Barcelona | ||||
Health Qual Life Outcomes. 2012 May 24;10:56 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Validation%20of%20a%20new%20tool%20to%20assess%20health-realted%20quality%20of%20life%20psoriasis%3A%20the%20PSO-LIFE%20questionnaire. | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2012 | English | , Quality of life | |
Psychometric performance of the CushingQol questionnaire in conditions of real clinical practice. | ||||
Santos A, Resmini E, Martínez-Momblán MªA, Crespo I, Valassi E, Roset M, Badia X, Webb S. | ||||
Health Economics and Outcomes Research, IMS Health, Barcelona, Hospital Sant Pau, Center of Biomedical Investigation in rare diseases. | ||||
Eur J Endocrinol. 2012 Sep;167(3):337-42 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Psychometric%20performance%20of%20the%20CushingQol%20questionnaire%20in%20conditions%20of%20real%20clinical%20practice. | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2012 | English | , Quality of life | |
Practice patterns in the management of prostate cancer in spain: results from a National Survey Among Radiation oncologists in 2009 | ||||
Zapatero A, López-Torrecilla J, Herruzco I, Calvo FA. | ||||
Department of Radiation Oncology, Health Research Institute IP, Hospital University of Princess, Madrid. | ||||
Clin Transl Oncol. 2013 Mar;15(3):226-32 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Practice%20patterns%20in%20the%20management%20of%20prostate%20cancer%20in%20spain%3A%20results%20from%20a%20National%20Survey%20Among%20Radiation%20oncologists%20in%202009 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | Spanish | , Survey research | |
Is The CAT Questionnaire Sensitive To Changes In Health Status In Patients With Severe COPD Exacerbations? | ||||
Alvar A, Soler J, Molina J, Muñoz MJ, García-Losa M, Roset M, Jones PW, Badia X. | ||||
Hospital of Clinic IDIBAPS, Barcelona & Ciber Respiratory diseases, Barcelona, Hospital of Requena, Neumonology Unit, Center if Health French,Spain, GlaxoSmithkline S.A. Medical, Spain, IMS Health, Barcelona, St. George´s Hospital Medical School, Respiratory Medicine, University of London, UK. | ||||
COPD. 2012 Aug;9(5):492-8 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=is%20the%20cat%20questionnaire%20sensitve%20to%20changes%20in%20health%20status%20in%20patients%20with%20severe%20copd%20exacerbations | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2012 | English | ||
Antithrombotic Therapy Prescription and Persistence in Patients With Atrial Fibrillation in France and Spain. | ||||
Huguet M, Shakespeare A, Haug HM, Miadi-Fargier H, Restovic G, Rafols C, Kempf C | ||||
ISPOR Annual European Congress, Berlin, Germany |
||||
, Poster | ||||
, France, Spain | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(12)02765-9/abstract | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2012 | English | , Pricing & Reimbursement | |
Treatment pattern by hormone receptors and HER2 status in patients with metastatic breast cancer in the United Kingdom, Germany, France, Spain, and Italy (EU-5): Results from a physician survey. | ||||
DeKoven M, Bonthapally V, Lee W, Pathak P, Jiao X, Ray S, Alexandria | ||||
IMS Health; Abbott Laboratories, Abbott Park, IL; IMS Health, Collegeville, PA | ||||
ASCO 2012; J Clin Oncol 30, 2012 (suppl; abstr 570) |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://ascopubs.org/doi/abs/10.1200/jco.2012.30.15_suppl.570 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective database analysis | |
Cost analysis of anemia treatment with erythropoieses-stimulating agents (ESAs) in patients with cancer receiving chemotherapy: a multi-country approach. | ||||
Duran A1, Spaepen E2, Lamotte M3, Walter E4, Lucioni C5, Pinheiro B6, Brosa M7, Kutikova L8, Pujol B8, Annemans L9 | ||||
1 IMS Health, London, United Kingdom 2 SBD Analytics, Belgium 3 IMS Health, Vilvoorde, Belgium 4 Institute for Parmacoeconomic Research, Vienna, Austria 5 Wolters Kluwer Health Italy, Milan, Italy 6 Centre de Investigaçao Sobre Economia Portuguesa, Lisboa, Portugal 7 Oblikue Consulting, Barcelona, Spain 8 Amgen (Europe), Zug, Switzerland 9 I-CHER Interuniversity Centre for Health Economics Research, Gent, Belgium | ||||
ISPOR 14th Annual European Congress 5-8 November 2011, Madrid, Spain |
||||
, Poster | ||||
, Austria, Italy, Portugal, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Cost analysis | |
Retrospective chart review study of the cost of care of systematic lupus erythematousus (SLE)in 5 European coutries | ||||
Doria A1, Amoura Z 2, Richter J3, Cervera R4, Khamashta M5, Guillemin F6, Garofanno A7, Maurel F7, Roset M8, Perna A9, Schmitt C10, Ager M9, Boucot I11, Gonzalez MC Quire S10, Birch H10. | ||||
1. University of Padova, Padova, Italy, 2. Université Paris VI Pierre et Marie Courie, Paris, France, 3. Heinrich-Heine-University, Düsseldorf, Germany, 4. Hospital Clinic, Barcelona, Spain, 5. The Rayne Institute, London, United Kingdom, 6. Centre d'épidémiologie clinique, Vandoeuvre-les-Nancy, France, 7. IMS Health, Paris, France, IMS Health, Barcelona, Spain, 9. GlaxoSmithKline, Brentford, United Kingdom, 10. GlaxoSmithKline, Uxbrige, United Kingdom, 11. GlaxoSmithKline, Marly-le-Roi, France | ||||
Abstract - Presentation PSY17 for the 14th European congress of ISPOR 2011 |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2011 | English | , Cost analysis, Cost of illness, Epidemiological study, Observational study, Retrospective cohort analysis | |
Costs of tumor necrosis factor blockers per treated patient across adult indications using real-world data in US commercially-insured population. | ||||
Schabert V1, Gandra SR2, Watson C2, Fox KM3, Yeaw J4, Goodman S4, Milev S5, Harrison DJ2. | ||||
1IMS Health, Falls Church, VA, USA, 2Amgen, Inc., Thousand Oaks, CA, USA, 3Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 4IMS Health, Watertown, MA, USA, 5IMS Brogan, A unit of IMS, Ottawa, ON, Canada | ||||
14th Annual European Congress, International Society of Pharmacoeconomics and Outcomes Research (ISPOR) |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.ispor.org/congresses/Spain1111/Posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2011 | English | , Budget impact | |
Cost Analysis: Treatment of Chemotherapy-induced Anaemia with Erythropoiesis-Stimulating Agents (ESAS) in Spain | ||||
Duran A1, Spaepen E2, Lamotte M3, Brosa M4, Gutierrez L5, Restovic G5, Annemans L6 | ||||
1IMS Health, London, UK, 2SBD Analytics BVBA/SPRL, Bekkevoort, Belgium, 3IMS Consulting Group, Vilvoorde, Belgium, 4Oblikue Consulting, Barcelona, Spain, 5Amgen S.A., Barcelona, Spain, 6Ghent University, Ghent, Belgium | ||||
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Cost analysis | |
Regional variability in the generic antidepressant market in Spain | ||||
Espinós B, Vieta A, Hurtado P, Badia X | ||||
IMS Health, Barcelona, Spain | ||||
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2011 | English | , Epidemiological study | |
Market access barriers for Biosimilars in Spain and Germany: Epoetin Alfa Example | ||||
Hurtado P, Vieta A, Espinós B, Badia X | ||||
IMS Health, Barcelona, Spain | ||||
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
||||
, Poster | ||||
, Germany, Spain | ||||
Condition | Year | Language | Analysis type | |
, Pricing and reimbursement | 2011 | English | , Market impact | |
Regional differences among Methadone maintenance programs in Spain | ||||
Vieta A, Hurtado P | ||||
IMS Health, Barcelona, Spain | ||||
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2011 | English | , Prospective study | |
Cost-effectiveness of Roflumilast (Daxas®) in the treatment of chronic obstructive pulmonary disease (COPD) in Spain. | ||||
Lindner L1, Camins de Valdenebro L2, Aparicio Martinez J2 | ||||
1IMS Health, Barcelona, Cataluña, Spain, 2Nycomed Pharma S.A., Madrid, Madrid, Spain | ||||
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.ispor.org/congresses/Spain1111/Posters3.aspx PRS34 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2011 | English | , Cost effectiveness | |
Surgery in patients with metastatic colorectal cancer in western Europe. | ||||
Z. Zhao, E. M. Pelletier, B. Barber, M. Bhosle, S. Wang, D. Klingman, S. K. Gao; Amgen Inc., Thousand Oaks, CA; IMS Health, Inc., Watertown, MA; IMS Health, Inc., Falls Church, VA | ||||
1Amgen Inc., Thousand Oaks, CA, USA, 2IMS Consulting, Watertown, MA, USA, 3IMS Consulting, Alexandria, VA, USA | ||||
2011 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2011, Chicago, IL, USA |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. | ||||
Jose´ R. Banegas 1,2*, Esther Lo´pez-Garcı´a 1,2, Jean Dallongeville3, Eliseo Guallar 4,5,6,7, Julian P. Halcox8, Claudio Borghi 9, Elvira L. Masso´-Gonza´lez 10, Francisco J. Jime´nez 11, Joep Perk12, Philippe Gabriel Steg13, Guy De Backer 14,and Fernando Rodrı´guez-Artalejo1,2 | ||||
1 Department of Preventive Medicine and Public Health, School of Medicine, Universidad Auto´noma de Madrid/IdiPAZ, Avda Arzobispo Morcillo, 2, 28029 Madrid, Spain; 2 CIBER of Epidemiology and Public Health, Madrid, Spain; 3 Inserm U 744, Institut Pasteur de Lille, 59019 Lille Cedex, France; 4 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 5 Department of Medicine, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 6 Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 7 Department of Cardiovascular Epidemiology and Population Genetics, National Center for Cardiovascular Research (CNIC), Madrid 28029, Spain; 8 Wales Heart Research Institute, Cardiff University, Heath Park, Cardiff CF14 4XN, UK; 9 Department of Internal Medicine, Aging and Clinical Nephrology, University of Bologna, Bologna, Italy; 10Medical Department, AstraZeneca Farmace´utica Spain, S.A., 28003 Madrid, Spain; 11Medical Department, AstraZeneca Europe, 1935 Zaventem, Belgium; 12School of Health and Caring Sciences, Linnaeus University, 391 82 Kalmar, Sweden; 13INSERM U 698, Assistance Publique–Hoˆpitaux de Paris and Universite´ Paris-Diderot, Paris, France; and 14Department of Public Health, University of Gent, 9000 Gent, Belgium | ||||
Eur Heart J. 2011 Sep;32(17):2143-52 |
||||
, Article | ||||
, Austria, Belgium, France, Germany, Greece, Norway, Spain, Sweden, Switzerland, Turkey, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21471134 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2011 | English | , Observational study, Prospective study | |
Country differences in patient characteristics and treatment in schizophrenia: data from a physician-based survey in Europe. | ||||
Papageorgiou G1, Cañas F, Zink M, Rossi A. | ||||
1Department of Psychiatry, Evangelismos General Hospital | ||||
Eur Psychiatry. 2011 Mar;26(1 Suppl 1):17-28. doi: 10.1016/S0924-9338(11)71710-2. |
||||
, Article | ||||
, Germany, Greece, Italy, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21440220 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2011 | English | , Survey research | |
Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study. | ||||
Guallar E, Banegas JR, Blasco-Colmenares E, Jiménez FJ, Dallongeville J, Halcox JP, Borghi C, Massó-González EL, Tafalla M, Perk J, De Backer G, Steg PG, Rodríguez-Artalejo F. | ||||
BMC Public Health. 2011 Sep 18;11:704. doi: 10.1186/1471-2458-11-704. |
||||
, Article | ||||
, Austria, Belgium, France, Germany, Greece, Norway, Russian Federation, Spain, Sweden, Switzerland, Turkey, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21923932 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2011 | English | , Observational study, Prospective study | |
Factors associated with hospitalisation of patients with schizophrenia in four European countries. | ||||
Gorwood P1. | ||||
1CMME, Sainte-Anne Hospital, University Paris Descartes | ||||
Eur Psychiatry. 2011 May;26(4):224-30. doi: 10.1016/j.eurpsy.2011.02.012. Epub 2011 Mar 23. |
||||
, Article | ||||
, Germany, Greece, Italy, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21429717 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2011 | English | , Survey research | |
Patients with schizophrenia : results of a physician-based survey conducted in four European countries (Germany, Greece, Italy and Spain). | ||||
Gorwood P1. | ||||
1CMME, Sainte-Anne Hospital, University Paris Descartes | ||||
Eur Psychiatry. 2011 Mar;26(1 Suppl 1):1. |
||||
, Article | ||||
, Germany, Greece, Italy, Spain | ||||
Abstract: https://www.cegedimstrategicdata.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2011 | English | , Survey research | |
Use of ziprasidone in patients with schizophrenia in four European countries. | ||||
Montes JM1. | ||||
1Hospital del Sureste, Arganda del Rey, Spain | ||||
Eur Psychiatry. 2011 Mar;26(1 Suppl 1):29-37. doi: 10.1016/S0924-9338(11)71711-4. |
||||
, Article | ||||
, Germany, Greece, Italy, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21440221 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2011 | English | , Survey research | |
Validation of the AF-QOL, a disease-specific quality of life questionnaire for patients with atrial fibrillation. | ||||
Arribas F1, Ormaetxe JM2, Peinado R3, Perulero N4, Ramírez P5, Badia X4 | ||||
1Unidad de Arritmias, Servicio de Cardiología, Hospital Universitario Doce de Octubre, Madrid, Spain 2Unidad de Arritmias. Servicio de Cardiología, Hospital de Basurto. Bilbao, Spain 3Unidad de Arritmias, Servicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain 4Health Economics and Outcomes Research, IMS Health, Barcelona, Spain 5MEDA Pharma; Madrid, Spain | ||||
Europace. 2010;12(3):364-70. |
||||
, Article, Manuscript in preparation | ||||
, Spain | ||||
Abstract: http://europace.oxfordjournals.org/cgi/content/abstract/eup421 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2010 | English | , Observational study, Prospective study, Quality of life | |
Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population. | ||||
Asukai Y1, Valladares A2, Camps C3, Wood E1, Taipale K4, Arellano J4, Cassinello A2, Sacristan JA2, Dilla T2. | ||||
1 IMS Health, London, UK 2 Eli Lilly SA, Madrid, Spain 3 Hospital General Universitario, Valencia, Spain 4 Eli Lilly, Windlesham, Surrey, UK | ||||
BMC Cancer. 2010 Jan 29;10:26 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/20113499 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Cost effectiveness | |
Spectacle independence and subjective satisfaction of ReSTOR® multifocal intraocular lens after cataract or presbyopia surgery in two European countries | ||||
Cochener B1, Fernández-Vega L2, Alfonso JF2, Maurel F3, Meunier J4, Berdeaux G5,6 | ||||
1 Centre Hospitalier de Brest, Brest, France; 2 Instituto Oftalmologico Fernandez Vega, Oviedo, Spain; 3 IMS Health, Health Economics Department, Puteaux, France; 4 Mapi Values, Lyon, France; 5 Alcon France, Health Economics Department, Rueil-Malmaison, France; 6 Conservatoire National des Arts et Métiers, Paris, France | ||||
Clin Ophthalmol. 2010 Mar 4;4:81-9. |
||||
, Manuscript in preparation | ||||
, France, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Cochener+B%5Bfirst+author%5D+AND+spectacle&TransSchema=title&cmd=detailssearch | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2010 | English | , Retrospective cohort analysis, Survey research | |
Impacto de la introducción de alitretinoína oral en los costes del eczema de las manos severo de origen profesional desde la perspectiva de las Mutuas de Accidentes de Trabajo y Enfermedades Profesionales en España. | ||||
Manuel Mascaró J, Quero Nasarre I, Lindner L, Prior M, Oliver J, Halbach R. | ||||
Manuel Mascaró J1, Quero Nasarre I2, Lindner L3, Prior M3, Oliver J4, Halbach R4. 1Servicio de Dermatología, Hospital Clínic de Barcelona. 2Servicio de Dermatología. MAZ de Zaragoza. 3IMS Health. 4Basilea Pharmaceuticals Iberia, S. L. | ||||
Rev. SEMST 2010; 5(1): 9-18 |
||||
, Article, Manuscript in preparation | ||||
, Spain | ||||
Abstract: http://dialnet.unirioja.es/servlet/articulo?codigo=3161177 | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Health economics | 2010 | Spanish | , Cost analysis, Cost consequence | |
Genotyping in patients in treatment with acenocumarol cost-effectiveness | ||||
Lindner L1, Lara N1, Tàssies D2, Tejedor D3, Jofre-Monseny L3 | ||||
Health Economics and Outcomes Research, IMS Health, Barcelona, Spain 2 Servicio de Hemoterapia y Hemostasia, Hospital Clinic Barcelona, 3 Progenika Biopharma S.A. | ||||
Revista Española de Economia de la Salud; 8(2): 77-84 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.economiadelasalud.com/ediciones/82/08_pdf/acenocumarol.pdf | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2010 | Spanish | ||
Treatment cost of hemophilia patients with inhibitors in the National Health System in Morocco | ||||
El Khorassani M, Hadjkhalifa H, By Z, Plun-Favreau J, Lindner L, Prior M. | ||||
Espérance Méd 2010; 17: 101-7. |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2010 | Spanish | , Cost effectiveness | |
Agreements with pharmaceutical industry: “Paying pay for results” | ||||
Badia X, Prior M. | ||||
Farm Hosp.2010;34(2):53–55. |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.sefh.es/fh/105_121v34n02pddf001.pdf | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2010 | Spanish | , Cost effectiveness | |
Prevalence of the Metabolic Syndrome and consistency in its diagnosis in type 2 diabetic patients in Spain. | ||||
Rodríguez A, Polavieja P, Reviriego J. | ||||
Endocrinol Nutr. 2010; 57(45):60-70. |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2010 | Spanish | , Burden of illness | |
Direct medical cost of Crohn disease in Spain. | ||||
Casellas F, Panés J, García-Sanchez V, Ginard D, Gomollón F, Hinojosa J, Marín-Jiménez I, Barreiro M, Bastida G, Lindner L, Giménez E, Vieta A. | ||||
Pharmacoeconomics Spanish Research Articles 2010;7(5):38-46. |
||||
, Article | ||||
, Spain | ||||
Abstract: http://adisonline.com/pecspanish/Articles/Vol%207%20Issue%201%20page%2038-46%202010.pdf | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2010 | Spanish | , Cost consequence | |
Regionalization of Market research. Why should it be evidence-based. | ||||
Badia X, Sabater J. | ||||
PM Farma 2010;XVII(105):54-55. |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2010 | Spanish | , Cost analysis | |
Impact of nocturia in the sleep quality in patients diagnosed of LUTS/BPH. | ||||
Hernández C, Estivill E, Cantalapiedra A. | ||||
Actas Urol Esp.2010;34(5):450-9. |
||||
, Article | ||||
, Spain | ||||
Abstract: http://scielo.isciii.es/pdf/aue/v34n5/original5.pdf | ||||
Condition | Year | Language | Analysis type | |
, Urology | 2010 | Spanish | , Methodology | |
Mirror questionnaire. Satisfaction value in Ostomized patients with the Health Care and dispositive. | ||||
Arias Alvarez M, Fernandez-García M.A., Gonzalez-Buenadicha AM, Pastor-Juan C, Payeras-Gelabert M, Perez-Salazar I, Real-Romaguera A, Rivas-Marín C, Ruiz-Fernandez MD, Sanchez-Crisol I, Sanchez de la Blanca-Martín MI, Espirac B, García-Alamino JM, Perulero N. | ||||
Revista Rol de Enfermeria 2010;33(5):328-337. |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Urology | 2010 | Spanish | , Methodology | |
Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain.[Spanish]. | ||||
Domingo J, Lara N , Malé N, Betegón L, Largeron N, Tricchard M. | ||||
1. Vaccine Investigation Area. CSISP Centre for Public Health Research, Avda Catalunya 21, Valencia, (46020), Spain. 2. HEOR, IMS Health, Dr. Ferran 25 - 27,Barcelona, (08034), Spain. 3. Market Access Manager Sanofi PasteurMSD, SNC, 8, Rue Jonas Salk, Lyon,(69367), France. | ||||
BMC Public Health 2010, 10:469 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927540/ | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2010 | Spanish | , Burden of illness | |
Recent trends in COPD prevalence in Spain: a repeated cross-sectional Survey 1997-2007. | ||||
Soriano JB1, Ancochea J, Miravitles M, García-Río F, Duran-Tauleria E, Muñoz L, Jiménez-Ruíz C.A, Masa J.F, Viejo J.L, Villasante C, Fernández- Fau L, Sánchez G, Sobradillo-Peña V. | ||||
1Fundació Caubet-CIMERA, Illes Balears, Mallorca, Spain | ||||
Eur Respir J 2010; 36: 758-765. |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2010 | English | , Survey research | |
Cost Evaluation study of oral treatment with Xeloda and Tarceva compared to intravenous chemotheraphy from the perspective of a Spanish private insurance company | ||||
Benito A1, Caballo B2, Gomez J2, Moyano N3, Gimenez E4, Prior M4. | ||||
1 Mapfre Familiar, 2 H. U.Madrid Sanchinarro, 3Hospital QuirónMadrid, 4 IMS Health, barcelona, Spain | ||||
Revista Española Economía de la Salud 2010;9(1):28-36 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | Spanish | , Economic evaluation | |
Differences in quality of life according to the type of atrial fibrillation [Spanish]. | ||||
Peinado R1, Arribas F2, Ormaetxe JM3, Badia X4. | ||||
1 Hospital Universitario La Paz, Madrid, Spain 2 Hospital Universitario 12 de Octubre, Madrid, Spain 3 Hospital Universitario de Basurto, Bilbao, Vizcaya, Spain 4 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain | ||||
Revista Esp. Cardiol. 2010; 63: 1402-1409 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2010 | Spanish | , Quality of life | |
Incidence rate of community acquired pneumonia in a population cohort registered in BIFAP | ||||
Chacón García A, Ruigómez A & García Rodríguez LA | ||||
Medicina Preventiva y Gestión de Calidad, Hospital General Universitario Gregorio Marañón, Madrid, Spain | ||||
Aten Primaria. 2010 Nov;42(11):543-9. doi: 10.1016/j.aprim.2010.05.004. Epub 2010 Sep 15 |
||||
, Abstract | ||||
, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20833449 | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Respiratory disease | 2010 | English | , Retrospective database analysis | |
Comparison of Prescribing Patterns for Asthma in Five European Countries | ||||
Laforest L, Schwalm MS, Dufour M, Broquet M, Bourke A & Van Ganse E | ||||
Cegedim | ||||
ICPE 2010 Pharmacoepidemiology and Drug Safety (19): S1-S347 |
||||
, Abstract, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://www.yumpu.com/en/document/view/5337032/poster-session-international-society-for-pharmacoepidemiology/13 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2010 | English | , Retrospective database analysis | |
Development and validation of a questionnaire to assess asthma control in pediatrics | ||||
Pérez-Yarza EG, Badía X, Badiola C, Cobos N, Garde J, Ibero M, Villa JR; on behalf of the CAN Investigator Group | ||||
Pérez-Yarza EG1, Badía X2, Badiola C3, Cobos N4, Garde J5, Ibero M6, Villa JR7; on behalf of the CAN Investigator Group81Department of Pediatrics, Division of Respiratory Medicine, Hospital Donostia, San Sebastián, Spain. 2Health Economics & Outcomes Research, IMS Health, Barcelona, Spain. 3Medical Department, GlaxoSmithKline, Tres Cantos, Madrid, Spain. 4Department of Pediatric Pneumology, Hospital Vall D’Hebron, Barcelona, Spain. 5Department of Pediatric Allergy, Hospital General, Elche, Alicante, Spain. 6Allergy Unit, Hospital de Terrassa, Terrassa, Barcelona, Spain. 7Department of Pediatric Pneumology, Hospital Niño Jesús, Madrid, Spain. 8Álvarez Gil D (Cabra), Anguita Carazo JL (Jaén), Antelo Landeira C (Madrid), Asensio De La Cruz O (Sabadell), Barrio Gómez De Agüero I (Madrid), Boné Calvo J (Zaragoza), Cortell Aznar I (Valencia), Cubero Sánchez M (Jaén), Delgado Romero J (Sevilla), Eseverri Asin JL (Barcelona), Feo Brito F (Ciudad Real), Fernández Alonso J (Palencia), Ferres Mataró J (Barcelona), García García ML (Leganés), Garde Garde J (Elche), Gómez Pastrana D (Jerez), González Y (Almería), Hernández M | ||||
Pediatr Pulmonol 2009;44(1):54-63. |
||||
, Article | ||||
, Spain | ||||
Abstract: www.ncbi.nlm.nih.gov/pubmed/19061230 | ||||
Condition | Year | Language | Analysis type | |
, Pediatrics, Respiratory disease | 2009 | English | , Observational study, Quality of life | |
Traducción y adaptación cultural de la versión española del cuestionario EQ-5D-Y en niños y adolescentes. [Tanslation and Cultural Adaptation of the Spanish Version of EQ-5D-Y Questionnaire for Children and Adolescents] | ||||
Gusi N1, Badia X2, Herdman M3, Olivares PR1. | ||||
1Facultad deCienciasdelDeporte,UniversidaddeExtremadura,Cáceres,España 2Health OutcomesResearchEurope,Barcelona,España 3Institut Municipal d’Investigació Mèdica(IMIM),Barcelona,España | ||||
Aten Primaria. 2009;41(1):19-23. |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19187838 | ||||
Condition | Year | Language | Analysis type | |
, Pediatrics | 2009 | Spanish | , Quality of life | |
Percepción de los médicos de Atención Primaria en el manejo clínico de la osteoporosis. Influencia de los Planes de Salud. [Primary care perception of clinical management of osteoporosis. The influence of healthcare policies] | ||||
Carbonell Abella C, Abizanda González M, Pérez Hernández M, Roset Gamisans M, Nogués Solán X | ||||
Carbonell Abella C1, Abizanda González M2, Pérez Hernández M3, Roset Gamisans M4, Nogués Solán X5 1 Centro de Salud Vía Roma. Barcelona. Facultad de Medicina. Universidad de Barcelona. España. 2 Centro de Atención Primaria Vila Olímpica. Barcelona. España. 3 Laboratorios Almirall. Barcelona. España. 4 IMS Health. Barcelona. España. 5 eUnidad de Investigación de Fisiopatología Ósea y Articular del Institut Municipal d'Investigacions Mèdiques (IMIM). Departamento de Medicina Interna. Universidad Autónoma de Barcelona. Hospital del Mar. Barcelona. | ||||
Semergen 2009;35(3)122-30 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.elsevier.es/revistas/ctl_servlet?_f=7012&articuloid=13135236&revistaid=40 | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2009 | Spanish | , Survey research | |
Desigualdades en la financiación de medicamentos entre comunidades autónomas en España [Inequalities in the financing of medicines among autonomous regions in Spain] | ||||
Vieta A, Badia X | ||||
Vieta A1, Badia X1 1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain, | ||||
Medicina Clínica (Barc). 2009;132(9):364-368 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Pricing and reimbursement | 2009 | Spanish | ||
Cost-effectiveness of insulin detemir compared with neutral protamine Hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in five European countries. | ||||
Gschwend MH1, Aagren M2, Valentine WJ1 | ||||
1 IMS Health, Basel, Switzerland, 2 Novo Nordisk Inc., New Jersey, United States | ||||
Journal of Medical Economics, 2009; 12(2): 114–123 |
||||
, Manuscript in preparation | ||||
, Belgium, France, Germany, Italy, Spain | ||||
Abstract: http://informahealthcare.com/doi/abs/10.3111/13696990903080344 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2009 | English | , Cost effectiveness | |
Cost utility analysis of 90y-Ibritumomab Tiuxetan following first-line chemotherapy compared to no follow-up in patients with stage III or IV follicular lymphoma in Spain | ||||
Eggington S1, Piñol C2, Musi E3, Valderrama A4 | ||||
1IMS Health, London, Camden, UK, 2Bayer HealthCare, Barcelona, Spain, 3Bayer HealthCare, Sant Joan Despí (Barcelona), Catalonia, Spain, 4Bayer Healthcare Pharmaceuticals Inc, Pine Brook, NJ, USA | ||||
ISPOR 12th Annual European Congress, 24th – 27th October 2009, Paris, France |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Cost utility | |
Validity of a Telephone Survey for Determining the Prevalence of Atopic Dermatitis and Its Seasonal Variation in Spain | ||||
García-Díez A1, Puig L2, Ortiz J3, Blanco A4. | ||||
1 Hospital Universitario La Princesa. Madrid. España 2 Hospital de la Santa Creu i Sant Pau. Barcelona. España. 3 Hospital 12 de Octubre. Madrid. España 4 Facultad de Medicina. Valladolid. España. | ||||
Actas Dermosifiliogr. 2009;100(4):298-306. |
||||
, Article, Manuscript in preparation | ||||
, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19463233 | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2009 | English | , Epidemiological study, Survey research | |
Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain. | ||||
Mayordomo JI, López A, Viñolas N, Castellanos J, Pernas S, Domingo Alonso J, Frau A, Layola M, Antonio Gasquet J, Sánchez J; ENIA Study Group. | ||||
1 Clínico Lozano Blesa, Zaragoza, Spain 2 Vall d’Hebron, Barcelona, Spain 3 Clínic i Provincial, Barcelona, Spain 4 Xeral-Cíes, Vigo, Spain 5 Institut Català d’Oncologia, L’Hospitalet-Barcelona, Spain 6 Virgen de la Arrixaca, Murcia, Spain 7 Provincial de Castellón, Castellón, Spain 8 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain 9 Amgen S.A., Barcelona, Spain | ||||
Curr Med Res Opin. 2009 Oct;25(10): 2533-42. |
||||
, Article | ||||
, Spain | ||||
Abstract: http://informahealthcare.com/doi/abs/10.1185/03007990903209563 | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2009 | English | , | |
The Economic Impact of Overactive Bladder Syndrome in Six Western Countries. | ||||
Irwin DE1, Mungapen L2, Milsom I3, Kopp Z4, Reeves P2, Kelleher C5 | ||||
1Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, NC, US 2 IMS Health incorporating Fourth Hurdle Consulting Ltd, London, UK 3 Department of Obstetrics & Gynaecology, Sahlgrenska Academy at the University of Gothenburg, Sweden 4 Pfizer Inc., New York, USA, , 5 Department of Obstetrics and Gynaecology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK | ||||
British Journal of Urology International (BJU International), 103(2):202-209 |
||||
, Article | ||||
, Canada, Germany, Italy, Spain, Sweden, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19278532?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=1 | ||||
Condition | Year | Language | Analysis type | |
, Overactive bladder | 2009 | English | , Budget impact | |
Coste social y asistencial de la Gastroenteritis Pediátrica por Rotavirus en España. [Cost of paediatric rotavirus gastroenteritis management in Spain]. | ||||
Lara N1, Paricio Talayero JM2, Martín Sobrino MA2, Tomás Vila M3, Collar del Castillo JI3, Beseler Soto B2, Sánchez Palomares M2, Gómez Sánchez D3, y Grupo de Investigadores del estudio REVEAL en España* | ||||
1IMS Health®. 2Servicio de Pediatría. Hospital «Marina Alta». Denia (Alicante). 3Servicio de Pediatría. Hospital «Francesc de Borja». Gandía (Valencia) | ||||
Acta Pediatr Esp. 2009;67(6):267-273. |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Pediatrics | 2009 | Spanish | , Cost analysis | |
Diseños secuenciales y análisis intermedio en la investigación clínica: tamaño frente a dificultad [Sequential designs and intermediate analysis in clinical research: size vs difficulty] | ||||
Monleón-Getino T1, Barnadas-Molins A2, Roset-Gamisans M3. | ||||
1Departamento de Estadística, Universidad de Barcelona, Barcelona, España 2Servicio deOncología Médica, Hospital de Sant Pau, Barcelona, España 3IMS Health, Health Economics and Outcomes Research, Barcelona, España | ||||
Med Clin(Barc).2009;132(11):437–442. |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B94RX-4VS9M4K-3&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=6d6bc4150d036492c82f145c912cb2b2 | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice | 2009 | Spanish | , Methodology | |
Coste-efectividad de la identificación genética en pacientes en tratamiento con acenocumarol. [Genotyping in patients in treatment with acenocumarol cost-effectiveness] | ||||
Lindner L, Lara N, Tàssies D, Tejedor D, Jofre-Monseny L. | ||||
Lindner L1, Lara N1, Tàssies D2, Tejedor D3, Jofre-Monseny L3. 1 Health Economics&Outcomes Research - IMSHealth; 2 Servicio deHemoterapia yHemostasia.Hospital Clínic Barcelona. 3 Progenika Biopharma S.A | ||||
Rev Esp Econ Salud. 2009; 8(2)77-84. |
||||
, Article, Manuscript in preparation | ||||
, Spain | ||||
Abstract: http://www.economiadelasalud.com/ediciones/82/08_pdf/acenocumarol.pdf | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2009 | Spanish | , | |
[Coste-efectividad de la identificación genética en pacientes en tratamiento con acenocumarol] Genotyping in patients in treatment with acenocumarol cost-effectiveness. | ||||
Lindner L, Lara N, Tàssies D, Tejedor D, Jofre-Monseny L | ||||
Lindner L1, Lara N1, Tàssies D2, Tejedor D3, Jofre-Monseny L3. 1Health Economics & Outcomes Research - IMS Health; 2Servicio de Hemoterapia y Hemostasia.Hospital Clínic Barcelona. 3 Progenika Biopharma S.A | ||||
, Article, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Hematology | 2009 | Spanish | , Cost effectiveness | |
Epidemiologic study to assess patients' involvement with adjuvant chemotherapy in breast cancer (PROSA study). | ||||
Tusquets I1, Espinosa Arranz E2, Méndez M3, JM Gil4, Guayar JL5, Perulero N6. | ||||
1 Servicio de Oncología, Hospital de Mar, Barcelona, Spain 2 Servicio de Oncología, Hospital de la Paz, Madrid, Spain 3 Servicio de Oncología, Hospital de Móstoles, Madrid, Spain 4 Institut Català de Oncologa- hospital Duran i Reynals, L’Hospitalet, Spain 5 Sanofi-Aventis, Barcelona, Spain 6 IMS Health, HEOR Barcelona, Spain | ||||
Clin Transl Oncol. 2009;11(4):221-7. |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19380299 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Epidemiological study | |
Patient perspectives on taking vitamin K antagonists: a qualitative study in the UK, USA and Spain | ||||
Wild D1, Murray M2, Donatti2, | ||||
1 Oxford Outcomes Ltd, Oxford, UK 2 Health Protection Agency, London, UK 3 IMS Health, London, UK | ||||
Expert Review of Pharamacoeconomics and Outcomes Research October 2009, Vol. 9, No. 5, Pages 467-474 |
||||
, Article | ||||
, Spain, UK, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Wild+D%5Bfirst+author%5D+AND+vitamin&TransSchema=title | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2009 | English | , Observational study | |
Does pharmaceutical consumption improve healthcare status? | ||||
Grandfils N1, Hauser S1, Amalric F1, Le Pen C2 | ||||
1IMS Health, Puteaux, France, 2Paris Dauphine University, Paris, France | ||||
ISPOR 12th Annual European Congress, Paris, France, 24–27th October 2009 |
||||
, Abstract, Poster | ||||
, Denmark, France, Germany, Italy, Spain, Sweden, UK | ||||
Abstract: http://www.ispor.org/congresses/paris1009/posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2009 | English | , Economic evaluation | |
Estudio EPI-SCAN: Resumen del protocolo de un estudio para estimar la prevalencia de EPOC en personas de 40 a 80 años de edad en España [The EPI-SCAN survey to assess the prevalence of chronic obstructive pulmonary disease in Spanish 40-to-80-year-olds: protocol summary] | ||||
Ancochea J, Badiola C, Duran-Tauleria E, Garcia Rio F, Miravitlles M, Muñoz L, Sobradillo V, Soriano JB. | ||||
Arch Bronconeumol. 2009;45:41-7. |
||||
, Article, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2009 | Spanish | , Epidemiological study, Observational study | |
Cost-effectiveness of biologic treatments for moderate to severe psoriasis | ||||
Carretero G1, Moreno JC2, Notario J3, Silvestre JF4, López-Belmonte JL5, Giménez E6, Sabater FJ7, Fonseca E8 | ||||
1Hospital Dr. Negrín, Las Palmas de Gran Canarias, Las Palmas de Gr, Spain, 2Hospital Reina Sofía, Córdoba, Andalucía, Spain, 3Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain, 4Hospital General de Alicante, Alicante, Alicante, Spain, 5Schering Plough S.A, Alcobendas, Madrid, Spain, 6IMS Health, Barcelona, Spain, 7Schering- Plough S.A, Alcobendas, Spain, 8Complejo Hospitalario Universitario Juan Canalejo, A Coruña, A Coruña, Spain | ||||
ISPOR 12th Annual European Congress 2009, 24 to 27 October, Paris, France |
||||
, Abstract, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2009 | English | , Cost utility | |
Cost-effectiveness of rivaroxaban versus enoxaparin for thromboprophylaxis after total knee replacement in the UK and Spain | ||||
Brosa M1, Diamantopoulos A2, Forster F2, Duran A2, Lees M3, Gilmour L4, Ashley D4, Piñol C5 | ||||
1Oblikue Consulting, Barcelona, Spain 2 IMS Health, London, UK 3 Bayer HealthCare, Uxbridge, UK 4 Bayer plc, Newbury, UK 5 Bayer SA, Barcelona, Spain | ||||
14th Congress of the European Association of Hospital Pharmacists, Barcelona, Spain, 25-27 March 2009 |
||||
, Poster | ||||
, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2009 | English | , Cost effectiveness | |
Cost-effectiveness of insulin aspart versus human soluble insulin in type 2 diabetes in four European countries: subgroup analyses from the PREDICTIVE study. | ||||
Palmer JL1, Goodall G1, Nielsen S3, Kotchie RW,2 Valentine WJ1, Palmer AJ1, Roze S1. | ||||
1IMS Health, Basel, Switzerland, 2Novo Nordisk, Bagsværd, Denmark, 3IMS Health, London, UK | ||||
Curr Med Res Opin. 2008; 24(5):1417-1428 |
||||
, Manuscript in preparation | ||||
, Italy, Poland, Spain, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Cost effectiveness | |
The impact of insulin detemir compared to Neutral Protamine Hagedorn insulin on long-term diabetes-related complications: a modeling analysis in type 1 diabetes patients in Belgium, France, Germany, Italy and Spain | ||||
Gschwend M1, Aagren M2, Valentine WJ1 | ||||
1 IMS Health, Basel, Switzerland, 2 Novo Nordisk A/S, Bagsværd, Denmark | ||||
ISPOR 2008 13th Annual International Congress |
||||
, Poster | ||||
, Belgium, France, Germany, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Economic evaluation | |
Long-term cost-effectiveness of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with type 1 diabetes using a basal–bolus regimen in Belgium, France, Germany, Italy and Spain. | ||||
Gschwend M, Aagren M, Valentine WJ | ||||
ISPOR 2008 13th Annual International Congress |
||||
, Poster | ||||
, Belgium, France, Germany, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Cost effectiveness | |
Cost-Effectiveness of Rivaroxaban versus Enoxaparin for Thromboprophylaxis after total knee replacement in the UK and Spain. | ||||
Diamantopoulos A1, Forster F1, Brosa M2, Lees M3, Gilmour L4, Ashley D4, Piñol C5. | ||||
1IMS Health, London, UK, 2Oblikue Consulting, Barcelona, SC, Spain, 3Bayer HealthCare, Uxbridge, UK, 4Bayer Healthcare Pharmaceuticals Inc, Newbury, UK, 5Bayer HealthCare, Barcelona, Spain | ||||
ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11, |
||||
, Poster | ||||
, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2008 | English | , Cost effectiveness | |
Direct medical costs of Crohn's disease in Spain: a Markov model | ||||
Casellas F1, Panés J2, Barreiro M3, Bastida G4, García V5, Guinard D6, Gomollón F7, Herrera JM8, Hinojosa J9, Marín I10, Lindner L11, Gimenez E11, Vieta A11 | ||||
1 Hospital Vall d’Hebron; 2 Hosp.Clínic de Barcelona; 3 Hosp. Clínico Univ.Santiago; 4 Hospital Univ. de Santiago; 5 Hosp Reina Sofía Cordoba; 6 Hospital Son Dureta; 7 Hosp. Clínico de Zaragoza; 8 Hosp Virgen del Rocío; 9 Hospital de Sagunto; 10 Hospital Gregorio Marañón Madrid; 11 HEOR IMS Health | ||||
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2008 | English | , Cost analysis | |
Global and Spanish Pharmaceuticals market trends | ||||
Prior M | ||||
The 28th days on Health economics: economics, behaviour and health, Salamanca 28-30 may 2008 |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2008 | Spanish | ||
Regional market access inequalities for new oncology drugs in Spain | ||||
Vieta A1, Gimenez E1, Badia X1 | ||||
1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain, | ||||
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2008 | English | ||
Nocturia in Spanish patients with lower urinary symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) | ||||
Hernández C1, Estivill E2, Prieto M3, Badia X4 | ||||
2 Institut Universitari Dexeus, Barcelona, Spain 3 Astellas Pharma, Madrid, Spain 4 IMS Health, Barcelona, Spain | ||||
Curr Med Res Opin 2008;24(4):1033-38 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://informahealthcare.com/doi/abs/10.1185/030079908X280473 | ||||
Condition | Year | Language | Analysis type | |
, Urology | 2008 | English | ||
Validation of the Spanish version of the QOLIE-10 quality of life in epilepsy questionnaire | ||||
Viteri C, Codina M, Cobaleda S, Lahuerta J, Barriga J, Barrera S, Morales MD; investigators group of the QOLIE-10 validation study | ||||
Neurologia 2008;23(3):157-67 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2008 | Spanish | , Quality of life | |
Cross-cultural comparisons of the overweight/obese population in the US and Europe | ||||
Annunziata K, Gupta S, Chapnick J, Pokras S, Klingman D | ||||
ISPOR 2008 13th Annual International Congress |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK, USA | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2008 | English | , Retrospective database analysis | |
Can the Spanish care system assume the new costs of medications against cancer? | ||||
Camps C, Caballero C, Sirera R, Blasco A, Cayuela D, Gil M, Badia X | ||||
Clin Transl Oncol 2008;10(2):96-101 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Cost consequence | |
Influencia del sexo en la mortalidad y el manejo del síndrome coronario agudo en España [Influence of Sex on Acute Coronary Syndrome, Mortality and Treatment in Spain]. | ||||
Joaquín Alonso1, Héctor Bueno2, Alfredo Bardají3, Xavier García-Moll4, Xavier Badia5, Miquel Layola5, Ágata Carreño5 | ||||
1Hospital de Fuenlabrada. Fuenlabrada. Madrid. España. 2Hospital General Universitario Gregorio Marañón. Madrid. España. 3Hospital Juan XXIII. Tarragona. España. 4Hospital de la Santa Creu y Sant Pau. Barcelona. España. 5IMS Health Economics and Outcomes Research | ||||
Rev Esp Cardiol Supl., 2008;8:8D-22D |
||||
, Article, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2008 | Spanish | , Epidemiological study | |
Expectativas, preferencias y satisfacción de los pacientes con artritis reumatoide en tratamiento con infliximab. [Expectations, preferences and satisfaction of patients with rheumatoid arthritis receiving infliximab treatment] | ||||
Carbonell J1, Badia X2, EXPRESAR GROUP | ||||
1Servicio de Reumatología. Hospital del Mar. Barcelona. 2Health Economics & Outcomes Research. IMS Health. Barcelona. España. | ||||
Med Clin (Barc) 2008;131(13):493-9. |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19007577 | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2008 | Spanish | , Quality of life | |
A new measure for assessing Health-Related Quality of Life (HRQOL) in patients with atrial fibrillation: AF-QOL | ||||
Arribas F Ormaetxe JM1, Peinado R2, Fernandez C, Ramírez P4, Badia X Lara N5 | ||||
1. Unidad de Arritmias, Servicio de Cardiología, Hospital Universitario Doce de Octubre, Madrid, Spain 2. Unidad de Arritmias, Servicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain 4. MEDA Pharma; Madrid, Spain 5. Health Economics and Outcomes Research, IMS Health, Barcelona, Spain | ||||
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2008 | English | , Quality of life | |
Using Triple Antiplatelet Therapy in Patients with Non-ST Elevation Acute Coronary Syndrome Managed Invasively: A Cost-Effectiveness Analysis | ||||
Latour-Pérez J1, de Miguel Balsa E1, Betegón L2, Badia X2 | ||||
1Intensive Care Unit, Hospital General Universitario de Elche, Elche, Spain; 2IMS Health Economics & Outcomes Research, Barcelona, Spain | ||||
Value in Health 2008;11(5)853–861 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2008 | English | , Cost effectiveness | |
Development of an instrument for assessing Health Related Quality of Life in patients with chronic urticaria | ||||
Garcia A1, Ortiz de Frutos J2, Peyrí J3, Serra E4, Rosales M5, Sabater FJ5, Badia X6 | ||||
1 H. de la Princesa, Madrid, Spain, 2 H.12 de Octubre, Madrid, Spain, 3 H. Bellvitge, Barcelona, Spain, 4H. de la Santa Creu I Sant Pau, Barcelona, Spain, 5 Schering Plough, Madrid, Spain, 6 IMS Health, Barcelona, Spain. | ||||
ISPOR 11th Annual European Congress 2008 8-11 November, Athens, Greece |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2008 | English | , Quality of life | |
Validation and clinical use of the CECA, a disease-specific quality of life questionnaire for patients with anogenital Condylomata Acuminata | ||||
Vilata JJ, Varela JA, Olmos L, Colombo JA, Llorens MA, de los Terreros MS, Badía X; ECCAVIM Study Group | ||||
Acta Derm Venereol. 2008;88(3):257-62 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2008 | English | , Quality of life | |
Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain. | ||||
Yurgin NR1, Boye KS1, Dilla T2, Lara N3, Badia X3 | ||||
1Eli Lilly and Company, Indianapolis, IN, USA; 2Eli Lilly and Company, Spain; 3HEOR, IMS Health, Spain | ||||
Patient Preference and Adherence 2008:2 87–95. |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.dovepress.com/physician-and-patient-management-of-type-2-diabetes-and-factors-relate-peer-reviewed-article-PPA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | ||
El impacto de la obesidad en el manejo y evolución de la diabetes mellitus [The impact of obesity in the management and evolution of diabetes mellitus.] | ||||
Dilla T1, Costi M1, Boye KS2, Reviriego J1, Yurgin N2, Badia X3, Lara-Suriñach N3 | ||||
1Clinical Research Department. Eli Lilly and Company. Madrid. España. 2Global Health Outcomes. Eli Lilly and Company. Corporate Center. Indianápolis. Estados Unidos. 3Health Economics and Outcomes Research (IMS Health). Barcelona. España. | ||||
Revista Clínica Española 2008; 208(9):437-43 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19000471 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | Spanish | , Epidemiological study | |
Evaluation of health-related quality of life in patients with Cushing’s syndrome with a new questionnaire | ||||
Webb SM1, Badia X2, Barahona MJ3, Colao A3, Strasburger CJ4 Tabarin A5 van Aken MO5 Pivonello R3 Stalla G5 Lamberts SWJ, Glusman JE. | ||||
1Department of Endocrinology, Hospital Sant Pau, Centre for Biomedical Research on Rare Diseases (CIBERER Unit 747), Barcelona, Spain, 2Health Economics and Outcomes Research, IMS Health, 3Department of Endocrinology, Charite´-Universita¨tsmedizin, Berlin, Germany, 4Department of Endocrinology, Centre Hospitalier Universitaire de Bordeaux, , France, 5Department of Internal Medicine, Rotterdam, The Netherlands, 6Department of Endocrinology, Munich, Germany and 7Oncology Clinical Research, Novartis Pharmaceuticals Corporation, New Jersey, USA | ||||
Eur J Endocrinol 2008;158:623-30 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.eje-online.org/cgi/content/abstract/158/5/623 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2008 | English | ||
Quality of Life in Acromegalic Patients during long-term Somatostatin Analog Treatment with and without Pegvisomant | ||||
Neggers SJ1, van Aken MO1, de Herder WW1, Feelders RA1, Janssen JA1, Badia X2, Webb SM3, van der Lely AJ1 | ||||
1Department of Internal Medicine, Erasmus University MC Rotterdam, PO box 2040, 3000 CA, Rotterdam, the Netherlands. 2 Health Economics and Outcomes Research, IMS Health, Barcelona, and Centre for Biomedical Research on Rare Diseases (CIBERER Unit 747), Spain. 3 Department of Endocrinology, Hospital Sant Pau, Autonomous University of Barcelona and Centre for Biomedical Research on Rare Diseases (CIBERER Unit 747), Spain. | ||||
Journal of Clinical Endocrinology & Metabolism 2008;93(10):3853-9 |
||||
, Online article | ||||
, Spain | ||||
Abstract: http://jcem.endojournals.org/cgi/content/abstract/93/10/3853 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2008 | English | , Quality of life | |
Anti-TNF treatment of Crohn’s disease. Analysis between recommended posology and clinical practice | ||||
Vieta A1 | ||||
1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain | ||||
The week of digestive diseases, Sitges (Spain), 5-8 June 2008 |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2008 | Spanish | ||
Prevalence and dietetic management of mild gastrointestinal disorders in milk-fed infants | ||||
Infante Pina D1, Badia Llach X2, Ariño Armengol B2, Villegas Iglesias V3 | ||||
1 Unit of Gastroenterology and Nutrition, Children Hospital Vall d'Hebron, Autonomous University, Barcelona, Spain 2 Health Outcomes Research Europe, Barcelona, Spain 3 CHIESI España, Barcelona, Spain | ||||
World J Gastroenterol 2008;14(2):248-254 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2008 | English | , Observational study | |
Cuestionario especifico de calidad de vida para pacientes con estreñimiento (CVE-20): Desarrollo y validación [Specific quality of life questionnaire for patient with constipation (CVE-20): development and validation] | ||||
Perona M. Mearin F, Guilera M, Minguez M, Ortiz V, Montoso M, Serra J, Casanova CO, Rey E, Alarcón O, Bujanda L, Lima A, Andreu M, Castro M, López A, Carrillo R, Senpere L, Badia X. Grupo de estudio de los trastornos funcionales digestivos de la asociación española de gastroenterología (AEG) | ||||
Medicina Clínica 2008;131(10):371-377 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18842210 | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2008 | Spanish | , Quality of life | |
Modelo de impacto presupuestario de la administración de darbepoetina alfa cada 3 semanas comparado con la administración de epoetina alfa y epoetina beta 3 veces por semana y semanalmente en pacientes con anemia inducida por quimioterapia [Budget impact model of darbepoetin alfa administered once every three weeks relative to epoetin alfa and beta administered three times per week or weekly in patients with chemotherapy induced anaemia] | ||||
Pérez-Alcántara F1, Badia Llach X1, Riera Febrer M1, Vieta Salomó A1, Arocho R2 | ||||
1IMSHealth®; 2Amgen S.A. | ||||
Revista Española de Economía de la Salud 2008; 7(1):41-48 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2008 | Spanish | , Cost consequence | |
Retos en la evaluación económica de productos oncológicos [Challenges in economic evaluation of oncological products] | ||||
Badia X1 | ||||
1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain, | ||||
Summer School of pharmacoeconomics: Economic evaluation of health intervention 2008 May 18-19, Granada, Spain |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2008 | Spanish | , Economic evaluation | |
Economic assessment of controlled-release Oxycodone for the treatment of chronic pain | ||||
Gálvez Mateos R, Camps Herrero C, Lara Suriñach N, Polanco Sánchez C | ||||
Rev Esp Econ Salud 2008;7(4):157-164 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2008 | Spanish | , Economic evaluation | |
Impacto sociosanitario en pacientes con enfermedades raras (estudio ERES) [Sociosanitary impact on patients with rare diseases (ERES study)] | ||||
Avellaneda Fernández A1,2, Layola M3, Izquierdo Martínez M1,4, Guilera M3, Badia Llach X3, Ramón JR1 | ||||
1Instituto de Investigación de Enfermedades Raras (IIER). Instituto de Salud Carlos III. Madrid. 2Centro Sanitario Los Cármenes. Comunidad de Madrid. Madrid. 3Grupo Health Outcomes Research Europe (Grupo HOR-Europe). 4Servicio de Análisis e Intervención en Salud Pública. Dirección General de Salud Pública y Alimentación. Comunidad de Madrid. Madrid. España. | ||||
Medicina Clinica 2007;129(17):646-51 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2008 | Spanish | , Market impact | |
Estudio del impacto económico de la gripe en el medio laboral [A study of the economic impact of influenza on the labour environment] | ||||
Badia Llach X1, Roset Gamisans M1, de Agustín de Oro T2, Álvarez Sanz C2, García Pulgar M2 | ||||
1 Health Economics and Outcomes Research. IMS Health. Barcelona. 2 Roche Farma, S.A. Madrid | ||||
Medicina del Trabajo 2008;17(1):21-29 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2008 | Spanish | , Observational study | |
Developing an improved measure of health outcomes: EQ-5D in transition | ||||
De Charro F1, Kind P1, Van Hout BA1, Badia X1,2 | ||||
1Euroqol Group, 2Health Economics and Outcomes Research, IMS Health, Barcelona, Spain, | ||||
ISPOR 13th Annual international Meeting 2008 3-7 may, Toronto, Canada |
||||
, Workshop | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2008 | English | , Quality of life | |
EuroQoL-5D: a measure in transition | ||||
Lara N1 | ||||
1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain, | ||||
The 28th days on Health economics: economics, behaviour and health 2008 may 28-30, Salamanca, Spain |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2008 | Spanish | , Quality of life | |
Impact of skeletal complications on patients' quality of life, mobility, and functional independence | ||||
Costa L1, Badia X, Chow E3, Lipton A4, Wardley A5 | ||||
1 Instituto de Medicina Molecular-Lisboa, Hospital de Santa Maria, Lisbon, Portugal 2 Health Economics and Outcomes Research, Barcelona, Spain 3 Radiation Oncology, Toronto-Sunnybrook Regional Cancer Centre, Toronto, Canada 4 Hershey Medical Center, Pennsylvania State University, Hershey, USA 5 Cancer Research Department of Medical Oncology, Christie Hospital NHS Foundation Trust, Manchester, UK | ||||
Support Care Cancer 2008;16(8):879-89. Erratum in Supportive Care in Cancer 2008;16(10):1201 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2008 | English | , Quality of life | |
Validation of the “QUICK” questionnaire. A tool for diagnosis of “wearing-off” in patients with Parkinson’s Disease | ||||
Martinez-Martín P, Tolosa E, Hernandez B, Badia X | ||||
Movement Disorders 2008; 23(6):830–836 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2008 | English | , Quality of life | |
Cost-effectiveness and development of new drugs in oncology | ||||
Badia X1 | ||||
1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain, | ||||
2nd Symposium New Paradigms of quality of oncological assistance 2008 June 20. Valencia, Spain |
||||
, Invited speaker | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | Spanish | , Cost effectiveness | |
Cost-effectiveness analysis of darbepoetin alfa every three week versus its weekly administration in the treatment of chemotherapy-induced anemia | ||||
Riera M, Pérez F, Vieta A, Arocho R | ||||
Pharmacoeconomics Spanish Research Articles 2008;5(1):1-10 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | Spanish | , Cost effectiveness | |
Cost-utility analysis in a Spanish setting of adjuvant therapy with trastuzumab (Herceptin®) in patients with her-2 positive breast cancer | ||||
Polanco C, Carulla M, Badia X, Ramirez-Arellano A | ||||
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Cost utility | |
Development of a questionnaire on the effects of hot flashes on the quality of life of patients with advanced prostatic cancer. ESCAPA study | ||||
Carballido Rodríguez JA, Tisaire JL, Perulero N | ||||
Medicina Clínica 2008;130(15):561-567 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | Spanish | , Quality of life | |
Economic evaluation of use of pegfilgrastim versus filgrastim in primary profilaxis in patients with breast cancer with febril neutropenia risk in Spain | ||||
Mayordomo Cámara JI, López Pousa A, Giménez García E, Badia Llach X, Lara Surinyach N, Sorio Vilela F, Liu Z, Arocho R | ||||
Pharmacoeconomics Spanish Research Articles 2008;5(3):71-81 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | Spanish | , Economic evaluation | |
Assessment of Patient Satisfaction and Preferences With Inhalers in Asthma With the FSI-10 Questionnaire. | ||||
Perpiñá Tordera M1, Viejo JL2, Sanchis J3, Badia X4, Cobos N5, Picado C6, Sobradillo V7, Martínez González Del Río J8, Duce F9, Muñoz Cabrera L10 | ||||
1 Servicio de Neumología, Hospital Universitario La Fe, Valencia, Spain 2 Servicio de Neumología, Hospital General Yagüe, Burgos, Spain 3 Servicio de Neumología, Hospital de Sant Pau, Barcelona, Spain 4 Health Outcomes Research, Barcelona, Spain 5 Unidad de Neumología Pediátrica, Hospital Vall d’Hebron, Barcelona, Spain 6 Servicio de Neumología, Hospital Clínic, Barcelona, Spain 7 Servicio de Neumología, Hospital de Cruces, Baracaldo, Vizcaya, Spain 8 Servicio de Neumología, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain 9 Servicio de Alergia, Hospital Clínico Lozano Blesa, Zaragoza, Spain 10 Servicio de Neumología, Hospital Reina Sofía, Córdoba, Spain | ||||
Arch Bronconeumol. 2008;44(7):346-352 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2008 | English | , Quality of life | |
Evaluación de las versiones simplificadas del Cuestionario de Control del Asma [Assessment of the simplified versions of the Asthma Control Questionnaire] | ||||
Badiola C, Badia X, Sastre J, Olaguibel JM, López-Viña A, Vega JM, Picado C; en representación del grupo investigador del estudio COVALAIR | ||||
Med Clin 2008;131(9):326-332 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2008 | Spanish | , Quality of life | |
Development and Validation of \"Asthma Control in Paediatrics\" Questionnaire (CAN) | ||||
Ibero M, Badia X, Cobos N, Garde J, Pérez-Yarza E, Villa J, Badiola C | ||||
Journal of Allergy and Clinical Immunology 2008;119(1):S73-S73 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2008 | English | , Quality of life | |
Validation of the Spanish version of the Asthma Control Questionnaire (ACQ) | ||||
Picado C, Badiola C, Perulero N, Sastre J, Olaguíbel JM, López-Viña A, Vega JM | ||||
Clinical Therapeutics 2008;30(10)1918-1931 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2008 | English | , Quality of life | |
Using HAQ to estimate HUI3 and EQ-5D utility values in Spanish rheumatoid arthritis patients | ||||
Fernández I, Varela C, Layola M, Ruiz MD, Navarro F | ||||
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2008 | English | , Quality of life | |
Estudio para el establecimiento de un sistema de priorización de pacientes en lista de espera para cirugía de varices [Study to establish a system for arranging patients in order of priority on a waiting list for varicose vein surgery]. | ||||
Bellmunt-Montoya S, Giménez-Gaibar A, Hospedales-Salomó J, González-Cañas E, Badia X, Lara-Suriñach N | ||||
Angiología 2008;60(5)333-345 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://biblioteca.universia.net/ficha.do?id=44765760 | ||||
Condition | Year | Language | Analysis type | |
, Surgery | 2008 | Spanish | ||
Risk factors for thiazolidinedione related peripheral edema | ||||
Tennis P, Roskell N, Andrews E & Rothman K | ||||
RTI Health Solutions, Spain | ||||
Pharmacoepidemiology and Drug Safety 17(S118-S119) |
||||
, Abstract | ||||
, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2008 | English | , Retrospective database analysis | |
Cost of initial prostate cancer treatment following diagnosis per patient by stage: estimates from the UK, France, Germany, Italy and Spain. | ||||
Benedict A, Black L, Stokes M, Dorval | ||||
1 United BioSource Corporation, Budapest, Hungary 2 GlaxoSmithKline, Research Triangle Park, NC, USA 3 United BioSource Corporation, Dorval, QC, Canada | ||||
ISPOR 11th Annual European Congress |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(10)66210-9/pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Cost effectiveness | |
Cost-Effectiveness of Rivaroxaban versus Enoxaparin for Thromboprophylaxis after total hip replacement in Spain. | ||||
Diamantopoulos A1, Forster F1, Brosa M2, Lees M3, Piñol C4, Febrer L4 | ||||
1IMS Health, London, UK, 2Oblikue Consulting, Barcelona, Spain, 3Bayer HealthCare, Uxbridge, UK, 4Bayer HealthCare, Barcelona, Spain | ||||
ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11, |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2007 | English | , Cost effectiveness | |
Cost-effectiveness of the addition of acarbose to the treatment of patients with type-2 diabetes in Spain | ||||
Piñola C, Roze S, Valentine W, Evers T. | ||||
Gaceta Sanitaria 2007;21(2):97-104 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17419924 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Cost effectiveness | |
Evaluating the cost-effectiveness of Biphasic Insulin Aspart 30 Versus Human Premix Insulin for the Treatment of Type 2 Diabetes in a Spanish Setting | ||||
Tucker D1, Valentine WJ1, Nielsen S2, Townsend C2, Kotchie R3, Scheijbeler H3 | ||||
1 IMS Health, Basel, Switzerland; 2 Novo Nordisk, Bagsværd, Denmark; 3 IMS Health, London, UK. | ||||
ISPOR 2007 10th Annual European Congress, 2007 October 20-23, Dublin, Ireland |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Cost effectiveness | |
Long-term clinical outcomes Of Insulin Detemir Versus NPH for Type I Diabetes Patients in Spain | ||||
Kotchie R1, Aagren M2, Nielsen S2, Valentine WJ3, Goodall G3 | ||||
1 IMS Health, London, UK; 2 Novo Nordisk A/S, Bagværd, Denmark; 3 IMS Health, Basel, Switzerland. | ||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Cost effectiveness | |
Evaluating the long-term cost-effectiveness of insulin aspart (Novorapid®) versus human soluble insulin in patients with type 2 diabetes in Spain and Italy | ||||
Erny-Albrecht K1, Goodall G1, Townsend C2, Kotchie RW3, Nielsen S2, Valentine WJ1 | ||||
1 IMS Health, Basel, Switzerland; 2 Novo Nordisk, Bagsværd, Denmark; 3 IMS Health, London, UK | ||||
ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20-23 October 2007 |
||||
, Poster | ||||
, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Cost effectiveness | |
Budget impact and medical resources used to control bleeds in patients hospitalized due to acute coronary syndrome (ACS) | ||||
Guijarro P, Marimón F, Guindo J, Coves FJ, Sionis A, Pedrós M, Layola M | ||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2007 | English | , Budget impact | |
Cost-efectivitat del tractament del malalt amb hipertensió arterial [Cost-effectiveness of treatment of patient with arterial hypertension] | ||||
Badia X1 | ||||
1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain, | ||||
20 Jornades Catalanes sobre Hipertensió Arterial; 14 Reunió de la Societat Catalana d’Hipertensió Arterial 2007 December 18-19 Barcelona, Spain |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2007 | Spanish | , Cost effectiveness | |
Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with atrial fibrillation (AF-QoL) | ||||
Badia X, Arribas F, Ormaetxe JM, Peinado R, Sainz de los Terreros M. | ||||
IMS Health, Barcelona, Spain. xbadia@es.imshealth.com | ||||
Health Qual Life Outcomes 2007;5:37 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Abstract: http://www.hqlo.com/content/5/1/37/abstract | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2007 | English | , Quality of life | |
Impacto económico y recursos empleados en el manejo del sangrado en pacientes ingresados por Síndrome Coronario Agudo [Economic impact and resources used in the management of blooding of patients treated for Acute Coronary Syndrome] | ||||
Marimón F, Guindo J, Coves FJ, Sionis A, Pedrós M, Layola M, Guijarro P | ||||
Congreso de la Sociedad Española de Cardiología 2007 october 18-20, Madrid, Spain |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2007 | Spanish | , Economic evaluation | |
Impacto socioeconómico de la hipercolesterolemia [Socioeconomic impact of hypercholesterolemia] | ||||
Badia X1 | ||||
1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain, | ||||
Cholesterol, implications of an insufficient approach: from European Union to Autonomous govenrment reality. 2007 March 22, Valencia, Spain |
||||
, Conference | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2007 | Spanish | , Burden of illness | |
Assessment of involved body surface area (BSA) in psoriasis patients. Validation of software assisted diagnosis BSA for the management of psoriasis | ||||
Espallardo O, Badia X, Bermudez L, Perulero N, Aragües M, Bordas X, Costa J, Dauden E, Filipe P, Ginarte M, Jimenez R, Pereiro M, Perez A, Sanchez JL, Servitje O, Vélez A | ||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2007 | English | , Epidemiological study | |
Cost-effectiveness of treatment of superficial basal cell carcinoma: surgical excision vs. imiquimod 5% cream | ||||
Vanaclocha F, Badia X, Guillén V, Sánchez J, Sáinz de los Terreros M, Llorens MA | ||||
British Journal of Dermatology 2007;156(4):769-771 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www3.interscience.wiley.com/journal/117983521/abstract | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2007 | English | , Cost effectiveness | |
Validez de una encuesta telefónica para determinar la prevalencia y la estacionalidad de la dermatitis atópica en España [Validity of a Telephone Survey for Determining the Prevalence of Atopic Dermatitis and Its Seasonal Variation in Spain] | ||||
García A1, Puig L2, Ortiz J3, Blanco A4 | ||||
1 Hospital Universitario La Princesa. Madrid. España. 2 Hospital de la Santa Creu i Sant Pau. Barcelona. España. 3 Hospital 12 de Octubre. Madrid. España. 4 Facultad de Medicina. Valladolid. España. | ||||
Actas Dermosifiliogr. 2009;100(4):298-306. |
||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2007 | Spanish | , Epidemiological study | |
Comparative study of annual treatment cost of glargine insulin and detemir insulin in patients with type 2 diabetes mellitus in Spain | ||||
Alvarez de Guisasola F, Casal Llorente C, Rubio C , Betegón L | ||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Cost analysis | |
Health Related Quality of Life of Patients with Type 2 Diabetes in Primary Care in Spain: Self-reported and Proxy Assessment using the EQ-5D. | ||||
Boye K S, Yurgin N, Dilla T, Cordero LA, Badia X, Lara Suriñach L, Perez P | ||||
J Med Econ 2007;10:41-58 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Quality of life | |
Health Related Quality of Life of Patients with Type 2 Diabetes in Primary Care in Spain: Self-reported and Proxy Assessment using the EQ-5D. | ||||
Boye K S, Yurgin N, Dilla T, Cordero LA, Badia X, Lara Suriñach L, Perez P. | ||||
J Med Econ 2007;10:41-58 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Quality of life | |
Quality of life in growth hormone deficiency and acromegaly | ||||
Webb S, Badia X | ||||
Endocrinol Metab Clin N Am 2007;36:221-32 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2007 | English | , Quality of life | |
Treatment of acromegaly improves quality of life, measured by AcroQol | ||||
Paisley AN1, Rowles SV1, Roberts ME1, Webb SM2, Badia X3, Prieto L4,Shalet SM1, Trainer PJ1 | ||||
1 Department of Endocrinology, Christie Hospital, Wilmslow Road, Manchester, UK, 2 Hospital Sant Pau, Autonomous University of Barcelona, Padre Claret, Barcelona, 3 Health Outcomes Research Europe Group, Barcelona, Spain, 4 HealthOutcomes Consultant, Madrid, Spain | ||||
Clin Endocrinol (Oxf). 2007;67(3):358-62 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2007 | English | , Quality of life | |
Changes over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study) | ||||
Garrigues V, Mearin F, Badia X, Balboa A, Benavent J, Caballero A, Domínguez E, Díaz-Rubio M, Roset M, Figueras M, Cucala M and RITMO Group | ||||
1 Digestive Medicine Department, Hospital Universitari La Fe, Valencia, Spain 2 Institute of Functional and Motor Digestive Disorders, Centro Médico Teknon, Barcelona, Spain 3 Health Outcomes Research Europe, Barcelona, Spain 4 Centro de Atención Primaria Clinic, Barcelona, Spain 6 School of Medicine, Granada, Spain 7 Gastroenterology Department, Hospital Universitario de Santiago de Compostela, Spain; 8 Hospital Clínico de San Carlos, Madrid, Spain 9 Novartis Farmace´utica, Barcelona, Spain | ||||
Aliment Pharmacol Ther 2007;25(3):323-32 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17217445 | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2007 | English | , Observational study | |
Treatment cost of ulcerative colitis: Is apheresis with Adacolumn cost-effective? | ||||
Panés J, Guilera M, Ginard D, Hinojosa J, González-Carro P, González-Lara V, Varea V, Domènech E, Badia X | ||||
Dig Liver Dis. 2007;39(7):617-25 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2007 | English | , Cost effectiveness | |
A cross-sectional validation of the mini-HIV questionnaire | ||||
Pedrol E, Ortega E, Sanz J, Suárez-Lozano I, Perulero N, García Pulgar MS, Escayola R | ||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2007 | English | , Quality of life | |
Conjoint analysis a technique to develop a questionnaire of treatment preferences in patients with lung cancer | ||||
Perulero N, Cardenal F, Garcia R, Juan O, Vázquez S, Barneto I, Varela C | ||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2007 | English | , Quality of life | |
Evaluación económica de medicamentos biotecnológicos: retos y oportunidades [Economic Evaluation of biotechnological drugs: challenge and opportunities] | ||||
Badia Llach X, Polanco Sánchez C | ||||
Rev Esp Econ Salud 2007;6(6):352-7 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2007 | Spanish | , Economic evaluation | |
From evidence-based medicine to health outcomes research:an approach to reality | ||||
Badia X, Lizán L. | ||||
Rev Esp Econ Salud 2007;6(1):42-44 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2007 | Spanish | , Methodology | |
Is the regulation of the pharmaceutical market justified? | ||||
Vieta A | ||||
Rev Esp Econ Salud 2007;6(5):278-81 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.economiadelasalud.com/Ediciones/65/08_pdf/regulation.pdf | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2007 | Spanish | ||
Impacto en el mercado de las políticas regionales de racionalización de la prescripción farmacéutica en Andalucía [Market impact of regional racionalization policies on pharmaceutical prescription in Andalucia] | ||||
Badia X1, Lara N1, Vieta A1 | ||||
1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain, | ||||
XXVII Jornadas de Economía de la Salud (AES). 2007June 6-8, La Coruña, Spain |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2007 | Spanish | , Market impact | |
Cost-Effectiveness Analysis of Enfuvirtide (ENF) Added to an Optimized Therapy vs an Optimized Therapy Alone in Patients With HIV/AIDS. | ||||
Badia X, Lizan L, Magaz S, Alvarez C, Green J, Serrano D. | ||||
HIV Clinical Trials 2007;8(4):235-45 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Abstract: http://www.druglib.com/abstract/ba/badia-x_hiv-clin-trials_20070700.html | ||||
Condition | Year | Language | Analysis type | |
, HIV AIDS | 2007 | English | , Cost effectiveness | |
Treatment of chronic hepatitis C genotype 1 with Peginterferon Alfa-2a (40KD) plus Ribavirin under routine clinical practice in Spain | ||||
Diago M, Olveira A, Solá R, Romero-Gómez M, Moreno-Otero R, Pérez R et al | ||||
Aliment Pharmacol Ther 2007;25(8):899-906 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2007 | English | ||
Asthma Control in Spain. Do season and treatment pattern matter? ESCASE study. | ||||
Fueyo A, Ruiz MA, Ancochea J, Guilera M, Badia X on behalf of the ESCASE group. | ||||
Respir Med 2007;101(5): 919-924 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2007 | English | ||
Developing a disease specific CushingQoL Questionnaire | ||||
Badia X, Barahona MJ, Glusman J, Pérez P, Webb S | ||||
ISOQOL Conference on Patient Reported Outcomes in Clinical Practice 2007 June 24-26, , Budapest, Hungary |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2007 | English | , Quality of life | |
Diagnostic management of osteoporosis patient attended in primary health care consults in Spain | ||||
Fuentes M, Ferrer J, Grifols M, Badia X, Guilera M | ||||
Semergen 2007;33(2):45-9 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2007 | Spanish | ||
The Patient Card Questionnaire to identify wearing-off in Parkinson disease | ||||
Martinez Martin P, Tolosa E, Hernandez B, Badia X | ||||
Clin Neuropharmacol 2007;30(5):266-75 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2007 | English | , Quality of life | |
Timing between primary symptoms and final diagnosis of patients with memory complains and/or cognitive impairment. [Tiempo entre la aparición de los síntomas y el diagnóstico del médico de atención primaria y el especialista en los pacientes con quejas de memoria y/o deterioro cognitivo] | ||||
Argimón JM, Riu S, Badia X, Cadenas E, Martínez JM. | ||||
Rev Esp Geriatr Gerontol 2007;42(2):75-82 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2007 | Spanish | ||
Clinical management and economic impact of cardiovascular risk factors monitoring in obese and overweight patients in primary care | ||||
Polanco Sánchez C, Franch Nadal J, Layola Brias M, Lara Suriñach N | ||||
Revista Española de Economía de la Salud 2007;6(8):436-46 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2007 | Spanish | , Market impact | |
Factores económicos de los avances en oncología [Economic factors of advances in oncology] | ||||
Faull I1 | ||||
1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain, | ||||
Congreso anual de la SEFH (Sociedad Española de Farmacia Hospitalaria)2007 Septembre 27. Tenerife, Spain |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | Spanish | ||
Final development and validation of the BOMET-QoL questionnaire for assessing quality of life in patients with malignant bone disease due to neoplasia. | ||||
Sureda A, Isla D, Cózar JM, Ruiz M, Domine M, Margelí M, Adrover E, Ramos M, Pastor M, Martín A, Llombart A, Massuti B, Muñoz M, Barnadas A, Fernández J, colomer R, Allepuz C, Gilabert M, Badia X | ||||
J Medical Econ 2007;10:27-39 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Quality of life | |
Questionnaire of treatment preferences in patients with advanced non-small cell lung cancer | ||||
Garcia R, Juan O, Vázquez S, Barneto I, Cardenal F, Varela C, Perulero N | ||||
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Quality of life | |
Resource use and time savings in Spain linked with new chemotherapy presentations: the case of oxaliplatin | ||||
Betegón L, Echevarria A, Soler F, Quer N | ||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Burden of illness | |
Economic evaluation of the postoperative recovery with OrthoPAT® compared to Standard therapy in knee replacement arthroplasty. | ||||
Muñoz Gómez M, Bisbe Vives E, García-Erce JA, Polanco Sánchez C, Badia Llach X. | ||||
PharmacoEconomics-Spanish Research Articles 2007;4(2):45-81 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Orthopedics | 2007 | Spanish | , Economic evaluation | |
Inequalities in the financing of drugs among autonomous regions in Spain | ||||
Badia X1, Vieta A1 | ||||
1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain, | ||||
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Pricing and reimbursement | 2007 | English | ||
Aplicación del análisis coste utilidad en estudios de EPOC [Applicability of cost-utility analysis in COPD studies] | ||||
Badia X | ||||
II Reunión del Grupo EPOC de la Sociedad Española de Medicina Interna (SEMI)[II Meeting of the COPD Spanish Internal Medicine Society Group (SEMI).] 2007 May 10-11. Valladolid, Spain |
||||
, Conference | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2007 | Spanish | , Cost utility | |
Validation of the Spanish version of the Asthma Control Test (ACT) | ||||
Vega JM, Badia X, Badiola C, López-Viña A, Olaguíbel JM, Picado C, Sastre J, Dal-Ré R | ||||
Journal of Asthma 2007;44(10):867-72 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18097865?dopt=AbstractPlus | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2007 | English | , Quality of life | |
A microsimulation-based cost-utility analysis of Rituximab (Mabthera®) in patients with rheumatic arthritis in Spain | ||||
Fernández I, Varela C, Badia X, Carreño Á, Polanco C | ||||
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2007 | English | , Cost utility | |
Health Outcome Research and its application in ambulatory major surgery | ||||
Lara N, Badia X | ||||
Cirugía Mayor Ambulatoria 2007;12(4):140-7 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Surgery | 2007 | Spanish | , Quality of life | |
Validation of the Spanish version of the Benign Prostatic Hyperplasia Impact Index Questionnaire. “Validart study” | ||||
Carballido Rodríguez J, Grunfeld Abellán A, Escudero Callen A, Gil Bermejo FJ, Regadera-Anechina L, Badía Llach X | ||||
Actas Urológicas Españolas 2008;32(2):230-239 |
||||
, Article, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Urology | 2007 | Spanish | , Quality of life | |
The effect of cancer drug vintage on cancer survival and mortality. | ||||
IMS Health | ||||
2007 European Society of Medical Oncology |
||||
, Article | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://academic.oup.com/annonc/article/18/suppl_3/iii67/214317/The-effect-of-cancer-drug-vintage-on-cancer | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | ||
Cost Minimization analysis of Bivalirudin versus Heparin plus planned abxicimab in patients undergoing Percutaneous Coronary intervention | ||||
Cequier A, Morís C, Badia X, Lara N | ||||
Rev Esp Econ Salud 2006;5(3):168-76 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2006 | Spanish | , Cost analysis | |
Osteoporosis in clinical daily practice. | ||||
Nogués X, Abizanda M, Carbonell C, Raber A, Balcells M, Roset M. | ||||
XXVI Congreso de la Sociedad Española de Medicina Familiar y Comunitaria (SEMFYC), Valencia (Spain) 15-18 November |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice | 2006 | English | ||
Health system impact of Atopic Dermatitis in Spain in pediatric population. | ||||
García Díez A, García-Patos Briones V, Zambrano Zambrano A, Gonzalez Hachero J, Polanco Allué I, Rodrigo Gonzalo de Liria C. | ||||
, In press/to be published | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2006 | English | ||
Impact of psoriasis on health-related quality of life | ||||
Ferrándiz Foraster C, García-Díez A, Lizán Tudela L, Bermúdez-Rey L, Badía Llach X | ||||
Med Clin 2007;128(9):325-9 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2006 | Spanish | , Quality of life | |
Impact of treatment with agalsidase beta treatment on health related quality of life in patients with Fabry’s disease. | ||||
Badia X, Perez P, Layola M, Checa D, Tutor A, Torra R, Torras J, de Arriba G, García-Moncó C, Puig JM, Torregrosa V. | ||||
13th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Lisbon (Portugal) 11-14 October |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2006 | English | ||
Patient reported outcomes in psoriasis | ||||
García-Díez A, Ferrandiz C, Bermudez-Rey L, Espallardo O, Lizan L, Badia X | ||||
ISPOR 2007 10th Annual European Congress |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2006 | English | , Quality of life | |
Agreement between patient and physician assessment of health-related quality life of patients with type 2 diabetes treated by primary care physicians in Spain. | ||||
Lara N, Secnik K , Yurgin N, Pérez P, Dilla T, Cordero LA, Badia X. | ||||
EuroQol Group Scientific Meeting 2006, Barcelona (Spain) 14-15 September |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2006 | English | ||
Management and treatment adherence in type 2 diabetic patients in Spain | ||||
Secnik K, Yurgin NR, Lara N, Badia X, Dilla T, Cordero LA | ||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2006 | English | ||
Patient and physician drivers of health-related quality of life of patients with type 2 diabetes in primary care in Spain | ||||
Yurgin NR, Secnik K, Lara N, Badia X, Dilla T, Cordero LA | ||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2006 | English | ||
Prevalence of metabolic síndrome in patients with Diabetes Mellitus 2 in Spain. | ||||
Rodríguez A, Polavieja P, García R, Cobo A, Reviriego J, Carreño A. | ||||
XXVI Congreso de la Sociedad Española de Medicina Familiar y Comunitaria (SEMFYC), Valencia (Spain) 15-18 November |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2006 | English | , Epidemiological study | |
Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life? | ||||
Koltowska-Häggström M, Mattsson A, Monson P, Kind P, Badia X, Casanueva F, Busschbach J, Koppeschaar HPF, Johannsson G. | ||||
Eur J Endocrinol;155:109-19 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2006 | English | ||
[Documento de consenso en el uso de la granulocitoaféresis en pacientes con enfermedad inflamatoria intestinal] Consensus document on the use of granulocytapheresis in patients with inflammatory bowel disease. | ||||
Cabriada JL1, Doménech E2, Gomollón F3, González-Carro P4, González-Lara V5, Hinojosa J6, Jiménez-López CE7, Nos P8, Obrador A9, Panès J10, Saro C11, Varea V12, Lafuente R13, Guilera M14. | ||||
1 Hospital de Galdakao. Galdakao. Vizcaya. España. 2 Hospital Germans Trias i Pujol. Badalona. Barcelona. España. 3 Hospital Lozano Blesa. Zaragoza. España. 4 Hospital La Mancha Centro. Alcázar de San Juan. Ciudad Real. España. 5 Hospital Gregorio Marañón. Madrid. España. 6 Hospital de Sagunto. Sagunto. Valencia. España. 7 Hospital Virgen del Camino. Pamplona. Navarra. España. 8 Hospital La Fe. Valencia. España. 9 Hospital Son Dureta. Palma de Mallorca. Baleares. España. 10 Hospital Clínic. Barcelona. España. 11 Hospital de Cabueñes. Gijón. Asturias. España. 12 Hospital Sant Joan de Déu. Esplugues de Llobregat. Barcelona. España. 13 Hospital Creu Roja. L’Hospitalet de Llobregat. Barcelona. España. 14 HOR-Europe. Barcelona. España. | ||||
Gastroenterol Hepatol. 2006;29(2):85-92 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/16448611 | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2006 | Spanish | , Methodology | |
Clinical Practice Guideline for irritable bowel syndrome | ||||
Tort S, Balboa A, Marzo M, Carrillo R, Mínguez M, Valdepérez J | ||||
Gastroenterol Hepatol. 2006;29(8):467-521 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2006 | Spanish | , Methodology | |
Impact of upper digestive symptoms in patients with irritable bowel syndrome. | ||||
Balboa A, Mearin F, Badía X, Benavent J, Caballero A, Domínguez-Muñoz JE, et al. | ||||
Eur J Gastroenterol Hepatol 2006;18(12):1271-7 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2006 | English | , Quality of life | |
Incidence and burden of illness in postoperative paralytic ileus in Spain. | ||||
Badia X, Roset M. | ||||
Med Clin (Barc) 2006;126(14):537-40 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2006 | English | , Burden of illness | |
Prevalence and dietetic management dietético of slight gastrointestinal diseases in breast-fed baby: EDEN Study. | ||||
Infante D, Badia X, Ariño B, Villegas V. | ||||
, In press/to be published | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2006 | English | ||
The Current and Future Burden and Cost of Overactive Bladder in Five European Countries. | ||||
Reeves P1, Irwin D2, Kelleher C3, Milsom I4, Kopp Z5, Calvert N1, Lloyd A1. | ||||
1 Fourth Hurdle Consulting, London, UK 2 Dept of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, NC,US 3 Dept of Obstetrics and Gynaecology, Guy's and St Thomas' NHS Trust, London, UK 4 Dept of Obstetrics and Gynecology, Sahlgrenska Academy at Goteborg University, Goteborg, Sweden 5 Pfizer Inc., New York, US | ||||
European Urology 2006; 50(5): 1050-1057 |
||||
, Manuscript in preparation | ||||
, Germany, Italy, Spain, Sweden, UK | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2006 | English | , Cost of illness | |
Assessing quality of life of rare diseases patients in Spain. ERES STUDY. | ||||
Badia X, Layola M, Pérez P, Avellaneda A, Izquierdo M. | ||||
13th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Lisbon (Portugal) 11-14 October |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2006 | English | ||
Economic evaluation in Spain: current situation. | ||||
Badia X. | ||||
VI Jornada de Seminarios. Health Economics (Revista Española de Economía de la Salud, IESE, Fundamed), Madrid (Spain) 26 October |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2006 | English | ||
Extension and implications of Health Outcomes Research(HOR). | ||||
Badia X. | ||||
XXIV Congreso of the Sociedad Española de Calidad Asistencial (Spanish Society of Quality in Assitance), Toledo (Spain) 24-27 October |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2006 | English | ||
Health outcomes research: economic evaluation of pain. | ||||
Badia X. | ||||
VI expert meeting on socioeconomic issues of pain. Salamanca (Spain) 25 September |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2006 | English | ||
Health-related quality of life in Outcomes Research. | ||||
Badia X. | ||||
VIII Jornadas Conjuntas de las Áreas 9 y 10 de Atención Primaria. The expectations and the achievements: we measure what we do or we do what we measure?, Getafe (Spain) 11 May |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2006 | English | ||
Is it efficient to inform the patient about the new drugs? An economic model for Spain. | ||||
Badia X. | ||||
Forum on ""New challenges for the patients"", Madrid (Spain) 25 October |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2006 | English | ||
Patient-Reported Outcomes (PRO). | ||||
Badia X. | ||||
XXIV Congreso de la Sociedad Española de Calidad Asistencial (Spanish Society of Quality in Assitance), Toledo (Spain) 24-27 October |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2006 | English | ||
Patients and physicians perceptions towards subcutaneous treatment. | ||||
Knobel H, Fumaz CR, Segador A, Lorenzo A, González J, García Pulgar M, Perulero N. | ||||
8th International Congress on Drug Therapy in HIV Infection, Glasgow (UK) 12-16 November |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2006 | English | ||
Premature mortality associated to obesity in Spain: Adjusted Life Years. | ||||
Betegón L, Oliva J, Echevarria A, Badia X. | ||||
XXVI Jornadas de Economía de la Salud (Spanish Association on Health Economy, AES), Toledo (Spain) 23-26 May |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2006 | English | ||
Review of the use of the EQ5D in cost-utility analysis. | ||||
Betegón L, Badia X. | ||||
EuroQol Group Scientific Meeting 2006, Barcelona (Spain) 14-15 September |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2006 | English | , Review | |
Review of the use of the Proxy version of the EQ-5D. | ||||
Lara N, Badia X. | ||||
EuroQol Group Scientific Meeting 2006, Barcelona (Spain) 14-15 September |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2006 | English | , Review | |
Socioeconomic perspective of patient information. | ||||
Badia X. | ||||
Health Law Congress, Madrid (Spain) 19-20 October |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2006 | English | ||
The new patient: the challenges of health and drugs information. | ||||
Badia X, Valentín C. | ||||
H.O.R. Europe, a unit of IMS | ||||
Madrid: MSD y Defensor del Paciente de la Comunidad de Madrid; 1st ed Merck Sharp & Dohme de España S.A, Madrid 2006;13-58 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2006 | English | , Review | |
Towards a better QALY model. | ||||
Abellán-Perpiñán J.M., Pinto-Prades J.L., Méndez-Martínez I, Badia Llach X. | ||||
Health Econ 2006;15:665-76 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2006 | English | , Quality of life | |
Use of EQ-5D questionnaire in economic evaluations | ||||
Betegón L,. Lara N, Badia X. | ||||
XXVII Jornadas de Economía de la Salud (AES). La Coruña 6-8 June |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2006 | Spanish | , Economic evaluation | |
Validation of the patient’s attitudes and perceptions towards HAART questionnaire. | ||||
Fumaz C, Knobel H, Segador A, Lorenzo A, González J, García Pulgar M, Badia X, Perulero N. | ||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2006 | English | ||
Visados de inspección: ¿garantía del uso adecuado de los medicamentos o medida de control del gasto? | ||||
Gutiérrez Nicuesa L, Magaz Marqués S, Badia Llach X. | ||||
Aten Prim;37(5):278-86 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2006 | Spanish | ||
When Direct-to-Patient health and prescription drug information is already a reality through the Internet. | ||||
Badia X, Alonso-Rodríguez Piedra N | ||||
Rev Esp Econ Salud 2006;5(5):272-5 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2006 | Spanish | ||
When the direct to patient information in health and prescription drugs is already a fact through Internet. | ||||
Badia Llach X, Alonso-Rodríguez Piedra N. | ||||
Rev Esp Econ Salud 2006;5(5):272-5 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2006 | English | ||
Mortalidad prematura vinculada a la obesidad en España: Años Potenciales de Vida Perdidos. | ||||
Betegón L, Oliva J, Echevarria A, Badia X. | ||||
XXVI Jornadas de Economía de la Salud. Toledo (España) |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2006 | Spanish | ||
Relationship between clinical outcomes and health related quality of life in patients with external genital warts. | ||||
Vilata JJ, Varela JA, Olmos L, Colombo JA, Llorens MA, Badia X. | ||||
5th Congress of the European Academy of Dermatology and Venereology-EADV, Rodhae (Greece) 4-8 October |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2006 | English | ||
Quality of life and social functioning in schizophrenic patients treated with olanzapine: 1 year follow-up naturalistic study. | ||||
Mayoral F, Montejo AL, Bousoño M, González-Torres MA, Olivares M, Ros S, et al. | ||||
Actas Esp Psiquiatr 2006;34(1):7-15. |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2006 | English | , Quality of life | |
Direct to Patient Information on prescription drugs: economic and health impact in public health in Spain. | ||||
Badia X. | ||||
Press lunch organized by MSD on DTPI 2006 6 July, Madrid, Spain |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2006 | English | , Review | |
Quality of life: definition and concepts. | ||||
Badia X, Lizán L. | ||||
Martínez Martín, P. Quality of life in neurology. Barcelona: Ars Medica, 2006. p. 3-18 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2006 | English | , Quality of life | |
Does an educational leaflet improve self-reported adherence to therapy in osteoporosis? The OPTIMA study. | ||||
Guilera M, Fuentes M, Grifols M, Ferrer J, Badia X. | ||||
Osteoporos Int. 2006;17(5):664-71 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2006 | English | , Observational study | |
The use of the EQ-5D in patients with osteoporosis. | ||||
Cadenas E, Perulero N, Lizán L, Badia X. | ||||
EuroQol Group Scientific Meeting 2006, Barcelona (Spain) 14-15 September |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2006 | English | , Quality of life | |
Las preocupaciones en salud de las mujeres con osteoporosis: su satisfacción y adherencia con el tratamiento. [The worries in health of the women with osteoporosis: its satisfaction and adherence with the treatment] | ||||
Ferrer J, Fuentes M, Grifols M, Perulero N, Badia X. | ||||
Rev Esp Enferm Metab Oseas. 2006;15(1):1-7. |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2006 | Spanish | , Quality of life | |
Clinical management of patients with complaints of memory decline and/or cognitive impairment in primary care in Spain. | ||||
Argimon JM, Riu S, Badia X, Lara N, Martínez J. | ||||
, In press/to be published | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2006 | English | ||
Cost minimisation analysis of antiepileptic drugs in Spain | ||||
Rubio M, Lizán L, Badia X, Escartín A, López-Trigo J, Rufo M, Echarri E. | ||||
Rev Neurol 2006;42(5):257-64 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2006 | Spanish | , Cost minimization | |
Initial management of patients with subjective complaints on memory and/or cognitive impairment in Primary Care. | ||||
Argimón JM, Riu S, Lizán L, Badia X, Martínez JM. | ||||
ISSEA Study. |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2006 | English | ||
Initial treatment of patients with subjective memory complaints and/or cognitive impairment in primary care: ISSEA Study | ||||
Argimón Pallás J, Riu Subirana S, Lizán Tudela L, Badia Llach X, Martínez Lage JM | ||||
Aten Prim 2007;39(4):171-9 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2006 | Spanish | , Epidemiological study | |
The Quick questionnaire identifies wearing-off in Parkinson's Disease patients. Validquick study | ||||
Martínez-Martín P, Tolosa E, Hernández B, Badia X | ||||
11th International Congress OF Parkinson's Disease and Movement Disorders. Istambul 3-7June |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2006 | English | , Quality of life | |
Costs of premature death attributed to obesity in Spain. | ||||
Echevarria A, Betegón L, Badia X. | ||||
ISPOR 11th Annual International Meeting. Philadelphia, Pennsylvania (USA) |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2006 | English | , Burden of illness | |
A comparative budget impact (BI) analysis of Aranesp® (darbepoetin alfa) 500µG Q3W versus other erythropoiesis stimulating proteins (ESP) in chemotherapy-induced anemia (CIA) in Spain | ||||
Pérez Alcàntara F, Badia X, Arocho R | ||||
1Health Outcomes Research, Barcelona, Barcelona, Spain, 2 Health Outcomes Research Europe, IMS Health, Barcelona, Spain, 3Amgen SA, Barcelona, Barcelona, Spain | ||||
ISPOR 9th Annual European Congress, 28-31 October 2006, Copenhagen, Denmark |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.ispor.org/congresses/denmark1006/posters2.asp#Cancer | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Budget impact | |
Cost analysis of febrile neutropenia management of breast cancer patients in clinical practice in Spain. | ||||
Mayordomo JI, Castellanos J, Pernas S, Ruiz-Borrego M, Velasco A, Frau A, Lamas MJ, Lara N. | ||||
31st European Society of Medical Oncology congress (ESMO), Estambul (Tukey) 29 Septiember-03 October |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Burden of illness | |
Cost effectiveness of cetuximab in combination with radiotherapy versus radiotherapy alone in the treatment of locally advanced head and neck cancer in Spain | ||||
Brosa M, Robinson P Brown B | ||||
Max Brosa, , Director1, Paul Robinson, BSc, MSc, Senior Economist2, Ben Brown, MSc, Economist21Oblikue Consulting, Barcelona, SC, Spain; 2 IMS Health Economics & Outcomes Research, London, United Kingdom | ||||
ISPOR Ninth Annual European Congress Copenhagen, Denmark October, 2006 |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Cost effectiveness | |
Cost of febrile neutropenia management in cancer patients in Spain. | ||||
Mayordomo JI, Lopez A, Viñolas N, Castellanos J, Pernas S, Alonso JD, Frau A, Layola M, Gasquet JA, Sanchez JA, on behalf of the ENIA Study Group. | ||||
American Society of Clinical Oncology (ASCO) Annual Meeting 2006, Atlanta (GA, US) 2-6 June |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Burden of illness | |
Economic evaluation of surgical treatment vs. Imiquimod 5% cream in patients with Superficial Basal Cell Carcinoma | ||||
Vanaclocha F, Badia X, Guillén V, Sánchez J, Sáinz de los Terreros M, Llorens MA. | ||||
Br J Dermatol. 2007 Apr;156(4):769-71. |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www3.interscience.wiley.com/journal/117983521/abstract?CRETRY=1&SRETRY=0 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Oncology | 2006 | English | ||
Economic evaluation of treatments for non-microcytic lung cancer | ||||
Alberola V, Antón A, Carrato A, Cortés-Funes H, Guillem V, Le Lay K, et al. | ||||
Rev Esp Econ Salud 2007;6(4):242-9 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | Spanish | , Economic evaluation | |
Validity of tests for initial diagnosis and its concordance with final diagnosis in patients with suspected benign prostatic hyperplasia | ||||
Carballido J, Badia X, Gimeno A, Regadera L, Dal-Ré L, Guilera M | ||||
Actas Urol Esp 2006;30(7):667-4 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | Spanish | , Quality of life | |
Impact of an inspector's stamp approval policy into the atypical antipsychotic market in andalusia (Spain) | ||||
Badia X, Vieta A, Lara N, Giménez E | ||||
ISPOR 2007 10th Annual European Congress |
||||
, Abstract | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Pricing and reimbursement | 2006 | English | ||
Cost of scheduled and unscheduled asthma management in seven EU countries. | ||||
Williams AE1, Lloyd AC2, Watson L1, Rabe KF3. | ||||
1 GlaxoSmithKline R&D, Greenford, 2 Fourth Hurdle Consulting Ltd, London, UK. 3 Leiden University Medical Centre, Leiden, The Netherlands | ||||
European Respiratory Review 2006; 15:(98): 4–9 |
||||
, Manuscript in preparation | ||||
, France, Germany, Italy, Netherlands, Spain, Sweden, UK | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2006 | English | , Burden of illness | |
Diagnosis of allergic asthma in allergy and pneumology outpatient clinics. | ||||
Borderías L, García-Ortega P, Badia X, Casafont J, Gambús G, Roset M, y el Grupo Prevalair. | ||||
Gac Sanit 2006;20(6):435-41 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2006 | English | ||
Efficiency of influenza vaccination in the working population in Spain. | ||||
Juanes JR, Cisterna R, Sanz J, Magaz S, Badia X. | ||||
Gac Sanit 2006;20(2):101-7 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2006 | English | ||
Study of flu costs. | ||||
Badia Llach X, Roset Gamisans M, Francés Tudel JM, Álvarez Sanz C, Rubio Terrés C. | ||||
Aten Primaria 2006;38(5):260-7 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2006 | English | , Burden of illness | |
Annual treatment costs of patients with rheumatoid arthritis with metotrexate and leflunomide in spain. | ||||
Rebollo P , Prieto L, Garcia A , Betegón L , Echevarria A | ||||
ISPOR 2007 10th Annual European Congress |
||||
, Abstract | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2006 | English | , Cost of illness | |
Development and validation of a satisfaction with treatment questionnaire in patients with rheumatoid artritis. | ||||
Carbonell J, Badia X and Grupo Expressar. | ||||
Reumatol Clin 2006;2(3):137-45 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2006 | English | , Quality of life | |
Clinical and economic evaluation of fondaparinux vs. enoxaparin in the prophylaxis of major orthopedic surgery. | ||||
Slof J, Badia X. | ||||
Pharmacoeconomics-Spanish Research Articles 2006;3(2):75-88 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Surgery | 2006 | English | ||